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The aminobenzoquinone mitomycins and the dihydrobenzoxazine FR compounds are 
potent antitumor antibiotics.  Despite structural differences, the compounds are reductively 
activated to analogous reactive metabolites known as leucoaziridinomitosenes.  
Leucoaziridinomitosenes contain two electrophilic sites at the C(1) and C(10) positions which are 
selectively attacked by two guanosines on complementary strands of DNA, thereby resulting in 
cross-link formation and cell death.  Much has been learned about the complex mechanism of 
action of these compounds, but a better understanding of their mechanisms of action and 
biological origins is required in order to produce more potent and less cytotoxic synthetic 
analogs. 
 The leucoaziridinomitosene derived from the semisynthetic derivative FK317 was 
targeted for total syntheses.  The tetracyclic core of the target was accessed via intramolecular 
Michael addition of a chiral lithioaziridine into a vinylogous amide.  Temporary protection of a 
stabilizing formyl group, reduction of an enoate, and subsequent transformation of the resulting 
alcohol provides the free C(10) carbamate.  The C(10) carbamate of the intact 
leucoaziridinomitosene proved to be extremely labile as it was lost under acidic, basic, and 
neutral conditions which were explored to remove the final aziridine protecting group.  
Surprisingly, in contrast to the mitomycin leucoaziridinomitosenes, C(10) heterolysis of the FR 
leucoaziridinomitosenes was more facile than C(1) heterolysis. Nonetheless, a fully 
functionalized leucoaziridinomitosene derivative of FK317 was obtained. 
 In order to probe the related biosynthetic pathways of mitomcyin C and 
FR900482, a mitosane derivative that could be a common precursor of both structural families 
was targeted for synthesis.  Multiple strategies for tetracycle construction focused on addition of a 
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lithioaziridine into an appropriate electrophile.  The successful strategy employed a palladium 
catalyzed coupling of a 3,6-diazabicyclo[3.1.0]hexan-2-one to a functionalized aryl triflate, 
followed by diastereoselective cyclization to the desired stereoisomer of the tetracycle via 
carbanion addition into an appended lactam.  The top face of the tetracycle is blocked by the large 
aziridine protecting group, which should facilitate diastereoselective reductive cleavage of a C(9) 
leaving group from the bottom face of the tetracycle to form the required C(9) stereochemistry.  
These studies culminated in the successful synthesis of a fully functionalized 9-oxo-





The Antitumor Antibiotic Mitomycins and FR Compounds 
 
The Anticancer Antibiotic Mitomycin Family 
The mitomycins are a well known family of natural products first discovered in the 1950s 
which exhibit antitumor and antibiotic activity.  Mitomycin A and B (Figure 1-1, 1,2) were 
isolated in 1956 by Hata and coworkers from the fermentation broth of Streptomyces 
caespituous.1 Two years later, Wakaki and coworkers isolated mito ycin C (3) from the 
fermentation broth of the same organism (Figure 1-1).2  The methylated analog of 3 named 
poriformycin (4) was isolated from Streptomyces verticillatus.3   These four natural products 
represent the first known examples of the mitomycin family.  
The structure of the mitomycins is quite unique among anticancer antibiotics.  Structure 
elucidation studies of 1 using chemical degradation, UV spectroscopy,4 and X-ray 
crystallography5 showed the presence of an aziridine ring fused to a pyrrolo[1,2a]indole and 
aminobenzoquinone.  Since 1 could be converted into 3 upon treatment with methanolic 
ammonia,4a structures 2-4 were assigned by analogy.  The unique scaffold of 1-4 was later 
confirmed by Kishi’s total syntheses,6 and the absolute stereochemistry was revised in 1983 using 
X-ray dispersion techniques.7  These compounds were the first examples of aziridine containing 
natural products, and currently there are over 1000 synthetic analogs.8   
The structurally unique fused aziridine pyrrolo[1,2-a]indole aminobenzoquinone core 
leads to a highly complex mechanism of action respon ible for cellular toxicity.  In order to 
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understand the relationship between structure, antitumor activity and mechanism of action, the 
mitomycins have been the subject of intense study over the past half century.9  
 
Figure 1-1. Mitomycins A, B, C and Poriformycin 
 During initial bioactivity studies it was found that both 1 and 3 had good antitumor 
activity in vivo with dose ranges between 8-1000 µg/kg.1,2  However, the LD50 values for 1 and 3 
in mice were found to be 2.0 mg/kg and 5.0 mg/kg respectively; therefore, 3 is considered the 
“safer” cytotoxic agent.  Ultimately, 3 became the best mitomycin candidate for clinical tri ls.10  
It was found that hypoxic cancer cells (low O2 tension and a reducing environment) are 
particularly sensitive to 3 at low doses,11 while non-hypoxic cancer cells and non-cancerous cell  
also become sensitive to 3 at higher dose levels.12  Since these initial activity studies, the effective 
dose ranges and dosing schedule for 3 have been optimized, and mitomycin C has been shown t  
be clinically effective in treatment against a number of cancers.13  However, even at therapeutic 
doses 3 can cause bone marrow suppression and gastrointestinal damage.  Consequently, it is 
generally used as a last resort against cancers that do not respond well to more conventional 
treatments such as radiation.  Therefore, Mitomycin C, marketed by BMS as Mutamycin®, has 
been a chemotherapeutic agent for the past forty years and is still used to treat breast, non-small 
cell lung, and head and neck cancers when used in combination therapy.14  
An ultimate goal of the study of the mitomycins is the generation of synthetic analogs 
that have better selectivity for cancerous cells over non-cancerous cells but without the severe 
toxic side effects.9b,9c,11  Achieving this goal is unlikely without a thorough understanding of the 
mechanism of action of these structurally unique heterocycles.  A multitude of mechanistic and 
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metabolite characterization studies show that the mechanism of action is quite complex.  Four 
main metabolites of 3 have been isolated upon exposure of DNA to 3 in cell cultures, and under 
various conditions in vitro.  The main metabolites isolated are the bis-alkylated DNA lesion 5,15 
the monoalkylated DNA lesions 616 and 7,17 and a reduced species 2,7-diaminoaziridinomitosene 
818 (Scheme 1-1).  The formation of each metabolite is indicative of a different form of activation 
of the mitomycin.  Therefore, the mechanism of activation leading to and the formation of each 
species will be discussed separately below. 
Scheme 1-1. Main DNA adducts of 3 
 
Events Leading to DNA Cross-linking by Mitomycin C 
 Mitomycin C is a highly active anticancer and antibacterial agent due to its ability to 
form interstrand DNA cross-links.  Although the reduction of the aminobenzoquinone of the 
mitomycins can lead to the generation of destructive super oxide radicals, hydrogen peroxide, and 
hydroxy radicals which cause single strand breakage,19-21 the cytotoxic event leading to cellular 
death is actually the formation of interstrand DNA cross-links.22 Interstrand cross-links impede 
the replication fork and thereby halt replication of the DNA, ultimately resulting in cell death.23  
These cross-links result in thermally stable double stranded DNA that “spontaneously” reanneals 
under denaturing conditions.    However, mitomycin C does not react with purified DNA until it 
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has been activated with a reducing enzyme or chemical reductants via a 2 electron reduction or 
two 1 electron reductions.22-25 Once the mitomycin is reduced, a mechanistic cascade initially 
proposed by Iyer and Szybalski is started that ultima ely leads to a metabolite capable of cross-
linking DNA (Scheme 1-2).24  Initial 2 electron reduction of 3 leads to the hydroquinone 
leucomitomycin  9.  Loss of the angular methoxy group followed by tautomerization to the indole 
forms the leucoaziridinomitosene 10 (so named due to loss of the methanol from C(9) and 
C(9a)).4a,24,26  In metabolite 10, the two latent electrophilic sites of 3, the aziridine and C(10) 
carbamate,26  are activated for heterolysis.   
It has been shown that the C(1) position is the first reactive site27 and derivatives without 
the aziridine present do not retain the described DNA alkylating activity.28  Ring opening of the 
aziridine ring is facilitated by release of ring strain and stabilization of the resulting “benzylic” 
carbocation at C(1) in the quinone methide 11.26  Once the alkylation at C(1) of 11 occurs, the 
C(10) carbamate is displaced in an SN1 manner by the indole nitrogen lone pair.
29,30  The second 
alkylation event can then occur at C(10).   Cross-linking of DNA occurs when an appropriately 
positioned deoxynucleoside of one DNA strand alkylates at C(1) followed by attack at C(10) by a 
deoxynucleoside on the complementary strand.  Thus, the two electrophilic sites at C(1) and 
C(10) of 3 are essential for cross-linking activity.    
 The proposed active metabolite 10 was found to be extremely reactive and unstable.24  
Due to the transient nature of the bis-alkylating metabolite, it cannot be isolated or characterized.  
However, various mechanistic investigations and characterization of the isolated DNA-3 adducts 
provide evidence that supports the proposed mechanism of action.  In efforts to elucidate the 
properties and structure of this bis-alkylating agent, the reactivity of reduced 3 in the presence of 
exogenous nucelophiles was investigated.  Hornemann and coworkers found that reduction of 3 
with Na2S2O4 in the presence of potassium ethylxanthate provided th  bis-alkylated products 15b, 
16b and monoalkylated products 15a and 16a (Scheme 1-3).31  The monoadduct was favored with 
fewer equivalents of the reducing agent, and it could be converted to the bis-adduct upon 
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retreatment with Na2S2O4.  This was the first chemical evidence that the reduc d mitomycin could 
alkylate at both the C(1) and C(10) positions.  Furthermore, the adducts were isolated in 
approximately a 1:1 cis:trans ratio suggesting that ring opening of the aziridine is an acid 
catalyzed SN1 process.  
Bean and Kohn found that ethyl monothiocarbonate was also an effective nucleophile for 
C(1) and C(10) attack (Scheme 1-3, 15c, 15d, 16c, 16d).32  They could favor monoadduct 
formation to give 15c and 16c by lowering the temperature.  Again, the isolation of both cis and 
trans isomers supports SN1 ring opening of the aziridine.  Although these studies showed that 
C(1) and C(10) acted as electrophilic sites under reductive activation, the isolation and 
characterization of a cross-linked DNA adduct by Tomasz in the 1980s finally confirmed the 
mechanistic proposal made twenty years earlier.15a 




Scheme 1-3. Mono- and Bis-alkylation of reduced 3 with exogenous nucleophiles 
 
The cross-linked DNA lesion 17a was obtained upon reduction of 3 with Na2S2O4 in the 
presence of Micrococcus luteus DNA.15a  Analysis of the peracetylated lesion 17b by 1H NMR 
spectroscopy, UV spectroscopy and FTIR showed that C(1) and C(10) had been attacked by the 
exo amino (N2) moiety of two deoxyguanosines (Figure 1-2).  Notably, Iyer and Szybalski 
reported in earlier studies that DNA with a higher p rcentage of CG base pairs had a greater 
occurrence of cross-link formation.24 Furthermore, three independent studies confirmed that
cross-link formation is specific for the 5′CG3′ sequence.33-35  Using computer constructed 
molecular models and examination of the van der Waals contacts Tomasz and coworkers 
observed a snug fit of the tetracyclic core of 3 into the minor groove of DNA resulting in only 
minor perturbation of the backbone.15a  Surprisingly, Tomasz and coworkers found that 
reductively activated 3 can form intrastrand cross-links at the 5′GpG3′ sequence in vitro; 
however, there is a preference for interstrand cross-link formation (Figure 1-2).15b  Thus, the long 
awaited isolation of the bis-alkylated DNA lesion of mitomycin C gave direct chemical proof of 





Figure 1-2. DNA lesion of 3, and schematic of interstand and intrastrand cross-linking. 
Isolation of the DNA lesion cross-link confirms tha reductively activated mitomycin C is 
a bis-alkylating agent at C(1) and C(10) capable of cr ss-linking complementary strands of DNA.  
However, the oxidation state of the bis-alkylating agent formed in the activation cascade of 3 has 
been the subject of much debate.  Iyer, Szybalski, and others proposed that upon 2 electron 
reduction the nitrogen lone pair of the leucomitomycin facilitates expulsion of the angular 
methoxy group via iminium ion formation to start the activation process.22-26,36 However, 1H 
NMR studies by Danishefsky showed that the leucomitomycin 19 formed upon hydrogenation of 
mitomycin 18 in pyridine does not spontaneously expel methanol t  form the 
leucoaziridinomitosene 20 (Scheme 1-4).25,37  Furthermore, subsequent oxidation of 19 by air 
affords the parent mitomycin 18 without noticeable degradation.37  When the 1 electron reducing 
agent ascorbic acid was used for reduction of 18, the quinone 23 which had lost methanol was 
isolated upon air oxidation.38  Initial formation of the semiquinone radical anio 21, followed by 
loss of methanol and rearrangement would provide the semiquinone radical 22.  Finally, 
oxidation of 22 affords the observed product 23.38  This mechanism for expulsion of the angular 
methoxy group at the quinone anion radical oxidation state was supported by Kohn’s 
observations that loss of methanol occurred upon 1 electron reduction of 3 in polar protic solvents 
under anaerobic conditions.39  
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Scheme 1-4. One electron reduction to initiate the activation cascade of N-methylmitomycin A
 
During the 1H NMR spectroscopy studies of the reductive activation of the mitomycins, 
Danishefsky and coworkers observed the elusive leucoaziridinomitosene 20.40  Reduction of the 
aziridinomitosene 23 under hydrogenation conditions in pyridine provided the unstable 20.  
Fortunately, 20 could be trapped as the isolable bis-triethyl silyl ether 24. Notably, the successful 
generation of the putative bis-alkylating agent 20 allowed further mechanistic studies on the 
activation of the mitomcyins.     
Since the semiquinone 21 was implicated in the expulsion of the C(9a) angular methoxy 
and therefore the start of the activation cascade, studies have tried to elucidate the possible role of 
the semiquinone in the alkylation events.  Danishefky ound that the leucoaziridinomitosene 20 
was not an efficient bis-alkylating agent when treated with potassium ethyl xanthate under 
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aqueous pyridine conditions.  However, reduction of 23 using catalytic Na2S2O4 did result in high 
yields of the alkylated products in aqueous pyridine.40  Crothers et. al. found that two electron 
reduction of 18 in the presence of DNA, followed by 1 electron oxidation with FeCl3 under 
anaerobic aqueous conditions provided a species that was a more efficient cross-linking agent 
than 20.41  Importantly, the possibility that the hydroquinone is also a bis-alkylating agent was not 
ruled out.  However, controlled electrochemical reduction to either the semiquinone or the 
hydroquinone of 3 in dimethylformamide (DMF) showed that the semiquinone was more stable 
than the hydroquinone25 consistent with Danishefsky’s observation of the instability of 20.   Thus, 
evidence has been provided that the leucoaziridinomitosenes at the hydroquinone oxidation state 
are too unstable and too inefficient as an electrophile to be the main bis-alkylating agent 
responsible for DNA cross-link formation.41   
Although the hypothesis that the bis-alkylating agent is at the semiquinone oxidation state 
(22) is quite intriguing, it has not been unambiguously confirmed.  Other analytical methods used 
during the reductive activation of the mitomycins do not substantiate claims of semiquinone 
radical formation during ring opening of the aziridine; however, they do not discount the 
formation of semiquinones such as 21 or 22 in vivo.42  Another puzzling observation by Hoey 
showed that dismutation of the semiquinone to the hydroquinone occurs before ring opening of 
the aziridine under aqueous buffer conditions.43  These inconsistencies may be due to the use of 
organic media instead of physiological conditions during Danishefsky’s and others work.  As a 
result of the various observations, the debate about which oxidation state of the activated 3 is 
responsible for cross-linking is still ongoing.  
Monoalkylation of DNA by Mitomcyin C 
Many efforts were made to confirm the bis-alkylating ature of the reduced mitomycins 
as described above; however, cross-link formation is only one example of how mitomycins can 
cause DNA damage.  Early studies with radioactively labeled 3 showed a greater amount of 
interaction of the drug with DNA than would be accounted for by the rare cross-link formation 
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proposed by Iyer and Szybalski.44  In fact, monoalkylation of DNA is actually 10-20 times more 
prevalent than the lethal DNA cross-link.44  Additionally, monoalkylated adducts block DNA 
polymerases from synthesizing DNA, and therefore, the monoadducts have moderate 
cytotoxicity.45   
Reductively activated 3 is monoalkylated selectively by the exo amino (N2) group of a 
deoxyguanosine nucleotide at the 5′CG3′ sequence (Figure 1-3, 6).46  The high selectivity for this 
sequence is due to hydrogen bond formation between the C(10) O of 3 and a 3′ deoxyguanosine 
in the 5′CG3′ sequence, which directs the C(1) electrophilic site into the correct proximity for 
attack by a 5′ deoxyguanosine on the complementary strand.34,47  The adjacent 3′ nucleotides 
downstream of the sequence also have a moderate to slight influence on monoalkylation 
selectivity of 5′CGN3′ sequences (C>T>G>A47 or G>T, C>A48) although the exact selectivity has 
not been agreed upon.  It is proposed that the high selectivity of the monoadduct for 
deoxyguanosine bases downstream of deoxycytosine bas s is necessary for the sequence 
specificity of cross-link formation (Figure 1-3).47  
 
Figure 1-3. Monoalkylated adduct 6 and schematic of precomplexing hydrogen bonding 
Since cross-link versus monoadduct formation is one of the factors determining the extent 
of toxicity of the mitomycins, an understanding of the factors that influence the formation of 
either DNA adduct is essential.   Tomasz and coworkers observed the product distribution of the 
DNA adducts of 3 under various reduction conditions (Scheme 1-5).27  It was found that product 
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distribution is dependent on the reduction kinetics, the presence of O2, and pH.
49  Tomasz and 
others observed that the monoalkylation pathway proceeds under autocatalytic conditions.50  
Thus, in the presence of catalytic amounts of reductant, the bis-alkylating hydroquinone (or 
semiquinone) 10 is oxidized by excess 3 to form the leucomitomycin 9, which loses methanol to 
reform 10, and the aziridinomitosene 25.  Aziridinomitosene 25 is activated for alkylation at C(1), 
but not C(10).  Attack at C(1) by N2 of the deoxyguanosine forms the monoadduct 6. However, 
in the presence of larger amounts of reducing agent and at low pH, the formation of 6 was 
essentially shut down.  It is known that cross-link formation is favored at acidic pH.17b,35,51  
Therefore, under acidic conditions excess reducing agent or enzyme allows the buildup of the bis-
alkylating agent 10 which can then follow the bifunctional pathway to provide 14 and 26.    
Importantly, the bis-alkylation pathway is shut down and the monofunctional pathway is 
promoted by bubbling O2 through the system, implicating reoxidation of the monoadduct 12 
before elimination of the C(10) carbamate occurs.27  Additionally, the monoadduct 25 can be 
reactivated as a cross-linking agent with Na2S2O4 to form the cross-link adduct 14,
27 although this 
















































































Aziridinomitosenes such as 25 were first isolated by Patrick and coworkers as 
degradation products of the parent mitomycins.36  Consistent with the mechanistic outline 
presented above, they were found to have similar rectivity patterns to the parent mitomycins 
under reductive conditions.  In contrast to the parent mitomycins however, they are more 
susceptible to C(1) solvolysis with  a half life of only 3 min at pH 7.0 (Scheme 1-6: 27a,27b).52  
Furthermore, 25 can monoalkylate DNA in vitro without reductive activation (27c).53 However, 
the C(10) carbamate of 25 is not activated for alkylation as shown by the formation of 27d upon 
treatment of 25 with aniline at high pH.54  Therefore, monofunctionalization of aziridinomitosene 
25 at C(1) is favored at high pH in the presence of a strong nucelophile.   
13 
 



















27 a Nuc = OH
27 b Nuc = OMe, OEt
27 c Nuc = DNA
27 d Nuc = aniline
25
 
Activation of the C(10) carbamate of the mitomycins and aziridinomitosenes is required 
for formation of DNA cross-links.  Evidence suggests that the activation at C(10) occurs by an 
SN1 mechanism via the stable hydroquinone iminium ion 13 (Scheme 1-5).
29  Displacement of the 
C(10) carbamate is favored at the hydroquinone stage due to the  increased electron density of the 
hydroquinone and mitosene nitrogen.  On the other hand, consistent with the mechanism for 
monoalkylation described above, displacement of the carbamate of the quinone via an SN1 
mechanism would be inhibited due to the presence of the strong electron withdrawing quinone.  
The SN1 mechanism of alkylation at C(10) is supported by the observation that the 10-
decarbamoyl analog of 3 cannot form DNA cross-links upon reductive action27 thereby implying 
that a good leaving group at C(10) such as carbamate is necessary. 
Formation of 2,7-Diaminomitosene and its DNA adduct 
The third major metabolite of DNA alkylation with 3 is the ring opened product 2,7-
diaminomitosene (2,7-DAM) (8) and its monofunctional DNA adduct 7 (Scheme 1-7).17,18,55  
Exclusive formation of 8 is observed at low pH (5.5) in the absence of nucelophi es via an 
electrophilic substitution process.54  Under acidic conditions, the quinone methide 11 is capable 
of trapping a proton at C(1) due to the electron desity of the C(5) phenol.  This tautomerization 
restores the quinone functionality, thereby affording 8.  However, in the presence of strong 
nucleophiles such as aniline or DNA, the quinone methid  is trapped at C(1) and then the trapped 
metabolite is funneled to cross-link or monoalkylation pathways.49  The propensity for trapping of 
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11 by nucelophiles suggests that formation of 2,7-DAM occurs if 11 is not close enough to DNA 
for cross-link formation.54     
Scheme 1-7. Formation of the 2,7-DAM  8 and the DNA monoadduct 7.
 
Formation of 2,7-diaminomitosene and subsequent alkylation at C(10) to form 7 was 
found to be the major pathway of reductive metabolism of the mitomycins.55,56  The adduct 7 was 
first observed by Prakash et. al..17b They noted that the new adduct was thermally labile, and in 
stark contrast to the other DNA adducts, lesion 7 was formed by alkylation of the less reactive 
C(10) moiety by the N7-amine of deoxyguanosine (Scheme 1-7, 7) in the major groove of the 
double helix.17b  The monoadduct 7 is obtained by treating 3 or 8 and DNA in vitro with the two 
electron reducing enzyme DT-diaphorase at pH levels b low 7.  As described above, this 
observation suggests that 8 is a metabolite of 3, which upon further reduction is reactive at C(10) 
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for monoalkylation.  Significantly, it was found that the C(10) carbamate of the reduced 2,7-
DAM is displaced by the strongly nucleophilic N7 residue in an SN2 process instead of a SN1 
process.17a  Furthermore, formation of 8 was promoted at low 3:DNA ratios in in vitro model 
studies.  DNA adduct 7 is responsible for much of the damage induced by 3; however, it is less 
cytotoxic towards cells under hypoxic and aerobic conditions than the analogous adducts of 
mitomycin C.56  Consequently, formation of the 2,7-DAM monoadduct 7 is considered a 
detoxification metabolic pathway of the mitomycins.54    
Summary of Mitomycin C Activation 
 Based on the studies of Tomasz, Kohn, Danishefsky and others, the different activation 
pathways for the mitomcyins can be summarized (Scheme 1-8).49  Mitomcyin C is reductively 
activated to the leucomitmycin (or semiquinone) 9 via a one or two electron process.  Loss of 
methanol then provides leucoaiziridinomitosene 10.  At this stage the pathways can diverge 
depending on the conditions.  Under catalytic reduction conditions and high pH, 10 will reduce 3 
and be converted into the aziridinomitosene 25.  Activation of the C(1) electrophilic site and 
subsequent ring opening and alkylation lead to the monoalkylation adducts.  When 3 is fully 
reduced and under acidic conditions, the leucoaziridinomitosene is activated for ring opening.  
Charge delocalization leads to a longer lifetime of the ring opened quinone methide 11, which can 
attack an acidic proton at C(1).  A second reduction o 28 then activates the C(10) position for 
alkylation by the N7 of dexoyguanosines.  In the third pathway, the C(1) position is alkylated by 
the nucleophilic N2 of a deoxyguanosine forming 12, followed by activation of the C(10) 
carbamate and displacement to lead to cross-link 5.  This summary of the three mechanistic 
pathways of 3 is a testimony to the complexity of the activation cascade of the mitomycins in vivo 
and in vitro.  The ultimate goal of understanding the mechanism of action of 3 is to obtain the 
ability to fine tune the specificity and reactivity of DNA alkylating agents in order to design more 




Scheme 1-8. Summary of three activation pathways of mitomycin C. 
 
The Antitumor Antibiotic FR Family of Compounds 
 In the mid 1980’s a new class of compounds was isolated from the fermentation broths of 
Streptomyces sandaensis by scientists at the Fujisawa Pharmaceutical Company during an 
endeavor to find efficient antitumor antibiotics.  The natural product FR900482 29 was isolated 
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as a mixture of isomers that equilibrate when separated.57  Based on chemical derivation, 1H 
NMR studies, and X-ray crystallography the structure was shown to contain a unique 
hydroxylamine hemi-aminal imbedded in a dihydrobenzoxazine core.58  Furthermore, 29 shares 
the unique aziridine and carbamate functionality with the mitomycins, but does not possess the 
bioactive quinone moiety.  A dihydro congener of 29 denoted FR66979 (30) was also isolated 
from S. sandaensis.59  In initial activity studies, 29 was found to have similar or better activity 
than the clinically used mitomycin C against some cancer cell lines, without the severe 
thrombocylopenic and myelosuppressive side effects associated with mitomcyin C.57c,57d  Studies 
also showed that 29 was active against mitomycin C resistant P388.57c  Structural similarities of 
29 and 30 to 3 led to the hypothesis that these novel antitumor antibiotics also form interstrand 
DNA cross-links. Furthermore, it was found that FR900482 inhibits the synthesis of DNA and 
RNA presumably through cross-link formation, but does not induce DNA single strand breakage 
like mitomycin C.60  Due to the equal or better activity and generally weaker side effects, the FR 
compounds were considered viable alternatives to the widely used antitumor antibiotic 3.57d  
 
Figure 1-4. The FR antitumor antibiotics 
 In an effort to increase the efficacy of these antitumor antibiotics, synthetic analogs of 
FR900482 were synthesized and tested.  The triacetyl t d semi-synthetic derivative FK973 (1) 
was the most promising candidate.61  It was found to have better or equal activity and to be more 
stable than 29, and to have better or equal activity with a larger dose range than mitomycin C in 
vitro.62  Comparison studies between 3 and 31 showed that both caused dose dependent inhibition 
of cancerous cells; however, unlike 3 which had full potency immediately upon addition of 
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cancerous cells, 31 required an induction period for efficient activity.63  Furthermore, it was found 
that 31 did not have activity against isolated nuclei.63  These combined results suggest that FK973 
requires activation in the cytoplasm of the cell befor  it can alkylate DNA.  Since 31 was the 
most promising candidate, it was advance to phase 1 clinical studies; unfortunately, FK973 was 
dropped from clinical studies when it was found to induce the severe side effect of vascular leak 
syndrome (VLS).64 
 An understanding of the mode of action of the FR compounds is essential to designing 
analogs that do not cause severe side effects but still retain high levels of activity.  The structural 
similarities of 29-31 to 3 led to the hypothesis that the FR compounds cross-link DNA via an 
aziridinomitosene analogous to that which is formed in the mitomcyin series (Scheme 1-9).  
Fukuyama and Goto proposed that the aziridinomitosene is unmasked by 2 electron reduction of 
the N-O bond to form the benzazocinone 33, followed by subsequent condensation (34), 
dehydration (35), and aromatization (36).65  Heterolytic cleavage of the hydroxylamine hemi-
aminal induced by nucleophilic attack at C(2) has also been proposed,66 although it has not been 
widely accepted.  Isolation of the dihydroindole 39 upon reductive activation of 30 in vitro 
supports the intermediacy of the hemi-aminal 34 and iminium ion 35 en route to the activated 
structure.67  In contrast to the mitomycins the presence of iron salts is required for efficient 
activation of the FR compounds in vitro; the strong reductant Na2S2O4 does not efficiently 
activate the FR compounds in the absence of iron salts.67  Finally, the isolation and 
characterization of the peracetylated DNA lesion of 40 obtained after treatment of DNA with 30 
substantiates the proposal that the FR compounds undergo bioreductive activation to 



































































Figure 1-5. Isolated peracetylated DNA lesion of 30 and schematic of orientation isomers 
 
The lesion 40 shows a high degree of similarity to the DNA lesion f rmed by mitomycin 
C (Figure 1-5).  The C(1) position and C(10) positin are covalently linked to the N2 amine of the 
deoxyguanosine residues, and the dihydrobenzoxazine has been reduced to an indole or mitosene 
(mitomycin nomenclature and numbering).  As expected based on the mitomycin analogy, the FR 
compounds are specific for the 5′CG3′ sequence as shown by inhibition of cross link formation 
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when a deoxyguanosine is replaced by a deoxyinosine.69  Furthermore, cross-links are formed in 
the minor groove, and the distance between the two amine moieties on the guanosines matches 
the distance between C(1) and C(10).70  Williams and Rajski found that two cross-link orientation 
isomers with dramatically different electrophorectic mobilites are also possible (Figure 5).70  
Isolation of the cross-linked lesions proves that DNA-alkylation is, at least in part, responsible for 
the complex biological profile of these interesting heterocycles.   
 As with the mitomycins the FR compounds are also capable of monoalkylating DNA.  
The selectivity for monoalkylation at the 5′CG3′ site is 5-fold less than the selectivity of the 
analogous mitomycin C adduct.71  This decrease in selectivity is indicative of an absence of the 
precomplexing hydrogen bond necessary for the observed selectivity of the mitomycins.  
However, Williams proposes that some selectivity is still present due to a precomplexing 
hydrogen bond between the phenol at C(8) and the N3 group of guanosine on the non-bonding 
strand (Figure 1-6).70  On the other hand, Hopkins attributes the decrease in selectivity of 
monoalkylation to a more reactive quinone methide 41 formed upon ring opening of the aziridine.  
Hopkins proposes the electrophilicity of quinone methide 11 is attenuated by the presence of the 
electron donating phenol, while the lack of the analogous electron density in quinone methide 41 
increases the electrophilicity of the intermediate and therefore reduces its selectivity.71  
Interestingly, mass spectrometry analysis of the monoadducts obtained by Hopkins via thiol 
mediated reduction of 30 showed thiol incorporation consistent with alkylation at C(10).71  
Further studies on this intriguing result suggest tha monoalkylation by the FR compounds is not 
on the cross-linking pathway.  Furthermore, the decreased selectivity of monoadduct formation 
and displacement of the C(10) carbamate of the monoadduct may be factors contributing to the 













































Figure 1-6. Hydrogen bonding facilitating monoalkylation and quinone methides 41 and 11 
The Promising Semi-synthetic Candidate FK317   
 After 31 was dropped from phase 1 clinical trials, a new semi-synthetic analog of 29 was 
advanced.  The semi-synthetic analog FK317 2 is a di-acetylated intermediate which has a 
methoxy group at the C(8) position instead of a phenol (Figure 1-4).72  Reduction of 32 to the 
presumed aziridinomitosene analog is required in order for it to cross-link DNA.  The 2 electron 
reducing enzyme DT-diaphorase present at high levels in some cancer cell lines has been 
implicated as the enzyme responsible for reduction.72  As with 31, FK317 has equivalent or better 
activity than FR900482 and mitomycin C in vivo, and FK317 has activity against multidrug 
resistant cell lines in vitro.72  Initial studies found that FK317 is deacetylated in the cytoplasm of 
the cell before it is bioreductively activated.72c  The deacetylation is a key factor in FK317 
activity against multidrug resistant cells because th  membrane bound efflux p-glycoprotein 
present in cancer cells cannot interact with the metabolite to remove the drug from the cell.72b    
In contrast to FR compounds 29 and 31, FK317 did not lead to VLS in a rat model.73  The 
mode of cell death induced by 29 and 32 has been implicated as a factor leading to VLS.  The
parent 29 induces necrotic cell death at all concentration leve s, and necrotic cell death is marked 
by swelling of the cytoplasm and eventual rupture of the cell membrane.74  Ultimately, cell 
membrane rupture of multiple cells and/or tissues undergoing necrotic cell death leads to 
inflammation responses.  However, FK317 induces necrotic cell death at low doses but apoptotic 
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cell death at high doses.74   In apoptotic cell death, the cytoplasm shrinks and the apoptotic bodies 
that bleb off are engulfed by phagocytes, which prevents inflammation.75  Furthermore, research 
shows that FR900482 enhances the expression of the Bcl-2 protein which inhibits apoptotic cell 
death.74  This switch in mode of cell death is especially intriguing since the proposed active 
structure of 29 and 31 only differ at one carbon (C(8)).   
After multiple studies, various inconsistencies between the mechanism of action of 
FK317 and the other FR congeners, and the mechanism of action of the mitomycins have become 
apparent.  First, FK317 is selective for the 5′CG3′ site, but it cannot undergo precomplexation via 
hydrogen bonding between the C(8) methoxy (mitomycin numbering) and a guanosine nucleotide 
which was proposed for 29 and 30 and which is essential for mitomcyin C.76  The C(8) methoxy 
group cannot donate a hydrogen bond to the N3 position of a guanosine in order to properly align 
the compound for alkylation at C(1).  However, based on the selectivity and reactivity of FK317, 
the methoxy group is sufficiently electron rich to activate the C(1) bond for alkylation (Scheme 1-
10).  Secondly, recent studies on fully synthetic analogs of the FR compounds that contain a 
C(10) hydroxymethyl group show that the C(10) carbamate is not essential for efficient cross-link 
formation.77  Furthermore, recent observations show that monoalkylation followed by DNA-
protein cross-linking in nucleosomal DNA is more prevalent than interstrand cross-linking.78  All 
of these observations suggest that the activation and mechanism of action of the FR compounds 




Scheme 1-10. Activation of FK317 32  
 
Asymmetric Syntheses of Aziridinomitosenes Derived from the FR compounds 
 Multiple strategies have been used for the synthesis of the aziridinomitosene tetracyclic 
core.  Five previously described enantioselective approaches to the tetracyclic core of the 
aziridinomitosenes will be discussed below.  The syntheses presented below fall into one of two 
categories: formation of the aziridine at a late stage, or installation of the intact aziridine early in 
the synthesis.  It is worth noting that the majority of the examples discussed access the 
aziridinomitosene core without the proper oxidation state at C(10) (mitomycin numbering), and in 
only two examples is the deprotected aziridinomitosene obtained.  This reflects the difficulties of 
handling the fully functionalized aziridinomitosenes and is a testimony to the inherent instability 
of these functionally dense tetracycles. 
 Sulikowski and coworkers showcased metal carbene chemistry to form the mitosene core 
(Scheme 1-11).79  They began with conversion of the known chiral pyrrolidine 4580 to the 
deprotected pyrrolidine 46.  Palladium catalyzed amination with 2-bromoiodobenzene 47 
provided the N-arylated pyrrolidine 48.81  Coupling of the aryl bromide with silylketene acetal 49 
provided aryl acetate 50.  Acetate 50 was then converted in 9 steps to the diazoacetate precursor 
carbamate 51.  Carbamate 51 was smoothly converted to the diazoester 52 in good yield.  After 
examining three sets of reaction conditions, it wasfound that treating 52 with copper (I) triflate in 
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the presence of ligand 53 provided good conversion to the mitosenes 54 and 55 (9:1) after 
oxidation with chloranil.  The major regioisomer resulted from carbine insertion via path a, and 
the minor was formed via path b.  The desired isomer 54 was then converted to the tosyl-
protected aziridinomitosene 56 in 3 steps and good yield.  Although this was an intriguing way to 
obtain the mitosene core, many steps were required to install the cis carbamate with the correct 
absolute stereochemistry necessary for diazo transfer on 52.  





















































































 A second approach by Michael and coworkers targets the mitosene by Heck arylation 
chemistry.82 Their synthesis began with the known chiral (–)-2,3-O-isopropylidene-ᴅ-
erythronolactone 57.83  Lactone 57 was converted to N-aryl lactam 58 in good yield over three 
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steps.  Conversion of the amide into the thioamide 59 was followed by conversion into the 
vinylogous amide 60 using an atypical Reformatsky reaction.  Intramolecular Heck arylation, 
originally developed by Rappaport for the synthesis of aziridinomitosenes derived from the 
mitomycins84 using Pd(OAc)2 in the presence of triphenylphosphine and a complex mixture of 
solvent, base and additive, provided the mitosene 61 in excellent yield.  The acetal 61 was 
converted to the azido alcohol 62 over three steps, and then converted into an azido mesylate and 
reduced in the presence of trimethyl phosphite to provide the phosphoramidate 63.  Notably, 
reduction of the mesylate under standard Staudinger conditions afforded an unprotected 
aziridinomitosene 64 described by the authors as unstable.   
Scheme 1-12.  Michael’s Heck arylation to form tetracycle 63
 
 The asymmetric synthesis of the aziridinomitosene core via peptide catalyzed azide 
conjugate addition was reported by Miller in 2004.85  Starting with commercially available 
alcohol 65, Miller synthesized diene 66 in 6 steps (Scheme 1-13).  Ring closing metathesis using 
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ruthenium alkylidene complex 67,86 and subsequent deprotection and oxidation of the allylic 
alcohol provided enone 68.  Tertiary-amine base catalyzed azidation of enone 68 with 
trimethylsilyl azide and a peptide catalyst provided the conjugate addition product 69 in good 
yield and modest enantioselectivity (88% yield, 35% ee).  Conversion of the ketone to the 
mitosene 70 proceeded in moderate yield over four steps.  Bromination to an azido-bromide 
followed by reductive ring closing was unsuccessful as the unprotected aziridinomitosene 71 
proved to be unstable.  However, nitration of the C(6) position followed by bromination and 
reductive ring closing provided the desired unprotected aziridinomitosene 72 in modest yield. 
Scheme 1-13. Miller’s asymmetric synthesis of unprotected aziridinomitosene 72   
 
Ziegler and coworkers targeted an aziridinomitosene by the convergent coupling of an 
indole and aziridine subunit (Scheme 1-14).87  The triflate aziridine 76 was synthesized in 6 steps 
from chiral epoxide 73.88  The glycidate 73 was protected as a silyl ether, ring opened with NaN3, 
and the resulting azido alcohol was cyclized under reduction conditions with PPh3 to provide 74 
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in 57% yield over the three steps as a separable mixture of trans:cis isomers (12:1).  The trans 
isomer of 74 was protected with di-tert-butyl dicarbonate to provide the protected aziridine 75.  
Removal of the silyl ether with TBAF followed by conversion of the alcohol to the triflate 
provided the electrophilic aziridine 76.  The in situ generated 76 was then treated with the 3-
cyanoindole 77 under basic conditions to provide the coupled product 78 in good yield (72%).  
The methyl carboxylate was saponified with LiOH and converted to the thiohydroxamic acid 
anhydride 79.  Ziegler and coworkers envisioned a stereoselective radical cyclization via a chiral 
aziridinyl radical addition into the indole core.  In the event, photolysis of 79 with a 500 W 
tungsten halogen lamp provided a complex mixture of products including the dimer 80.  
Disproportionation of 80 under photolysis conditions with a medium pressure Hanovia Hg lamp 
provided the desired indole 81 in 22% yield.  Although the yields were poor and the dimer 
formation was the major pathway, this strategy allows stereoselective formation of an 
aziridinomitosene.  However, removal of the protecting group at the aziridine nitrogen and 





































































 A second approach to aziridinomitosenes utilizing a chiral aziridine was developed by 
Vedejs and Little.89  Beginning with the N-trityl L-serine methyl ester 82, the chiral aziridine 83 
was obtained in 35% yield over 7 steps.90  Excess indole-3-carboxylic acid ethyl ester 84 was 
alkylated with nosylate 83 under basic conditions to provide the cyclized precu sor 85.  
Competitive deprotonation at C(2) (indole numbering) during attempted tin-lithium exchange 
inhibited efficient formation of the tetracycle.  Therefore, the C(2) position was blocked with 
deuterium.  Facile tin-lithium exchange with excess MeLi, cyclization to the tetracycle, and 
trapping of the enolate provided tetracycle 87 which re-aromatized upon workup to provide the 
aziridinomitosene 88.  The aziridinomitosene was found to be relatively stable under acid 
catalyzed reductive detritylation conditions thereby providing the N-H aziridinomitosene 89 in 
moderate yield.91  In contrast to the system reported by Miller and Michael, this intermediate was 
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relatively stable.  Alkylation of the aziridine nitrogen with methyl iodide installed the methyl 
group of 90, and subsequent reduction of the enoate with excess LiAlH4 afforded the 
hydroxymethyl group of aziridinomitosene 91.  Notably, the synthesis of 91 differs from the 
previous examples in that the C(9) and C(10) carbons are at the correct oxidation state of the 
aziridinomitosenes derived from the FR compounds.   
Scheme 1-15. Vedejs and Little’s asymmetric synthesis of the deprotected aziridinomitosene 91 
 
Summary 
 Since the initial discovery of the mitomycins over 50 years ago, and more recently the FR 
compounds, considerable effort has been devoted to the study of these compounds.  Not only 
were they the first examples of aziridine containing atural products, but the high levels of 
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cytotoxicity are a direct result of the unique struc ure of each family.  Extensive investigation of 
the mechanism of action has resulted in a better understanding of how these “prodrugs” exert 
their anticancer activity upon activation.  However, lucidation of the role of various metabolites 
in the mechanism of action is warranted.  The ultima e goal of such a study is the generation of 
less toxic anticancer drugs that can be activated under specific conditions to selectively attack 
cancerous cells over non-cancerous cells.      
The putative aziridinomitosenes corresponding to the FR compounds have been targeted 
for total synthesis.  However, the synthesis of the fully functionalized aziridinomitosene derived 
from FK317 (or the other FR compounds) has not been r ported.  The main hurdle to overcome in 
a successful synthesis of these functionally dense compounds with the correct oxidation state at 
C(9) and the unprotected aziridine is the instability of the fully functionalized system.  The 
system is inherently reactive due to the high electron density of the core and the “benzylic” sites 
at C(1) and C(10).    Most strategies circumvent this problem by installing the acid labile aziridine 
at a late stage.  However, this often requires a large number of steps to install the aziridine with 
the correct stereochemistry.   
 
Figure 1-7. Target aziridinomitosene derived from FK317. 
 Ziegler et. al. and Vedejs and Little show that installation of the sensitive aziridine early 
in the synthesis is possible.87,89  Furthermore, Little provides an example of an activ ted 
aziridinomitosene with a potentially labile hydroxymethyl group at C(10).  Therefore, we have 
targeted the fully functionalized aziridinomitosene 42 derived from FK317 via a strategy 
analogous to that of Little.92  However, new strategies will be required to install the potentially 
labile requisite functionality at C(10) and C(1).  The synthesis of a fully functionalized advanced 
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aziridinomitosene will be described in Chapter 2.  A successful synthesis of the putative active 
intermediate in the activation cascade of FK317 could lead to opportunities to explore the 
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Chapter 2.  




The FR family of oxygen-bridged hydroxyl hemi-aminal dihydrobenzoxazines 1-4 are 
anticancer prodrugs related to the mitomycin family (Figure 2-1).1,2,3,4  Similar to mitomycin C 6,5 
the FR compounds are reductively converted to an active form which is responsible for DNA 
cross-linking at the 5′CG 3′ sequence.6  This family was found to have better activity and less 
toxicity than the mitomycins.4,7,8  Fukuyama proposed that N-O bond cleavage to a 
benzazocinone core followed by loss of water produces an aziridinomitosene 5 (Figure 2-1),9 
similar to the aziridinomitosenes derived from the mitomycins.5  It is generally accepted that the 
aziridinomitosene is the active form of the FR family, although the compounds have never been 
isolated or synthesized.  The characterization of a FR66979 (2) DNA lesion shows DNA 
alkylation at the C(1) and C(10) position of an aziridinomitosene core, which supports the 
proposed active structure.10  These aziridinomitosenes are synthetically challenging functionally 
dense heterocycles due to the presence of the acid labile aziridine and carbamate.  Our research 
group is interested in the total synthesis of these compounds while discovering chemistry that can 










1 FR900482 R= H, R'= H, R''= CHO
2 FR66979 R= H, R'= H, R''= CH2OH
3 FR973 R= Ac, R'=Ac, R''=CHO




























Figure 2-1. The FR compounds, aziridinomitosene 5, and Mitomycin C. 
 
Prior reports from our laboratory describe the synthetic strategy towards the 
aziridinomitosene 7 derived from FK317 4 (Scheme 2-1).11-13  The dihydrobenzoxazine 4 is an 
active diacetylated derivative of 1 which has better activity and fewer side effects such as 
vascular leak syndrome.14  The key intermediate in the synthetic strategy towards 7 was the 
tetracycle 8.13  The risk of heterolysis at C(1) due to the acid sensitive aziridine is lowered by the 
electron withdrawing aldehyde at C(6), which reduces el ctron density in the indole core allowing 
for late stage manipulation.   Aziridinomitosene 8 was accessed by 1,4-addition of a 
lithioaziridine, derived from 9 via tin-lithium exchange, into the appended enoate.11  Indole 9 was 
accessed by alkylation of the functionalized indole 1015 with a known aziridinol 11, derived from 
chiral (L)-serine methyl ester hydrochloride.12  In the previous report, late stage installation of the 
carbamate at C(10) on 7 was accomplished, but the removal of the trityl protecting group was not 
successful in the presence of the acid labile carbamate.13  We now report our continued efforts 
towards 7, which have focused on earlier removal of the trityl protecting group at the stage of key 
intermediate 8.  These studies have culminated in the synthesis of an advanced aziridinomitosene 




Scheme 2-1. Retrosynthetic analysis of the aziridinomitosene 7 derived from FK317. 
 
The Synthesis of a fully functionalized Aziridinomitosene 
In the course of the studies summarized in Scheme 2-1, it became apparent that alkylation 
of 10 with an electrophile derived from 11 is difficult (Scheme 2-2).11-13  The reaction requires 
heating an excess of the deprotonated 10 with 12 for 3-4 days in order to give acceptable 
conversion to product 9a.  The low reactivity reflects steric hindrance near the leaving group 
resulting from the bulky N-trityl and tributylstanna e substituents.12  For example, alkylation of 
10 with known mesylate 12 gave only a moderate yield (54%) of 9a after 4 d of heating at 60 °C 
(Table 1, entry 1).  The unexpected desilylated 9b was also obtained from this reaction (17%), 
contributing to the low yield of 9a.  Because of poor reactivity, long reaction time, and byproduct 
formation, new conditions were examined in order to increase efficiency. 




   In an attempt to improve the alkylation of 10, the reaction variables were reinvestigated.  
Thus, the mesylate was replaced by an iodide leaving group (13), obtained in excellent yield 
using Mistunobu conditions (Eq 1).16   Treating 13 with 3 equivalents of NaHMDS, 3 equiv of 10, 
and heating in a 2:1 mixture of THF and DMPU for 20 h gave 9a in improved 62% yield, along 
with trace amounts of 9b and unreacted starting 13 (1H NMR assay, Table 2-1, entry 2).  Longer 
reaction times resulted in increased formation of 9b and decomposition of 13.  However, when 
the reaction was quenched after 3 h of heating at 60 °C, 72% of 9a was isolated and no 9b was 
apparent by 1H NMR assay of the crude reaction mixture (Table 2-1, entry 3).  Therefore, the 
optimized conditions to alkylate 10 used 3 equiv of 10 and 3 equiv of NaHMDS in a 2:1 mixture 
of THF: DMPU (60 °C for 3 - 4 h).  These improvements allowed more efficient utilization of the 
valuable aziridine subunit and provided sufficient material to explore construction of the 
tetracycle of 7. 
 
Table 2-1. Preparation of 9a from 10 a 
entry aziridine NaHMDS time 9ab 9bb 
1 12 3.3 4 d 54% 17% 
2 13 3 20 h 62% trace 
3 13 3 3 h 72% -- 
aConditions: 3 equiv of 9 treated with 3 equiv of 
NaHMDS at -78 °C.  Aziridine was added, and the 
reaction was warmed to rt while concentrating under 
N2.  The reaction was then warmed to 60 °C. 
bIsolated yield. 
 
Once 9a was in hand, tetracycle formation was targeted by intramolecular 1,4-addition of 
a lithioaziridine into the appended enoate (Scheme 2-3).13  Direct tin-lithium exchange on 9a is 
not viable due to the acidity of the C(2) proton (idole numbering).11-13  The resulting C(2) 
metallation (14) impedes the 1,4-addition of the lithioaziridine into the enoate.  To avoid this 
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problem, a deuterium blocking group was deliberately installed at C(2) by selective deprotonation 
with the bulky mesityllithium in the presence of TMEDA; subsequent quenching with EtOD 
provided deuterated indole 15a in 91% yield with excellent (>95%) deuterium incorpation.  No 
mesityllithium addition into the indole was detected.  Due to a large kinetic isotope effect,11,12 15a 
undergoes tin-lithium exchange without significant C(2) lithiation when treated with excess 
MeLi.  Trapping the enolate 16 with phenylselenyl chloride followed by aqueous workup, results 
in spontaneous elimination and rearomatization to the indole core producing the desired 18.     
The isolation and purification of tetracycle 18 proved to be difficult.  The tin-lithium 
exchange on 15a gave good conversion to cyclized product, but a small amount of 17 due to 
incomplete elimination was always present.  This byproduct could not be removed by Et3N 
deactivated silica gel chromatography and attempted urification of the mixture led to increased 
decomposition of the desired 18.  Treating the mixture with H2O2
17 or heating to 65 °C in CHCl3 
for 1 h to induce elimination decreased the amount of 17, but decomposition of 18 was also 
observed.  Therefore, the inseparable mixture was taken forward.  Treatment of 18 and 17 with 
TBAF afforded a mixture of primary alcohols.  Based on the difficulties encountered in the 
purification of 18, non-polar selenium residues were removed by quick filtration through a silica 
gel plug.  Oxidation of the alcohol mixture with TPA /NMO then gave good conversion to a 
mixture of aldehydes;13 however, aldehyde 8 decomposed during crystallization attempts and 
streaked on silica gel. The selenium adduct was finally removed by dissolving the crude residue 
from oxidation in acetone, and adding hexanes to preci itate 8 in 35% yield over the 3 steps from 
15a.  Once isolated, 8 could be stored at low temperature.  The sensitivity to purification of 18 
and its derivatives is a result of the electron density of the indole core which increases the 
potential for heterolysis at C(1).  Fortunately, this sensitivity is manageable with the relatively 




Scheme 2-3. Tetracycle formation. 
 
   Due to its improved stability, tetracycle 8 is the best candidate for removal of the trityl 
protecting group.  Using acidic reductive detritylaion conditions,18 deprotection provided N-H 
aziridinomitosene 19 in moderate to good yield (Scheme 2-4) as a mixture of nitrogen 
invertomers.19  Two pairs of broad aziridine methine protons appered between δ = 3 and 4 ppm 
by 1H NMR assay, and a coupling constant of 4.9 Hz was extracted for one of the invertomers by 
homonuclear decoupling and D2O exchange experiments.  This coupling is small for a cis 
aziridine, but it is consistent with aziridinomitosenes synthesized previously.12,15,20  The structure 
of 19 was confirmed by treating the material with trityl chloride and Hünig’s base to regenerate 8.  
Compound 19 is more susceptible to ring opening than 8 due to removal of the bulky trityl group, 
but once isolated 19 can be stored at low temperature for long periods of time.  As proposed, 
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deprotection of 8 was the safest choice because the aldehyde and enoate destabilize the 
“benzylic” carbocation resulting from heterolysis of the C(1) –N bond; thereby allowing removal 
of the trityl group. 
Scheme 2-4. Removal of the trityl protecting group from 8. 
 
 The key aziridinomitosene 19 is partially stabilized by both the enoate and aldehy  
substituents, but installation of the requisite carbamate at C(10) required temporary protection of 
the aldehyde to allow selective reduction of the enoate.  The primary alcohol at C(10) of the 
tetracycles is highly labile under acidic conditions if the formyl group at C(6) is not present; 
therefore, an aldehyde protecting group is required that survives reduction and that can be 
removed under basic conditions.   The base labile pyrrole carbinol developed by Evans21 and 
Dixon22 was investigated for this purpose.  Installation and removal of the pyrrole carbinol was 
evaluated on m-anisaldehyde 21 as a simple model system (Scheme 2-5).  Aldehyde 21 was 
treated with excess C4H4NLi, generated from  pyrrole and n-BuLi at -78 °C,
22 and the tetrahedral 
intermediate 22 was trapped using hexafluoroisopropyl alcohol (HFIP)23 as a weakly acidic 
proton source to afford 23 in 96% yield.  Treating a solution of 23 with pH 9 or 10 buffer gave 
good conversion back to 21.  These studies showed that the pyrrole carbinol was easy to install 
and remove under basic conditions.  However, to further reduce the risk of C(10) heterolysis for 
eventual use in the “real” system, other conditions to remove the pyrrole carbinol that do not 




Scheme 2-5. Pyrrole carbinol installation on m-Anisaldehyde 21. 
 
It is known that pyrrole carbinols protected as silyl ethers are converted directly to 
aldehydes when treated with fluoride sources.21  As expected from the precedents, the silylated 
pyrrole carbinol 24 (from 23 and TBSCl/imidazole, 58%)21 was easily cleaved with TBAF to 
provide aldehyde 21.  A more direct route to the silylated pyrrole carbinols was trapping the 
tetrahedral intermediate 22 with a silyl triflate (Scheme 2-5).  Thus, treatment of 21 with 2 equiv 
of C4H4NLi, followed by 2 equiv of triisopropylsilyl triflate (TIPSOTf) provided 25 in moderate 
50% yield.  Quenching the tetrahedral intermediate of 21 with the less bulky triethylsilyl triflate 
(TESOTf) also provided the silyl ether 26, but in higher yield (67%).  The successful generation 
of the silylated pyrrole carbinols 24, 25, and 26 provided an alternative to an aqueous workup for 
unmasking the desired aldehyde.  Since work on generati g and masking pyrrole carbinols had 
been successful, the conversion of 19 to 20 commenced.   
In the fully substituted system, conversion to alcohol 20 was the initial goal.  Not 
surprisingly, installation of the pyrrole carbinol on tetracycle 19 proved to be more difficult than 
with the model.  Using the previously optimized conditions for the conversion to the unprotected 
pyrrole carbinol, mixtures of 19 and 27 favoring 19 were always recovered.  It was found that 
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adding one equiv of NaH to 19 prior to excess C4H4NLi provided 27 in improved 63% yield 
(Scheme 2-6).  Pyrrole carbinol 27 could be purified and was reasonably stable if stored in the 
freezer.  The stage was now set for the challenging reduction of the enoate of 27 with LiAlH 4.  
Isolation of the primary alcohol 28 with the pyrrole carbinol intact at C(6) would increase the risk 
of C(10)-O cleavage due to the absence of a stabilizing π acceptor; therefore, unmasking the 
aldehyde before isolation would be ideal.  With this in mind, 27 was treated with excess LiAlH4 
at 0 oC12 and the reaction was quenched with HPLC grade ethyl acetate, thereby making a risky 
aqueous workup unnecessary.24  The ethoxide generated upon reduction of the ethyl acetate 
facilitated the removal of the pyrrole carbinol in o e pot.  The material recovered was difficult to 
assay due to poor solubility, but two interesting characteristics could be observed:  a proton 
downfield at δ = 9.9 ppm in the 1H NMR spectrum (CD3OD), and a broad IR stretch at 3450 cm
-1.  
This information suggests successful reduction at C(10) and subsequent unmasking at C(6), but 
the C(10) methylene and aziridine protons could notbe observed.  Based on this limited 
information, the material was tentatively assigned as the desired alcohol 20, but the product could 
not be isolated or further characterized due to high polarity and insolubility.  Therefore, 
installation of the C(10) carbamate at the stage of 20 was not pursued, and the strategy for the 
synthesis of 7 was revised.   


































To improve purification and handling of 20, protection of the aziridine nitrogen with a 
large silyl group was evaluated.25  The t-butyldiphenylsilyl (TBDPS) protecting group was 
installed on 19 using 1 equiv of freshly prepared TBDPS triflate (TBDPSOTf)26 and Hünig’s base 
to provide 29 in moderate to good yield (Scheme 2-7; Table 2-2, entry 1).  On the other hand, 
excess TBDPSOTf resulted in significant decompositin of the tetracycle, most likely from 
electrophilic activation of the aziridine nitrogen.  In order to circumvent the acid sensitivity of 29,
a basic buffer solution (pH 10) was used during workup after the TBDPS protecting group 
installation.  Protection of the aziridine nitrogen with TIPSOTf and Hünig’s base resulted in poor 
yields of the desired aziridinomitosene (data not shown).  The TIPS protected aziridinomitosene 
proved unstable to purification and storage at low temperatures.  Because of the greater stability 
of the TBDPS protected aziridinomitosene 29, it was taken forward in the synthesis.   
Masking the aldehyde 29 as a pyrrole carbinol proved difficult, as the optimized 
conditions developed for preparation of 27 led to mixtures of 19, 29 and 30.  Fortunately, 
replacing the aqueous workup with a HFIP/ether quench led to the recovery of pyrrole carbinol 
30 in good yield (Scheme 2-7; Table 2-2, entry 2).   As with 27, the pyrrole carbinol moiety was 
only moderately stable:  pyrrole carbinol 30 could be purified using deactivated preparatory plate 
chromatography, but even storage at -20 °C could not prevent unmasking of the aldehyde over 
time.  Due to this instability, protection of the pyrrole carbinol as a silyl ether was attempted by 
trapping the tetrahedral intermediate from 29 with a silyl triflate.  However, attempts to silylate 
the carbinol oxygen using the optimized conditions re ulted in cleavage of the N-Si bond.  
Because of the stability problems with 30, it was decided to reduce the enoate of 30 immediately 
after purification.  The reduction of the enoate of 30 was expected to be quite challenging; 






























31 X = OH, C4H4N





















































Table 2-2. Characteristic 1H NMR Signals of 29 – 36a 
Entry Tetracycle C(1) C(2) C(3) C(10) 








3 31 3.22 d 3.28 t --b 
4.93 dd 
4.73 dd 





5 34 3.53 d --b --b 
5.66 d 
5.56 d 
6 35 3.36 d 3.29 t --b 
5.65 d 
5.20 d 





aChemical shifts given in ppm. bSignals obscured. 
 
The planned reduction of 30 to 31 was especially intimidating.  Without the C(6) formyl 
group to reduce electron density of the indole core, th  indole nitrogen lone pair can easily 
displace the C(10) hydroxyl group of 31 via acid catalyzed activation to form iminium ion 33
(Scheme 2-7).27  Furthermore, the ever present risk of acid-induce C(1)-N heterolysis of the 
aziridine ring increases as electron donation from the indole increases,28 a risk that also becomes 
larger without the C(6) formyl group.  It was suspected that even an aqueous workup of the 
reduction from 30 may be acidic enough to catalyze the undesired heteroly ic events from alcohol 
31.  Whereas 31 would be especially sensitive, the aldehyde 32 derived from the removal of the 
pyrrole carbinol of 31 should be less prone to activation at C(1) and C(10) because the π 
accepting C(6) formyl group is restored.  Therefore, if 31 could be converted to 32 during the 
workup of the LiAlH4 reduction, the material should be isolable.  With these considerations in 
mind, freshly purified 30 was treated with 5 mol equiv of LiAlH4 at 0 °C and quenched with ethyl 
acetate.  Two major products were detected (ca. 1:1 ratio), one of which was stable enough to 
isolate and was assigned as aldehyde 32.  Aldehyde 32 showed an ABX pair of signals (δ = 4.95 
ppm and δ = 4.76 ppm) coupled to a doublet of doublets (δ = 2.88 ppm), which were assigned as 
the C(10) methylene protons and the hydroxyl proton respectively (Table 2-2, entry 4).  The 
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distinctive C(1) and C(2) aziridine protons were present; however, the C(1) doublet moved 
upfield from δ = 3.62 ppm (29) to δ = 3.29 ppm (32), thereby confirming an oxidation state 
change at C(10) (Table 2-2, entries 1 and 4).  Like enoate 30, aldehyde 32 survived quick 
chromatography, but was found to decompose during storage in frozen benzene. The other 
product from reduction was too sensitive to isolate, but it was tentatively assigned as 31 due to 
the similarity of the upfield 1H NMR signals to those of 32 (Table 2-2, entry 3), plus signals 
consistent with the presence of the pyrrole moiety.  It was reasoned that the pyrrole carbinol of 31 
might be cleaved under the basic conditions required for carbamate installation in the next step, 
thereby avoiding the problematic chromatography.  Therefore, the mixture of 31 and 32 was 
taken on immediately from the ethyl acetate quench procedure.    
The inherent risk of C(10) heterolysis of alcohols 31 and 32 made it necessary to 
approach installation of the carbamate cautiously by using mild carbamoylating reagents and 
conditions (Scheme 2-7).  In a previous report from our laboratory, installation of the carbamate 
functionality on related aziridinomitosenes using the highly reactive trichloroacetyl isocyanate 
produced the desired C(10) carbamates.29,30  Accordingly, reaction of 32 with 1 equiv of 
trichloroacetyl isocyanate at -78 °C for 1 h followed by stirring at rt for 1 h gave a product 
corresponding to 34 by 1H NMR assay of the crude reaction mixture (Table 2-2, entry 5).  
However, attempted cleavage of the trichloroacetyl group from the presumed 34 with K2CO3 in 
MeOH29 resulted in disappearance of the characteristic AB doublets of C(10) but produced no 
signals corresponding to the free carbamate.  Therefor , an alternative method for carbamate 
installation using the milder Fmoc-NCO reagent was investigated (Scheme 2-7).15,31  The mixture 
of 31 and 32 was treated with freshly prepared Fmoc-NCO and Et3N to provide the Fmoc 
protected carbamate 35.  The C(10) methylene proton signals shifted downfield facilitating 
structure determination (Table 2-2, entries 4 and 6).  Treatment of protected carbamate 35 with 
excess TBAF on alumina provided the free carbamate 36 as a white solid after filtration and 
solvent removal.32,33  Attempts to remove the Fmoc protecting group from 35 with previously 
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optimized conditions of Et3N in CH3CN resulted in significant decomposition.
29  Surprisingly, 
after removal of the Fmoc with TBAF, the 1H NMR spectrum showed the characteristic TBDPS 
signals as well as the characteristic sharp doublet of C(1) and “triplet” of C(2) indicative of an 
intact, N-silylated aziridine (Table 2-2, entry 7).     
Deprotection Attempts on Fully Functionalized 36 
Due to the unexpected stability of the TBDPS group n 36, various conditions were 
screened for the final deprotection of the aziridine nitrogen.   Treatment of 36 with the inorganic 
fluoride sources CsF and KHF2 in THF showed unreacted 36 by TLC, while use of Et3N-HF and 
TAS-F resulted in decomposition.34  Surprisingly, when enoate 29 was dissolved in CD3OD and 
monitored by 1H NMR spectroscopy over 20 h the N-H aziridine 19 was regenerated and a new 
TBDPS signal appeared at δ = 0.99 ppm, as expected from attack of nucleophilic deuterated 
methanol at the silyl group.  Therefore, it was hypothesized that these conditions would be mild 
enough to deprotect 36.  Aziridinomitosene 36 was dissolved in CD3OD, and the sample was 
monitored by 1H NMR spectroscopy.  Despite seeing the TBDPS signal at δ = 0.99 ppm after 45 
min, the key C(1) and C(2) signals of the deprotected aziridine 7 were not observed.  After 2 d the 
1H NMR spectrum showed a mixture of aziridine ring opened products formed via acid catalysis.  
This NMR study further demonstrates the facile activ tion and high reactivity of the 
aziridinomitosene as well as the need for exceptionally mild conditions for TBDPS removal.   
It was hypothesized that the detrimental ring opening of the aziridine in deuterated 
methanol during silyl group cleavage might be inhibited by buffering the solvent with a carbonate 
base.  Therefore, carbamate 36 and Cs2CO3 were dissolved in deuterated methanol, and the 
reaction was monitored by 1H NMR spectroscopy.  Instead of the expected silyl group cleavage, 
the spectrum showed that tetracycle 36 had undergone surprising structural changes.  Multiple 
new peaks appeared while the peaks corresponding to 36 decreased in intensity.  A 1:1 ratio of 
new products was observed after 17 h, but after 6 d only one of these products was present.  Upon 
isolation, the 1H NMR spectrum of the new product showed that the characteristic pyrrole C(3) 
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and aziridine C(1) and C(2) protons had moved upfield compared to carbamate 36 (Table 2-3, 
entries 1 and 3), establishing that the protons are more shielded than in any other tetracycle in the 
series.  Even more surprising was that the C(10) AB methylene protons were missing, but two 
vinylic protons at δ = 5.55 and 6.23 ppm were present.  The nominal mass (ESMS; m/z = 514 
amu) corresponded to loss of the carbamate and incorporation of OCD3.  Based on the above data 
and comparison with the natural product mitomycin K (37),35 the structure of the isolated 
unknown was tentatively assigned as the exocyclic oefin 38 (Figure 2-2).   Structure 
determination was based on the characteristic chemical shifts of 37 (Table 2-3, entry 2).  Further 
confirmation of the structure by 13C NMR was not feasible due to the small quantity of 38 
isolated.         
In order to confirm the structure of 38 and to better understand the rearrangement, the N-
Tr aziridinomitosene 3912 (Figure 2-2) was exposed to the same conditions that had been used 
with 36.  Carbamate 39 and Cs2CO3 were dissolved in deuterated methanol and the reaction was 
monitored by 1H NMR spectroscopy.  Analogous structural changes appe red in the 1H NMR 
spectrum as observed starting with 36, and two major products were observed in a 1:1 ratio af er 
3 d.  One of the products correlated well with 37 and also with 38 in terms of 1H NMR chemical 
shifts (Table 2-3, entry 4).  Furthermore, the presence of two alkenyl carbons (δ = 140.2 and δ = 
114.4 ppm) and a quaternary hemi-aminal carbon (δ = 106.1 ppm) could be confirmed by 13C 
NMR spectroscopy; therefore, the structure was assigned as 40 and the structure of 38 was 
confirmed by analogy.  The second product was isolated, and the mass ion observed by ESMS 
correlated to loss of the C(10) carbamate and incorporation of OCD3 (M + Na, m/z = 540 amu).  
Inspection of the 1H NMR spectrum showed a pair of AB doublets at δ = 4.89 and 4.73 ppm, 
which is characteristic of the presence of an electron donating heteroatom at C(10) (i.e. alcohol 
31, Table 2-3, entry 5).  Comparison of the 1H NMR spectra of the unknown product to the 
methyl ether 41 (generated from 44 and MeOH by Kim, Eq 2) showed an exact match, except for 
the signals resulting from the methyl group on the C(10) oxygen (Table 2-3 entry 6).  The initially 
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“unknown” product was therefore assigned as 42, a substance that differs from 41 only by the 
presence of a CD3 in place of a CH3 (Table 2-3, entries 6 and 7). By analogy, the transient 
compound observed upon reaction of 36 with CsCO3 in deuterated methanol was assigned as 43 
(Table 2-3, entry 8).  Although the nucleophilic sub titution on these functionally dense 
heterocycles was quite intriguing from a mode of activ tion perspective, the susceptibility of the 
C(10) carbamate of 36 to nucleophilic attack further limits the strategies available for successful 
removal of the TBDPS group in the sensitive environme t.  
 
Figure 2-2. Selected aziridinomitosenes. 
Table 2-3. Characteristic 1H NMR signals of key tetracyclesa 
Entry Tetracycle C(1) C(2) C(3) C(10) 
































8 43b 3.41 d 3.53 dd - 4.87 d 
4.73 d 




The sensitivity of 36 to nucleophilic, basic, and acidic conditions made th aziridine 
deprotection extremely difficult.  Based on the difficulties associated with removal of the TBDPS 
group from 36, it was deemed necessary to test deprotection conditions on a model aziridine 45 in 
order to more fully explore possible strategies (Eq 3).  Although fluoride sources were 
unsuccessful on previous attempts to deprotect 36, fluoride anion was considered the best starting 
point for the model study due to its high affinity for silicon.   Treating 45 with 1 equiv of the 
widely used TBAF in DMF provided N-H aziridine36 46 in 56 % yield after 3 h (Table 2-4, entry 
1).  However, the impurities and residual water37 which are inevitably present in TBAF were 
causes for concern because of the sensitivity of 36 to acid and to hydroylsis.  Therefore, the non-
hygroscopic crystalline tetrabutylammonium difluorotriphenylsilicate (TBAT)38 was evaluated.  
Surprisingly, treating aziridine 45 with TBAT in deuterated DMF returned only starting material 
by 1H NMR assay after 3 d (Table 2-4, entry 2).  It was hypothesized that activation of the N-Si 
bond of 45 by the impurities of TBAF was responsible for the formation of 46, and that the 
analogous activation by an additive might allow cleavage of the TBDPS group by TBAT.   The 
non-nucleophilic hydrogen bond donor trifluoroethanol (TFE)23 was considered for this purpose.   
The fluorinated alcohol was expected to activate th N-Si bond because of its high 
hydrogen bond donor and ionizing power.23  The more polarized N-Si bond, resulting from the 
hydrogen bond between the aziridine nitrogen and TFE, should be more susceptible to 
nucleophilic attack by the fluoride anion.  Therefo, 45 was treated with 1 equiv of TFE and 1 
equiv of TBAT in deuterated DMF at rt.  Formation of 46 was indeed observed by 1H NMR 
spectroscopy after 1 d (Table 2-4, entry 3), confirming the need for activation of the N-Si bond.  
Under these activation conditions, the inorganic CsF proved to be a viable alternative to TBAT.  
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Treatment of 46 with 1 equiv of CsF and 1 equiv of TFE in deuterated DMF provided 46 after 
only 20 h (Table 2-4, entry 4).  Switching the solvent from deuterated DMF to acetonitrile 
provided 46 in 41% yield, 45 in 11%, and silylated TFE (TBDPSOCH2CF3) (Table 2-4, entry 5).  
Furthermore, when 44 was treated with 1 equiv of CsF in TFE as the solvent, aziridine 46 was 
isolated in 61% yield after 2 d (Table 2-4, entry 6).  Because the TBDPSOCH2CF3 was an 
unexpected byproduct, 45 was subjected to TFE without an added fluoride source to ascertain 
whether a fluoride anion was needed for the deprotecti n.  After 2 d, only 14% desilylated 46 was 
seen by 1H NMR assay as well as a t-butyl group corresponding to TBPDSOCH2CF3 (Table 2-4, 
entry 7), thereby suggesting that the fluoride anion is crucial for facilitating the TBDPS removal.  
From the above observations, it is possible that the TFE was both activating and cleaving the N-
Si bond, and that the fluoride anion facilitated the reaction by acting as a base. 
 
 
Table 2-4. Deprotection of Aziridine 45 
Entry Nucleophile Additive Solvent Time Conversiona 
1 TBAF (1) None DMF 3 h 56b 
2 TBATc  None DMF-d7 3 d 0
 
3 TBAT (1) TFE (1) DMF-d7 1 d 75
 
4 CsF(1) TFE (1) DMF-d7 20 h 93
 
5 CsF(1) TFE (5) CH3CN 3 d 41
b 
      6 CsF (1) None TFE 2 d 61b 
7 None TFE (1) DMF-d7 2 d 14 
a % conversion by 1H NMR assay. bIsolated yield.  c Excess reagent 
used. TBAT = tetrabutylammonium trifluorodiphenylsilicate. TFE = 
trifluoroethanol. 
 
Although mild conditions had been found to remove th  TBDPS group from aziridine 45, 
it was with trepidation that the conditions were applied to the deprotection of penultimate 
aziridinomitosene 36.  The ability of TFE to polarize the N-Si bond through hydrogen bonding 
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would also activate the C(1)-N bond for heterolysis, thereby leading to ring opening of the 
aziridine.    Despite the risk of heterolysis, 36 was treated with 1 equiv of CsF in TFE and THF 
(8:1) (Scheme 2-8).  No apparent reaction was detected after 2 h by TLC, so an excess of CsF 
was added.   After 1 d of stirring, the solvent volume was reduced, and the residue was analyzed 
by 1H NMR spectroscopy.  Not surprisingly, the attempted deprotection had resulted in 
heterolysis of the C(1)- N bond and the formation of two ring opened products.  Once isolated, 
both products showed a C(1) doublet downfield near δ = 4.6 ppm, which is coupled to a multiplet 
upfield near δ = 3.9 ppm.  The presence of a doublet downfield correlates wellith what others 
have seen upon solvolysis at C(1), namely, that the proton at C(1) moves downfield when 
adjacent to a heteroatom.39  Also, the C(10) methylene protons of both compounds had moved 
upfield near δ = 5 ppm, suggesting that the carbamate had also been lost and that a heteroatom 
had been incorporated (Table 2-3, entries 6 and 7).  Analysis of both products by mass 
spectrometry showed a mass ion corresponding to incorporation of 2 equiv of TFE (ESMS, M + 
Na, m/z = 701 amu).  Based on the above data, the products were tentatively assigned as 
diastereomers of the ring opened mitosene 47. Structure identification was confirmed by two 
triplets in the 19F NMR spectrum of both compounds, and by homonuclear and heteronuclear 
(19F) decoupling experiments.   A possible mechanism for formation of 47 could be displacement 
of the C(10) carbamate, followed by trapping with 1 equiv of TFE, then heterolysis at C(1) and 
trapping of the benzylic cation with another equiv of TFE.  Although the incorporation of 2 equiv 
of the non-nucleophilic TFE was unexpected, most surprising was the presence of the TBDPS 
protecting group on the nitrogen despite prolonged stirring with excess CsF.  Once again, the 
aziridinomitosene 36 had proven to be extremely sensitive to C(1)-N bond activation, and 






Scheme 2-8. Formation of mitosene 47 during final deprotection. 
 
Discussion  
 From the outset of the synthesis, the aziridine and carbamate moieties were expected to 
be challenging to install and manipulate due to their acid sensitivity.  The risk of acid catalyzed 
heterolysis of 36 was expected based on the C(1)-N and C(10)-carbamate bond cleavage of fully 
reduced mitomycin C under acidic conditions.  The observed ring opening of the aziridine, C(1)-
N heterolysis, of 36 corresponded well with the mitomycin C analogy, butthe cleavage of the 
C(10) carbamate under basic and nucleophilic, as well as acidic conditions, was unexpected.  In 
prior literature, it is generally proposed that theC(10) carbamate of mitomycin C is less reactive 
than the C(1) aziridine, and that in the cross-linking mechanism for fully reduced mitomycin C, 
alkylation occurs at C(1) before C(10).40  Furthermore, under certain conditions, monoalkylation 
of DNA by mitomycin C is known, where alkylation occurs at C(1) but not at C(10).41   
Kohn showed that mitomycin C derived aziridinomitosene 49 is an intermediate in one 
activation pathway of mitomycin C.42  Under neutral conditions, 49 was able to monoalkylate 
DNA.42  Also, in the presence of exogenous nucleophiles, 49 was attacked at C(1) and not C(10), 
producing a mixture of cis and trans diastereomers (Scheme 2-9).39d   The lower reactivity at 
C(10) of 49 could be due to the conjugation of the pyrrole-N to the electron withdrawing quinone 
carbonyls, but a smilar conjugation effect would apply at C(1).28b  The aziridinomitosene 36 also 
has an electron withdrawing formyl group at C(6) which should reduce the electron density of the 
indole core, but observations show that the indole N is still capable of facilitating the cleavage of 




Scheme 2-9. Solvoylsis of aziridinomitosene 49. 
 











































A direct comparison of the reactivity of the C(10) carbamate can be made between the 
FK317 aziridinomitosene derivative 36 and an aziridinomitosene A derivative 51.  In the 
attempted synthesis of aziridinomitosene A (Scheme 2-10), the carbamate at C(10) did not have 
the reactivity that was observed in 36. The C(10) carbamate survived treatment with basic 
(K2CO3, MeOH), as well as acidic (TfOH, TESH) conditions.
29  As expected based on Kohn’s 
work, the C(1)-N bond of 51 was found to be more susceptible to activation and hydrolysis under 
acidic conditions than the C(10) carbamate bond, an under basic conditions, the carbamate was 
not displaced by methoxide anion.   In contrast, when 36 was treated with Cs2CO3 and CD3OD, 
the methoxide ion was incorporated at C(10), and when 39 was treated with methanesulfonic acid 
and triisopropyl silane, a hydride was incorporated at C(10) (Scheme 2-11).  The difference in 
reactivity at C(10) of 36, 39 and 51 supports the hypothesis that the quinone of 51 reduces the 
electron density of the tetracycle more efficiently than the C(6) formyl group of 
aziridinomitosene 36 and 39. 
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Scheme 2-11. Summary of the reactivity of the C(10) carbamate of 36 and 39. 
 
As shown above, the C(10) carbamate of 36 was much more susceptible to heterolysis 
than in the analogous aziridinomitosenes described by Kohn and Bobeck (Scheme 2-11).41,29  
Based on our observations, we believe that an SN1 mechanism was responsible for cleavage of the 
C(10) carbamate under basic as well as acidic conditi s.  The electron rich indole should 
facilitate heterolysis at C(10) to form iminium ion 54.27,28b  The iminium ion can then be trapped 
by an available nucleophile, including the non-nucleophilic TFE, via an SN1 mechanism.  
Trapping of 54 at C(9a) is also possible as shown by the formation of exocyclic alkenes 38 and 
40.  Invoking the SN1 formation of iminium ion 54, which is disfavored in 49 due to the quinone, 
explains the differences in reactivity at C(10).     
The proposed reductive activation of FK317 (4) invokes the formation of 
aziridinomitosene 7 as the active DNA cross-linking agent.43  The tetracycle 7 has two sites that 
are active for DNA alkylation: the C(1) aziridine, and the C(10) carbamate.  However, based on 
the observed reactivity of the carbamate at C(10) of 36,  the carbamate may have another role in 
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the activation pathway of the FR family.  Therefore, it is apparent that DNA cross-linking by 
FK317 (and by analogy the FR family) is more complex than originally proposed.   
In summary, the fully functionalized N-H aziridinomitosene of FK317 4 remains an 
elusive target.  The most direct route using deprotcted 19 proved difficult due to insolubility and 
polarity; therefore, the synthesis continued with a silyl protected aziridinomitosene 29.  The bulky 
TBDPS protecting group of 29 allowed easier handling of the advanced tetracycles and enabled 
successful installation of the carbamate functionality; however, selective removal of the TBDPS 
could not be accomplished as 36 failed to react or decomposed under multiple reaction 
conditions.  Although 7 was not obtained, the synthetic studies provide insight into the role of 






General Methods.  Solvents and reagents were purified as follows: diethyl ether and 
tetrahydrofuran (THF) were distilled from sodium/benzophenone or purified using an Anhydrous 
Engineering solvent purification system using columns packed with A-2 Alumina; 
dichloromethane (CH2Cl2) was distilled from P2O5 or purified using an Anydrous Engineering 
solvent purification system using columns packed with A-2 Alumina; CH3CN was stirred over 
molecular sieves for 24 h, then distilled from P2O5; benzene, toluene, triethylamine, i-PrEt2N, 
TMEDA, and DMPU were distilled from CaH2; methanol was distilled over activated magnesium 
turnings, the purified reagents and solvents were us d immediately or stored under nitrogen. 
Alkyl and aryllithiums were titrated using the procedure of Watson44 before use.  Unless 
otherwise noted, all chemicals were used as obtained from commercial sources and all reactions 
were performed under nitrogen atmosphere in glassware dried in an oven (140 °C) or flame dried 
and cooled under a stream of nitrogen.  All reactions were stirred magnetically unless otherwise 
noted and liquid reagents were dispensed with all PP/PE plastic syringes or Hamilton Gastight 
microsyringes.  Preparatory layer chromatography was performed using Whatman Partisil® K6F 
silica gel 60 Å 200 µm or 1000 µm plates. Flash chromatography was performed with 230-400 
mesh silica gel 60. 
 
(2R,3R)-3-iodomethyl-2-tributylstannyl-N-triphenylmethylaziridine (12) 
To a solution of PPh3 (0.56 mmol, 147 mg) in 2 mL toluene at 0 C was added 
diisopropylazodicarboxylate neat (0.56 mmol, 0.12 mL) via syringe, and the reaction mixture 
turned yellow.  After 5 min of stirring, aziridinol 11 as a solution in toluene (0.37 mmol, 1.7 mL) 
was added to the PPh3/DIAD mixture dropwise via cannula, and the mixture was stirred 5 min.  
Neat iodomethane (0.52 mmol, 0.03 mL) was added to the reaction mixture via syringe, and the 
mixture turned cloudy white.  The reaction vessel was pulled out of the cooling bath, warmed to 
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rt, fitted with a reflux condenser and heated to 70 C.  After 6 h, the reaction mixture was cooled 
to rt, and the solvent was removed under reduced prssu e.  The cloudy residue was purified 
immediately by flash column chromatography on silica gel (2 x 15 cm, 15:1 hexanes/ethyl acetate 
with 2% Et3N, Rf = 0.82).  Fractions 7-11 provided 257 mg (97 %) of a clear colorless oil.  
Molecular ion (M – C4H9) calculated for C34H46INSn = 658.0993, found (EI) m/z = 658.1004, 
error = 2 ppm; 500 MHz 1H NMR (CDCl3, ppm) δ 7.47 (6H, m) 7.27-7.24 (6H, m) 7.21-7.20 
(3H, m) 3.57 (1H, dd, J = 10.0, 5.0 Hz) 3.00 (1H, dd, J = 9.5, 8 Hz) 1.62 (1H, ddd, J = 8.0, 6.8, 
5.0 Hz) 1.5-1.4 (6H, m) 1.32 -1.24 (6H, m) 1.08-0.94 (7H, m) 0.86 (9H, t, J = 7.3 Hz); 100 MHz 




To a solution of pyrrole (1.84 mmol, 0.13 mL) in 1.5 mL THF at -78 °C was added n-BuLi in 
hexanes (1.52 M, 1.84 mmol, 1.21 mL) dropwise via syringe.22  After 15 min at -78 °C, aldehyde 
22 as a solution in THF (0.37 mmol, 0.5 mL) was added ropwise via cannula.  The solution was 
stirred for 1 h at -78 °C, and then quenched with (CF3)2CHOH (1.8 mmol, 0.19 mL).  The 
mixture was stirred at -78 °C for 10 min, then warmed to rt and poured into H2O.  The mixture 
was extracted 3 x with Et2O, the organic phase was washed 1 x with brine, and then dried over 
MgSO4.  Removal of the solvent under rotary evaporation provided a yellow oil.  Purification by 
preparatory plate TLC on silica gel 60 Å (20 cm x 20 cm x 1000 µm) with 3:1 hexane/ethyl 
acetate, Rf = 0.29, provided 53 mg (71%) of pyrrole 23. Molecular ion (M + H) calcd for 
C12H13NO2 = 203.0946, found (electrospray) m/z = 203.0952, error = 3 ppm; IR (neat, cm
-1) 3431, 
OH; 400 MHz 1H NMR (CDCl3, ppm) δ 7.28 (1H, t, J = 10 Hz) 6.94-6.86 (3H, m) 6.82 (2H, t, J 
= 2.8 Hz) 6.52 (1H, d, J = 4.5 Hz) 6.21 (2H, t, J = 2.8 Hz) 3.79 (3H, s) 2.89 (1H, dd, J = 4.5, 






To a solution of 23 (25 mg, 0.12 mmol) in 1.2 mL CH2Cl2 at 0 °C was added imidazole (0.18 
mmol, 12mg).21  Neat TBSCl (23 mg, 0.15 mmol) was added in one portion, and the mixture 
turned cloudy white. The mixture was stirred and warmed to rt over 20 h, and then 1 mL of sat. 
NaHCO3 was added.  The mixture was extracted 3 x with CH2Cl2, washed 1 x with brine, and 
dried over Na2SO4. Rotary evaporation of the organic solvent provided a mixture of 23 and 24.  
Purification by preparatory plate TLC on silica gel 60 Å (20 cm x 20 cm x 1000 µm) with 9:1 
hexanes/ethyl acetate, Rf = 0.42, provided 22 mg (58%) of 24 as a yellow oil.  Molecular ion (M 
+ Na) calcd for C18H27NO2Si = 340.1709; found (electrospray) m/z = 340.1722, error = 4 ppm; 
400 MHz 1H NMR (CDCl3, ppm) δ 7.23 (1H, t, J = 7.2 Hz) 6.95 (1H, br s) 6.88-6.80 (2H, m) 
6.75 (2H, t, J = 2.1 Hz) 6.43 (1H, s) 6.14 (2H, t, J = 2.1 Hz) 3.78 (3H, s) 0.92 (9H, s) 0.12 (3H, s) 
-0.08 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 159.6, 143.2, 129.4, 119.0, 118.1, 113.6, 
111.3, 108.5, 82.8, 55.2, 25.7, 18.1, -5.42, -5.45. 
 
1-((3-methoxyphenyl)(triisopropylsilyloxy)methyl)-1H-pyrrole(25)  
To a solution of pyrrole (1.05 mmol, 0.07 mL) in 4 mL THF at -78 °C, was added n-BuLi as a 
solution in hexanes (1.55 M, 0.65 mL, 1.0 mmol) dropwise via syringe.  After stirring the 
solution at -78 °C for 15 min, aldehyde 21 (0.50 mmol, 0.06 mL) as a solution in 1.2 mL THF 
was added slowly to the cloudy solution via cannula.  Upon addition the solution cleared.  The 
solution was stirred for 30 min, and then triisopropylsilyl triflate (TIPSOTf) (1.0 mmol, 0.27 mL) 
was added slowly.  After 30 min of stirring, the solution was diluted with 2 mL cold Et2O, a 
scoopful of celite was added, and then the mixture was warmed to rt.  Upon warming the 
colorless solution became pale yellow.  The organic phase was decanted away from the solid 
material and removed under rotary evaporation to provide a yellow oil.  The residue was purified 
by flash column chromatography on silica gel (3 x 15 cm, 15:1 hexanes/ethyl acetate, Rf = 0.36).  
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Fractions 10-16 provided 200 mg of 25 contaminated with an unknown impurity.  Further 
purification using analytical preparatory plate TLC (200 x 200 x 200, 15:1 hexanes/ethyl acetate) 
provided 90 mg (50%) of clean 25. Molecular ion calcd for (M + Na) C21H33NO2Si: 382.2178; 
found (electrospray) m/z = 382.2168; error = 3 ppm; 500 MHz 1H NMR (CDCl3, ppm) δ 7.22 
(1H, t, J = 8 Hz) 7.01 (1H, br s) 6.9 (1H, d, 10 Hz) 6.83-6.79 (3H, m) 6.49 (1H, s) 6.11 (2H, t, J = 
2.2 Hz) 3.78 (3H, s) 1.20-1.10 (3H, m) 1.04 (9H, d, J = 7.5 Hz) 0.99 (9H, d, J = 7.5 Hz); 125 
MHz 13C NMR (CDCl3, ppm) δ 159.8, 143.8, 129.5, 118.8, 118.1, 113.8, 111.2, 108.6, 83.2, 55.4, 
18.1, 17.9, 12.5. 
 
1-((3-methoxyphenyl)(triethylsilyloxy)methyl)-1H-pyrrole (26) 
To a solution of pyrrole (7.1 mmol, 0.50 mL) in 7 mL THF at -78 °C was added a solution of n-
BuLi in hexanes (1.44M, 6.5 mmol, 4.5 mL).  An aliquot of C4H4NLi (0.62 M, 1.0 mmol, 1.67 
mL) was added to a solution of aldehyde 21 in 5 mL THF at -78 °C.  After stirring for 15 min, 
triethylsilyl triflate (0.23 mL, 1.0 mmol) was adde dropwise via syringe.  The yellow mixture 
was stirred at -78 °C for 30 min, then diluted with cold Et2O.  Celite was added and the organic 
phase was decanted off the inorganic solids, and the solvent was removed under an N2 stream. 
The crude residue was purified by flash chromatography on silica gel (2 x 15 cm, 15:1 
hexanes/ether with 2 % Et3N in the eluent, Rf = 0.60) to provide 106 mg of (67%) of the pyrrole 
carbinol 26 as a yellow oil. Molecular ion (M + Na) calcd for C18H27NO2Si = 340.1709; found 
(electrospray) m/z = 340.1704, error = 1 ppm. 500 MHz 1H NMR (CDCl3, ppm) δ 7.23 (1H, t, J = 
7.7 Hz) 6.95 (1H, br s) 6.88-6.80 (2H, m) 6.76 (2H, t, J = 2 Hz) 6.43 (1H, s) 6.14 (2H, t, J = 2Hz) 
3.78 (3H, s)  0.91 (9H, t, J = 8.0 Hz) 0.60 (6H, q, J = 8.0 Hz); 100 13C NMR (CDCl3, ppm) δ 





Attempted preparation of tetracyclic alcohol 20: 
To a solution of 1913 (0.008 mmol, 2.5 mg) in 1 mL THF at -78 °C was added NaH as a solution 
in THF (0.25 M, 0.009 mmol, 0.04 mL) dropwise via syringe.  Meanwhile, to a solution of 
pyrrole (0.06 mL, 0.040 mmol) in 0.20 mL THF at -78 °C was added n-BuLi as a solution in 
hexanes (0.43 M, 0.040 mmol, 0.09 mL) dropwise via syringe.  The solution of C4H4NLi was 
stirred at -78 °C for 15 min, then transferred via cannula to the solution of 19 and NaH.  Upon 
addition, the solution turned orange, and then the color faded to yellow.  The mixture was stirred 
at -78 °C for 30 min, and then quenched with (CF3)2CHOH (80 µL, 0.76 mmol).  The crude 
mixture was warmed to rt, poured into H2O, and extracted 3 x with EtOAc.  The combined 
organic phases were washed with brine, and dried over MgSO4.  Rotary evaporation of the 
solvent produced a yellow residue as a mixture of 27 and 19.  The yellow residue was dissolved 
in EtOAc, washed with H2O, dried over MgSO4, and concentrated to provide a white film 
consisting of a mixture of diastereomers and nitrogen invertomers of 27.  Partial spectroscopic 
data for 27 in the presence of Et3NHX: 400 MHz 
1H NMR (CDCl3, ppm) ABq with broad 
doublets at 4.22-4.06 (2H) 4.03 (0.10H, unidentified s) 3.92-3.84 (3.7H, two s in a 1.0 to 0.9 
ratio) 3.73(unidentified s) 3.58-3.48 (1H, br s) 3.49 (0.14H, unidentified s).  The crude residue 
was used without purification. 
 To a solution of 27 and 19 from above (4.8 mg) in 0.5 mL Et2O and 0.20 mL THF at 0 °C 
was added LAH as a solution in THF (0.5 M, 0.13 mL, 0.065 mmol) dropwise via syringe.  The 
resulting cloudy green mixture was stirred at 0 °C overnight (temperature maintained in a 
cryocool).  The mixture was quenched with ethyl acet te, and allowed to stir for another 40 min.  
Filtration through celite with methanol followed by solvent removal produced a yellow/orange 
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film.  Analysis of the film by 1H NMR showed an aldehyde peak at δ = 9.89 (CD3OD); also, an 








Preparation of N-TBDPS tetracyclic enoate (29) 
To a solution of 19 in 1.9 mL CH2Cl2 was added i-Pr2EtN (0.02 mL, 0.14 mmol).  The solution 
was cooled to -78 °C and TBDPSOTF26 as a solution in CH2Cl2 (0.62 M, 0.16 mL, 0.096 mmol) 
was added dropwise via syringe (1 drop/5 sec).  After 30 min at -78 °C, the mixture was poured 
into pH 9.6 carbonate buffer.  The mixture was extracted 3 x with CH2Cl2 (10 mL), and the 
combined organic phases were washed with brine and dried over Na2SO4.  Removal of the 
solvent under rotary evaporation provided a yellow il.  The yellow oil was purified by flash 
chromatography on silica gel (2 x 15 cm, 2:1 hexanes/EtOAc with 2% Et3N).  Fractions 22-39 
provided 37 mg of (72%) 29 as a pale yellow oil.  Analytical TLC on silica gel 60 Å with 1:1 
hexanes/EtOAc, Rf = 0.58.  Molecular ion (M + Na) clculated for C32H34N2O4Si: 561.2186; 
found (electrospray) m/z = 561.2179, error = 1 ppm; IR (neat, cm-1) 1721, 1690 C=O; 400 MHz 
1H NMR (CDCl3, ppm) δ 9.98 (1H, s) 7.64-7.58 (4H, m) 7.48-7.32 (7H, m) 7.18 (1H, s) 4.29 (1H, 
dq, J = 12.0, 7.2 Hz) 4.27 (1H, d, J = 11.6) 4.08 (1H, m) 4.07 (1H, dd, J = 11.6, 3.6) 4.06 (3H, s) 
3.62 (1H, d, J = 3.6 Hz) 3.84 (1H, dd, 3.6, 3.6 Hz) 1.15 (9H, s) 1.07 (3H, t, J = 7.2 Hz) 100 MHz 
NMR 13C (CDCl3, ppm) δ 191.8, 163.4, 154.7, 153.2, 135.85, 135.78, 134.7, 132.7, 131.9, 130.9, 





Preparation of tetracyclic pyrrole carbinol (30) 
To a solution of pyrrole (0.10 mL, 1.44 mmol) in 3 mL THF at -78 °C was added n-BuLi as a 
solution in hexanes (0.92 mL, 1.40 M, 1.3 mmol) via syringe.  The resulting C4H4NLi was stirred 
at -78 °C for 15 min.  To a solution of aldehyde 29 (0.067 mmol, 36 mg) in 1.10 mL THF at -78 
°C was added C4H4NLi (1.3 M, 0.13 mmol) as a solutin in 0.39 mL THF/hexanes.  The 
resulting solution was stirred at -78 °C for 15 min, a d then (CF3)2CHOH as a solution in Et2O 
(0.10 mL, 1.9 M, 0.19 mmol) was added.  The solution was diluted with 2 mL cold Et2O, and a 
tipful of celite was added.  The organic phase was decanted from the insoluble material, and the 
solvent was removed under N2.  The residue was immediately purified by preparative TLC on 
silica gel 60 Å (20 cm x 20 cm x 1000 µm) pre-treated with Et3N vapors for ≥ 30 min, providing 
33 mg of a 1:1 diastereomeric mixture of product as a residue; 2:1 hexanes/EtOAc, Rf = 0.28. IR 
(neat, cm-1) 3411, OH; 1696, C=O; 400 MHz 1H NMR (CDCl3, ppm, 15% aldehyde 29 present, 
42% Et3N) δ 7.64-7.58 (9H, m) 7.48-7.32 (14H, m) 6.88-6.82 (6H, m) 6.68-6.62 (4H, m) 6.21 
(3.5H, t, J = 2.5 Hz) 4.31-4.22 (2.75H, m) 4.17 (2H, d, J = 11.2 Hz) 4.10-4.02 (3.3H, m) 3.96-









31 X = C4H4N, OH















Preparation of tetracyclic carbamate aldehyde (36) 
To a solution of pyrrole carbinol 30 (33.6 mg, 0.055 mmol) in 1 mL Et2O at 0 °C was added LAH 
in a solution of THF (0.28 mL, 1.0 M, 0.28 mmol, 5 mol equiv) dropwise via syringe.  The 
cloudy non-homogenous mixture was stirred vigorously at 0 °C.  After 45 min, 0.5 mL EtOAc 
was added slowly at 0 °C, and the mixture was allowed to warm to rt and stirred for an addition 
hour.  The crude mixture was then filtered through celite with CH3CN (3 x 10 mL), and the 
combined organic washes were concentrated under reduced pressure to provide 17.4 mg of a 4:1 
mixture of alcohols 31 and 32 as a clear bright green oil.  Selected data for 31: 400 MHz 1H NMR 
(CDCl3, ppm) δ 4.93 (1H, ABX dd, J = 12.4, 5.3 Hz) 4.73 (1H, ABX dd, J = 12.4, 8.2 Hz) 3.28 
(1H, dd, J = 3.4, 3.4 Hz) 3.22 (1H, d, J = 4.0 Hz) 2.99 (1H, ABX dd, J = 8.2, 5.3 Hz). Selected 
data for 32: IR (neat, cm-1) 3539 OH, 1681 C=O; 400 MHz 1H NMR (CDCl3, ppm) δ 9.95 (1H, s) 
7.62-7.58 (4H, m) 7.48-7.36 (6H, m) 7.32 (1H, s) 7.08 (1H, s) 4.95 (1H, ABX dd, J = 12.8, 5.6 
Hz) 4.76 (1H, ABX dd, J = 12.8, 8.0 Hz) 4.26 (1H, d, J = 11.2 Hz) 4.06 (3H, s) 4.03 (1H, ABX 
dd, J = 11.2, 3.2 Hz) 3.6 (1H, ABX dd, J = 3.6, 3.2 Hz) 3.29 (1H, d, J = 3.6 Hz) 2.88 (1H, ABX 
dd, J = 8.0, 5.6 Hz) 1.15 (9H, s).  
 The mixture of alcohols 31 and 32 (17.4 mg, 0.035 mmol) in 1 mL CH2Cl2 was cooled to 
-78 °C.  The solution was charged with Et3N (0.72 M, 0.04 mmol) in 0.06 mL of CH2Cl2 and 
Fmoc-NCO? (0.46 M, 0.07 mmol) in 0.15 mL of CH2Cl2 was added via syringe.  After 20 min of 
stirring at -78 °C, the yellow green solution was warmed to rt and stirred for 1 h (the mixture 
turned dark yellow upon warming).  The CH2Cl2 was removed under N2, and the crude residue 
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was dissolved in 1 mL THF and cooled to 0 °C.  Next, TBAF on Al2O3
? (314 mg, 0.18 mmol) 
was added in one portion and the mixture was stirred and warmed to rt in the cooling bath.  After 
2 h, the crude reaction mixture was filtered through celite with EtOAc and the solvent was 
removed under reduced pressure to provide 22 mg of residue.  The  residue was purified by 
preparative TLC on silica gel 60 Å (20 cm x 20 cm x 250 µm) pre-treated with Et3N vapors for ≥ 
30 min, providing 36 as a white amorphous powder; 1:1 hexanes/EtOAc; Rf = 0.28. Molecular 
ion calculated for C30H31N2O2Si: 479.2155; found (electrospray) m/z = 479.2168, error = 3 ppm; 
IR (neat, cm-1) 3473, 3348, CONH2;  400 MHz 
1H NMR (CDCl3, ppm) δ 9.94 (1H, s) 7.63-7.61 
(4H, m) 7.43-7.38 (6H, m) 7.31 (1H, s) 7.05 (1H, s) 5.47 (2H, AB q, J = 12.2 Hz) 4.41(1H, br s) 
4.23 (1H, d, J = 11.2 Hz) 4.02 (1H, ABX dd, J = 11.2, 3.2 Hz)  3.97 (3H, s) 3.41 (1H, d, 4.0 Hz) 
3.36 (1H, ABX dd, J = 4.0, 3.2 Hz) 1.15 (9H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 192.0, 
156.9, 154.6, 146.5, 135.9, 135.8, 132.1, 132.0, 13.0, 127.9, 127.8, 125.1, 104.5, 98.2, 59.6, 
55.5, 47.5, 41.4, 33.2, 27.5, 19.3. 
Attempted preparation of tetracycle 34 and 36 
To a solution of 32 (0.0046 mmol, 2.28 mg) in 0.30 mL CH2Cl2 at -78 °C was added 
trichloroacetyl isocyanate as a solution in CH2 l2 (0.28 M, 0.0051 mmol, 18 µL) via 
microsyringe.  The dark yellow solution was stirred at -78 °C for 1 h, and then pulled out of the 
cooling bath and allowed to warm to rt.  After 1 h, pH 9.6 carbonate buffer was added and the 
mixture was stirred for 5 min, extracted 3 x with CH2 l2, washed 1 x with brine, and dried over 
pulverized Na2SO4.  Solvent removal provided a yellow film.  Analysis of the residue by 
1H 
NMR spectroscopy (CDCl3, ppm) showed a complex mixture; however, AB doublets at δ = 5.66 
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(J = 12.0 Hz) and 5.56 (J = 11.5 Hz) were observed.  The crude residue was dissolved in 0.30 mL 
MeOH and 0.30 mL K2CO3 (5% w/v) in MeOH
29 and stirred vigorously for 2.5 h.  The mixture 
was extracted with ethyl acetate and solvent removal under reduced pressure provided an orange 
film.  Analysis of the residue by 1H NMR spectroscopy showed loss of the AB doublets and  
complex mixture of compounds.   
 
1H NMR scale reaction of tetracycle 29 with D2O in CD2Cl2 (19)  
A residue of 29 (2.3 mg) was dissolved in CD2Cl2 saturated with D2O, and the sample was 
monitored by 1H NMR spectroscopy.  After 3 h of no reaction, the NMR tube containing the 
sample was gently heated with an oil bath to 35 °C; no deprotected 19 was observed after 2 h of 
heating. 
 
1H NMR scale reaction of tetracycle 29 with 2,2,2-trifluoroethyl alcohol in  CDCl3 (19) 
A residue of 29 (2.3 mg) was dissolved in CDCl3 with an excess of TFE, and the sample was 
monitored by 1H NMR spectroscopy.  After 3 h of no reaction, the NMR tube containing the 
sample was gently heated with an oil bath to 35 °C; no deprotected 19 was observed after 20 h. 
 
1H NMR scale reaction of tetracycle 29 with deuterated methanol (19) 
A residue of 29 (2.3 mg) was dissolved in CD3OD and monitored by 
1H NMR spectroscopy.  
New peaks were apparent between δ = 4.4 and 3.4 ppm after 1.5 h, and the intensities had 
continued to increase at 3 and 5 h.  Also, two signals appeared upfield: a triplet at δ = 1.43 ppm 
corresponding to the CH3 of the ethyl enoate, and a singlet at δ = 1.04 ppm corresponding to a 
new TBDPS species.  After 20 h, no starting material was apparent by 1H NMR.  Selected data 
for 19: Molecular ion (M + Na) calcd for C16H16N2O4 = 323.1, found (electrospray, nomial mass) 
m/z = 323.1; 400 MHz 1H NMR (CD3OD, ppm) δ 9.94 (1H, s) 7.72-7.66 (4H, m) 7.56 (1H, s) 
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7.48-7.38 (6H, m) 7.21 (1H, s) 4.37 (2H, q, J =7.2 Hz) 4.28 (1H, br s) 4.04-3.96 (4H, m) 3.75 
(1H, br s) 1.43 (3H, t, J =7.2). 
 
1H NMR scale reaction of tetracycle 36 with deuterated methanol 
A residue of 36 was dissolved in CDOD3 and monitored by 
1H NMR spectroscopy over a 4 h 
period.  After 15 min, the aziridine C(1) and C(2) protons at δ = 3.53 and 3.49 ppm, respectively 
as well as the C(10) methylene protons at δ = 5.41 and 5.34 ppm began to decrease in intensity.  
The singlet at 1.09 ppm corresponding to the tert-butyl of the TBPDS group was less intense, 
while a singlet at 1.01 ppm began to appear.  At 45 min, the intensity of the C(1), C(2) and C(10) 
peaks had further decreased, and no new aziridine methine peaks were visible.  By 2 h, the C(1) 
and C(2) peaks were no longer visible, and after 4 h, the singlet at 1.09 ppm had disappeared.  
While monitoring the sample, no peaks corresponding to 7 were observed; however, the presence 
of a tert-butyl signal at 1.01 ppm implies deprotection.  After 2 days, the sample showed ring 
opened products which were not isolated.      
 
1H NMR scale reaction of tetracycle 29 with deuterated methoxide (19)  
A residue of TBDPS aziridinomitosene 29 was dissolved in a solution of Cs2CO3 (5 mg) in 0.5 
mL CD3OD.
45  The sample was monitored by 1H NMR spectroscopy over 5 h.  No change was 
observed after 5 min, but after 15 min, a triplet, corresponding to the enoate of 19, at δ = 1.43 
ppm and a singlet, corresponding to a new TBDPS species, at δ = 1.01 ppm had appeared.  After 
1 and 4 h, the signal intensity of both the triplet and singlet had increased.  At 5 h, the relative 
amount of 19 was determined by integration of the unobscured triplet at 1.43 ppm, and was 





1H NMR scale reaction of tetracycle 36 with deuterated methoxide (38 and 43) 
A residue of tetracycle 36 was dissolved in a mixture of Cs2CO3 (5 mg) in 0.5 mL CD3OD and 
the sample was monitored by 1H NMR spectroscopy every 15 min for 10 h.  After 1 h, new 
signals corresponding to the C(1) and C(2) methine protons began appearing around δ = 3.5 and 
3.4 ppm as well as two new ABX methylene protons appe ring near δ = 4.7 and 4.9 ppm.  Two 
methine protons upfield near 2.6 and 2.4 ppm also began appearing after 1 h.  The intensity of 
these signals continued to increase during the 10 h period.  At 17 h, all four methine signals were 
still present; however, after 6 d, the methine protons near δ = 3.5 and 3.4 ppm had disappeared, 
but the signals near δ = 2.6 and 2.4 ppm were still present.  The sample was purified by analytical 
preparatory TLC on silica gel 60 Å (20 cm x 20 cm x 250 µm) pre-treated with Et3N fumes (≥ 30 
min) to provide a yellow residue.  Selected data for 38: Molecular ion (M + H) calcd for 
C31H31D3N2O3Si = 514.3, found (electrospray, nomial mass) m/z = 514.3; 500 MHz 
1H NMR 
(CDCl3, ppm) δ 9.92 (1H, s) 7.45-7.30 (m) 6.89 (1H, s) 6.78 (1H, s) 6.29 (1H, s) 5.55 (1H, s) 4.01 
(3H, s) 3.55 (1H, d, J = 12.0 Hz) 3.34 (1H, d, J = 12.0, 1.4 Hz) 2.66 (1H, d, J = 3.1 Hz) 2.43 (1H, 
dd, J = 3.1, 1.4 Hz) 0.84 (9H, s); Selected data for 43: 500 MHz 1H NMR (CDOD3, ppm) δ 4.86 
(1H, d, J = 11.0 Hz) 4.72 (1H, d, J = 11.0 Hz) 3.50 (1H, m) 3.40 (1H, d, J = 3.5 Hz).   
 
1H NMR scale reaction of tetracycle 39 with deuterated methoxide (40 and 42) 
To a sample CD3OD (0.50 mL) was added Cs2CO3 (10 mg, 0.03 mmol).
 Then the solvent was 
decanted away from any insoluble material, and thenadded to a residue of 36.  The sample stood 
at rt and was monitored by 1H NMR spectroscopy.  After 1.5 h, the ratio of compounds 39:40:42 
was 75:11:14 (% determined by integration) as observed by 1H NMR spectroscopy.  After 26 h, 
the ratio of 39:40:42 observed by 1H NMR spectroscopy was 12:42:44.  After 67 h, the solvent 
was removed under N2 flow and the residue was purified by analytical preparatory plate TLC on 
silica gel 60 Å (20 cm x 20 cm x 250 µm) pre-treated with Et3N fumes (≥ 30 min) with 2:1 
pentane/ethyl acetate providing 40 and 42 as yellow oils (yield not determined).  Selected data for 
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40: Molecular ion (M +Na) calcd for C34H27D3N2O3 = 540.2342, found (electrospray with formic 
acid) m/z = 540.2360, error = 3 ppm; 500 MHz (CDCl3, ppm) δ 9.97 (1H, s) 7.26-7.20 (6H, m) 
7.18-7.12 (9H, m) 6.96 (1H, d, J = 0.5 Hz) 6.93 (1H, s) 6.30 (1H, s) 5.47 (1H, s) 3.80 (1H, d, J = 
12.5) 3.40 (1H, dd, J = 12.5, 1.5 Hz) 2.28 (1H, d, J = 4.5 Hz) 2.13 (1H, dd, J = 4.5, 1.5) 125 MHz 
13C (CDCl3, ppm) δ 192.1, 157.1, 156.8, 144, 1, 140.2, 138.8, 129.3, 127.4, 126.6, 120.9, 114.4, 
106.1, 104.0, 103.9, 73.8, 55.6, 51.5, 45.3, 37.0.  Selected data for 42: Molecular ion (M +Na) 
calcd for C34H27D3N2O3 = 540.2342, found (electrospray with formic acid) m/z = 540.2341, error 
= 0.2 ppm; 500 MHz 1H NMR (CDCl3, ppm) δ 9.97 (1H, s)  7.49 (6H, d, J = 7.5 Hz) 7.38 (3H, d, 
J = 14.0 Hz) 7.30 (6H, t, J = 7.5 Hz) 7.25 (1H, m) 7.07 (1H, s) 4.90 (1H, d, J = 11.5 Hz)  4.73 
(1H, d, J = 11.5 Hz) 4.44 (1H, d, J = 11.0 Hz) 4.10 (1H, dd, J = 11.0, 3.5 Hz) 3.04 (1H, d, J = 5.0 
Hz) 3.01 (1H, dd, 5.0, 3.5 Hz); 125 MHz 13C NMR (CDCl3, ppm) δ 192.1, 154.8, 145.3, 144.1, 




To a solution of aziridine?? (469 mg, 2.24 mmol) in 20 mL CH2Cl2 at -78 °C was added i-Pr2NEt 
(0.58 mL, 3.36 mmol).  One equiv of tert-butyldiphenylsilyl triflate (0.92 mL, 2.24 mmol) was 
added dropwise via syringe, and the solution was stirred at -78 °C.  After 2.5 h, 0.5 equiv 
TBDPSOTf was added, and the reaction continued.  After reaction completion according to TLC 
analysis, the mixture was poured into pH 7 buffer and extracted 3 x with CH2Cl2.  The organic 
phase was washed with brine, and dried over Na2SO4.  Removal of the solvent by rotary 
evaporation provided a cloudy white oil.  Purificaton by flash chromatography on silica gel (3.5 
x 15 cm, with 100 % hexanes and 2 % Et3N) provided 777 mg (78 %) of 45.  Molecular ion (M + 
H ) calcd for C31H33NSi = 447.2382; found (electron impact) m/z = 447.2375, error = 2 ppm; 400 
MHz (CDCl3, ppm) δ 7.73-7.67 (2H, m) 7.62-7.56 (2H, m) 7.50-7.24 (11H, m) 7.12- 7.10 (3H, 
m) 6.74-6.67 (2H, m) 3.00 (1H, d, J = 4.8 Hz) 2.9 (1H, dd, J = 14.3, 3.5 Hz) 2.46 (1H, dd, J = 
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14.3, 8.8 Hz) 2.13 (1H, ddd, J = 8.8, 4.8, 3.5 Hz) 1.15 (9H, s); 100 MHz 13C NMR (CDCl3, ppm) 
δ 139.2, 128.3, 136.2, 133.4, 132.3, 129.49, 129.46, 128.8, 127.8, 127.53, 127.48, 126.7, 125.9, 
40.8, 39.8, 34.5, 27.6, 19.2; an unknown signal at 29.3 ppm was also detected. 
 
Deprotection of 45 with TBAF (Table 2-4, entry 1) 
To a solution of aziridine 45 (0.24 mmol, 107.7 mg) in 2.4 mL DMF at rt was added TBAF as a 
solution in THF (1.0 M, 0.24 mL).  After 3 h of stirring at rt, saturated NaHCO3 (1.0 mL) was 
added.  The mixture was extracted 3 x with Et2O, the combined organics were washed 1 x with 
brine, and then dried over MgSO4.  Removal of the solvent by rotary evaporation provided an oil.  
Purification of the crude residue by flash chromatography on silica gel (2 x 15 cm silica gel, 1:1 
hexanes/Et2O, Rf = 0.18) provided 28.2 mg (56%) of aziridine 46.
36   
 
NMR scale deprotection of 45 with TBAT (Table 2-4, entry 2) 
Aziridine 45 was dissolved in approximately 1 mL DMF-d7, and a sp tula tipfull of TBAT was 
added to the solution.  Only 45 and TBAT were observed by 1H NMR spectroscopy at 5 h and 3 
d. 
 
NMR scale deprotection of 45 with TBAT and TFE (Table 2-4, entry 3) 
To a sample of 45 (0.58 mmol, 25.9 mg) in 1 mL DMF-d7 was added TFE (0.58 mmol, 4.2 µL) 
and TBAT (0.58 mmol, 32 mg).  The sample was monitored by 1H NMR spectroscopy.  At 1 h, 
peaks corresponding to 46 had appeared; at 2 h, 27% (calculated by integration of the 1H NMR 
signals) of 46 was present.  After 24 h, 75% of 46 was present. Selected data for 46: 400 MHz 1H 
NMR (DMF-d7, ppm) δ 7.46 (2H, d, J  = 7.2 Hz) 7.36 (2H, t, J = 7.4 Hz) 7.30-7.22 (3H, m) 7.20-
7.08 (3H, m) 3.34(1H, dd, J = 9.0, 6.2 Hz) 2.55 (1H, dddd, J = 9.0, 7.2, 6.4, 6.4 Hz) 2.44 (1H, dd, 




NMR scale deprotection of 45 with CsF and TFE (Table 2-4, entry 4) 
An oven dried NMR tube was charged with CsF (0.10 mmol, 15 mg) and capped with a rubber 
septum under an inert atmosphere.  A solution of aziridine 45 in DMF-d7 (0.06 mmol, 27.5 mg, 
0.5 mL) was then added to the NMR tube through the septum via syringe.  Neat TFE (0.06 mmol, 
4.3 µL) was then added to the NMR tube.  The NMR tube was shaken for 30 sec and then the 
insoluble material was allowed to settle.  The sample was monitored by 1H NMR without 
spinning.  After 10 min, 46 began to appear, and after 2 h, 48% of 46 was present.  At 20 h, 93% 
of 46 was observed.   
 
Deprotection of 45 with CsF and TFE in CH3CN (Table 2-4, entry 5) 
To a non-homogenous solution of 45 (0.26 mmol, 114.1 mg) in 1.8 mL CH3CN as added CsF 
(0.30 mmol, 47 mg) as a solution in CH3CN (0.8 mL) and TFE (0.10 mL, 1.39 mmol).  The 
resulting white non-homogenous mixture was stirred vigorously.  The solution cleared after 3 d of 
stirring, and a saturated solution of NaHCO3 was added.  The mixture was extracted 3 x with 
Et2O, the combined organics were washed with brine, and dried over MgSO4.  Removal of the 
solvent under rotary evaporation provided a clear yellow oil.  The residue was purified by 
preparatory plate TLC on silica gel 60 Å (20 cm x 20 cm x 1000 µm) pre-treated with Et3N fumes 
(≥ 30 min) with 9:1 hexane/ethyl acetate.  Elution of the bands with ethyl acetate provided 
TBDPSOCH2CF3 (yield not determined), 13 mg (11%) of 45 and 22 mg (41%) of 46.  Selected 
data for TBDPSOCH2CF3: 
 
Deprotection of 45 with CsF in TFE (Table 2-4, entry 6): 
To a solution of aziridine 45 (0.33 mmol, 147 mg) in 1.3 mL TFE was added CsF was a solution 
in TFE (0.17 M, 2.0 mL, 0.33 mmol).  Aziridine 45 was insoluble in TFE, so the reaction vessel 
was placed in a sonicator to break up the insoluble material.  Then the non-homogenous solution 
was stirred vigorously at rt.  After 2 d of stirring, 2 mL of satd NaHCO3 was added, and the 
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mixture was extracted 3 x with Et2O, washed 1 x with brine, and dried over MgSO4.  Solvent 
removal under rotary evaporation provided an oily residue.  The crude residue was purified by 
flash chromatography with silica gel (2 x 15 cm, 3:1 hexanes/ethyl aceate, with 2% Et3N in the 
eluent).  Fractions 25-32 provided 42 mg (61%) of 46.  
 
NMR scale deprotection of 45 with TFE (Table 2-4, entry 7): 
To a solution of 45 (0.049 mmol, 21.8 mg) in DMF-d7 was added neat TFE (0.049 mmol, 3.5 
µL).  The resulting sample was monitored by 1H NMR.  After 2 d, only 14% of 46 was observed 
by 1H NMR. 
 
 
Attempted deprotection of 36 with CsF in TFE (47) 
To a cloudy solution of 36 (0.0019 mmol, 1 mg) in 0.05 mL THF was added TFE (5.6 mmol, 
0.40 mL).  The solution cleared and turned bright yellow.  A solution of CsF in TFE (0.11 M, 
0.0022 mmol, 20 µL) was added to the reaction vessel via microsyringe.  After no apparent 
reaction by TLC, another equiv of CsF was added at 2 and 5 h, and 2 equiv of CsF was added at 
6.5 h for a total of 5 equiv of CsF.  After 24 h of t tal reaction time, the solvent was removed 
under a flow of N2 to provide an orange solid.  The crude residue was purified by preparatory 
plate TLC on silica gel 60 Å (20 cm x 20 cm x 250 µm) pre-treated with Et3N fumes (≥ 30 min) 
with 100% ethyl acetate to provide a residue containing two compounds in approximately a 1:1 
ratio (by integration of crude residue).  Selected data for major diastereomer 47a: Molecular ion 
(M + Na) calculated for C34H36F6N2O4Si = 701.2, found (electrospray, nomial mass) m/z = 701.3; 
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500 MHz partial 1H NMR (CDCl3, ppm) δ9.91 (1H, s) 7.70 (2H, dd, J = 8.1, 1.4 Hz) 7.65 (2H, 
dd, J = 8.1, 1.4 Hz) 7.46-7.37 (7H, m) 7.08 (1H, s) 5.09 (1H, d, J = 11.8 Hz) 4.99 (1H, d, J = 11.8 
Hz) 4.74 (1H, s) 4.34 (1H, dd, J = 10.5, 5.5 Hz) 4.06-4.00 (1H, m) 4.00 (3H, s) 3.93 (2H, q, J H,F= 
8.8 Hz) 3.89 (1H, dd, J = 10.5, 2.0 Hz) 3.56-3.44 (2H, dq, J = 12.3 Hz, J H,F = 8.6 ) 1.01 (9H, s); 
376 MHz 19F (CDCl3, ppm) δ -74.0 (t, J
F,H = 8.8 Hz) -74.4 (t, JF,H = 8.6 Hz).  Selected data for 
minor diastereomer 47b: Molecular ion (M + Na) calculated for C34H36F6N2O4Si = 701.2, found 
(electrospray, nomial mass) m/z = 701.3; 500 MHz partial 1H NMR (CDCl3, ppm) δ 9.94 (1H, s) 
5.11 (1H, d, J = 12.0 Hz) 4.85 (1H, d, J = 12.0 Hz) 4.56 (1H, d, J = 4.5 Hz) 4.09 (1H, m) 3.98-
3.88 (4H, m) 3.84 (1H, m); 376 19F NMR (C6D6, ppm) δ -73.7 (dd, J = 9.0, 8.6 Hz) -73.9 (dd, J = 
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Synthesis of a 9-Oxo-pyrrolo[1,2-a]indole Related to FR900482 
 
Brief Overview of Mitomycin C and FR900482 
Over the last half century much interest has been dedicated to the DNA alkylating pro-
drug mitomycin C (Scheme 3-1, ).1-5  Mitomycin C is an effective anticancer agent selectiv  for 
solid tumors and hypoxic cells due to its unusual mechanism of action.6,7  An in depth discussion 
of the mechanism was provided in Chapter 1, but a brief overview is presented below.  Enzymatic 
or chemical reductive activation of the quinone core t  a leucoaziridinomitosene (3a) in vivo or in 
vitro is required for its activity.  The leucoaziridinomitosene is responsible for cross-linking 
double stranded DNA, and the presence of the cross-link results in a catastrophic cellular event 
where the DNA can no longer undergo strand separation and replication.3,4  The bioreductive 
activation events of 1 also lead to radical species such as hydroxyl radical and hydrogen peroxide, 
which cause cellular damage leading to severe side effects, thereby limiting the therapeutic dose 
range of 1.8,9  Even with its high cytotoxicity, 1 is marketed as Mutamycin® by Bristol-Meyers-
Squibb, and it remains in use as a chemotherapeutic agent for the treatment of breast, head and 




Scheme 3-1. Biosynthetic intermediates leading to 1 and 2. 
 
There have been many endeavors to design analogs of 1 with improved activity and 
reduced cytotoxicity.  Thousands of analogs have been obtained either by way of synthesis or by 
doping the fermentation broths of the mitomcyin C producing organism with biosynthetic 
synthons.2,12  In the late 1980s, scientists at the Fujisawa Pharmaceutical Company discovered a 
new class of compounds with the isolation of FR900482 (2), which was envisioned to be a viable 
alternative to 1.13  The FR class of compounds consist of a unique dihydrobenzoxazine core with 
a hydroxylamine hemi-aminal (Scheme 3-1).  Importantly, this class of compounds also cross-
links DNA upon reductive activation through aziridinomitosene 3b (discussion in Chapter 1).1,2   
Unlike 1, the reduction of 2 does not involve the formation of superoxide or thesubsequent 
hydroxyl radicals and hydrogen peroxide; therefore, th  FR class does not have the cytotoxicity 
problems associated with 1.  However, due to the occurrence of vascular leak syndrome as a 
severe side effect during clinical trials, the FR compounds did not live up to their early 
therapeutic potential.14   
The relationship between Mitomycin C and FR900482 
As alluded to in the previous section, the development of new compounds for the 
selective destruction of cancerous cells instead of healthy cells remains a goal of anticancer 
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research efforts.  Scientists have recognized the high complexity of the mechanisms of action of 
these remarkable natural products, and that “elucidating cellular events that mediate cytotoxicity” 
may lead to the development of improved drug.2  Also important to this research is the 
understanding of the biological origins and drug producing organisms that are involved in the 
biosynthesis of 1 and 2.  Therefore, to take full advantage of the therapeutic potential of the 
mitomycin and FR classes of compounds, a better comprehension of the biosynthetic pathways 
leading to each natural product is required.    
Mitomycin C was isolated from multiple Streptomyces organisms including S. lavendulae 
NRRL 2564,15 while FR900482 was isolated in 1987 from the fermentation broth of S. 
sandaensis No. 6879.16  The building blocks of these anticancer antibiotics were determined 
through radioactive labeling studies.  It was found that an intact ᴅ-glucosamine unit makes up 
carbons 1-3, 9-10, and the aziridine nitrogen (Scheme 3-1).17,18 Also, uptake of L-[NH2CO-
13C,15N]  citrulline in the biosynthesis of 1 was responsible for C(10) carbamate formation.19,20  
The most likely candidates for the origin of the remaining amino-methylbenzoquinone carbons 
were glucose or shikimic acid, derived from the Shikimate pathway of amino acid synthesis; 
however, neither of these labeled precursors were incorporated into 1.17,21   Finally, Anderson and 
coworkers identified the progenitor of the benzoquinone as the unusual amino acid 3-amino-5-
hydroxy-benzoic acid (AHBA) 6.22 Amino acid 6 is biosynthetically derived via the recently 
discovered ammoniated shikimate pathway.23 Scientists at the Fujisawa Pharmaceutical Co. found 
that [7-14C] 6 was incorporated into 2 when S. sandaensis No. 6897 was inoculated with the 
labeled amino acid.  Furthermore, ᴅ-[1-13C]glucosamine was  incorporated into 2 when it was 
added to fermentation broths.24  These findings suggest that both 1 and 2 are derived from the 
same building blocks originating from two different organisms. 
A possible explanation for similarities of 1 and 2, i.e. incorporation of the same building 
blocks and the presence of the aziridine and carbamate in both, is that mitomycin C and 
FR900482 are derived from a common biosynthetic intermediate.  It is proposed that a coupling 
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event between AHBA 6 and ᴅ-glucosamine could lead to functionalized amine 5, with the intact 
ᴅ-glucosamine unit.25 Subsequent oxidation and cyclization could produce mitosane 4, which has 
the requisite carbons for formation of either 1 or 2 (Scheme 3-1).  Evidence to support the 
proposal of a common biosynthetic intermediate in two different organisms has been obtained by 
the Sherman group. 
  Sherman and coworkers have identified the gene clusters of S. lavendulea and S. 
sandaensis responsible for the biosynthesis of 1 and 2.  Identification of the gene cluster of S. 
lavendulea was accomplished by gene disruption studies, and by monitoring the expression of 1 
from mutant strains of S. lavendulae.26  Preliminary assignment of enzyme function was possible 
based on these studies.  Two enzymes, MitE, an acyl AMP ligase, and MitB, a glycosyl 
transferase, have been implicated in the condensatio  of the building blocks 6 and ᴅ-glucosamine 
thereby leading to amine 5 (Scheme 3-1).25  Recent mapping of the gene cluster responsible for 
the synthesis of 2 showed that it possesses high identity and similarity to that of 1.27  
Consequently, the function of enzymes in the S. sandaensis gene cluster can be assigned by 
analogy to the S. lavendulae gene cluster.   
As implied above, the presence of the aziridine and carbamate in 1 and 2 implicates the 
divergence of the biosynthetic pathways at a relatively late stage, i.e. after installation of these 
functional groups.  Subsequent tailoring steps such as amination, methylation, and oxidation to 
the quinone of 1 would occur after the point of divergence. Contributing to the hypothesis that the 
pathways diverge at a late stage is the presence of a cytochrome P450 hydroxylase in the gene 
cluster of S. sandaensis that is not present in S. lavendulae.  Sherman et. al. propose that the 
hydroxylase could be responsible for the oxidation f the mitosane core of 4 to the 
hydroxylamine hemi-aminal of 2.27  Although structural features of 1 and 2 imply a certain order 
of events, the exact sequence of transformations in the biosynthetic pathways has not been 
determined.      
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In order for 4 to lead to 2, oxidation of the mitosane core must occur.  Dmitrienko 
confirmed that oxidation of the mitosane pyrrolo[1,2-a]indole core present in 1 to the 
dihydrobenzoxazine hydroxylamine hemi-aminal core of 2 is chemically possible.28  The 
oxidation of  9a-hydroxy-2,3,9,9a-tetrahydropyrrolo[1,2-a] indole 7 with Davis’ reagent resulted 
in ring expansion into the hydroxylamine hemi-aminal core 12 of the FR compounds (Scheme 3-
2).  Oxidation of the hemi-aminal 8 to N-oxide 9 followed by ring opening affords benzazocinone 
11, and subsequent condensation of the N-oxide onto the ketone then provides the bicycle 12.  An 
alternative mechanism for formation of 12 is oxidation of the ring opened tautomer 10 to 
hydroxylamine 11.  The successful oxidation of a mitosene as well as a mitosane into a 
dihydrobenzoxazine further supports the hypothesis that structurally different 1 and 2 are derived 
from a common biosynthetic intermediate.   
Scheme 3-2. Conversion of pyrrolo[1,2-a]indole 8 to dihydrobenzoxazine 12. 
 
In an effort to investigate the point of divergence in the parallel pathways, and also to 
confirm the proposed enzymatic function, we have targeted the potential biosynthetic probes 
aziridinomitosane 13a or 13b for total synthesis (Scheme 3-3).  In collaborative experiments, 
Sherman and coworkers will load thioesters 13a,b onto an acyl carrier protein and subject it to 
purified enzymes obtained by over-expression of the genes from the biosynthetic pathways.  High 
priority in testing will be given to the gene responsible for C(10) carbamoylation (mmcS);27b 
89 
 
presumably carbamate installation occurs before the point of divergence since the functionality is 
present in both 1 and 2.  The oxidases mmcN, and mmcT, as well as the unique oxidase from the 
FR900482 gene cluster will also be tested with 13a,b.  These enzymes are proposed to be 
responsible for oxidation of C(5) and C(7) in the biosynthesis of 1, and therefore, substrate 
recognition by these enzymes should occur after the point of divergence of the two pathways.  
Furthermore, other enzymes potentially responsible for methylation of C(9a) and deoxygenation 
of C(6) will also be evaluated.  Most notable in the biosyntheses is the difference in the 
stereochemistry at C(9) between 1 and 2.  Studies with the stereoisomer 13a,b could elucidate 
where in the biosyntheses the stereochemistry difference arises.  All of the above studies should 
facilitate a better understanding of the timing of events leading to the mitomycins and FR 
compounds, and ultimately lead to the exploitation of the biosynthesis for the construction of 
novel mitomycins.  The key structural features of 13a,b are the acid labile aziridine, hemi-aminal, 
and C(10) hydroxymethyl moieties.  Thioesters 13a,b are planned to arise from the α-hydroxy 
ketone mitosane 14a or the allylic alcohol 14b via late stage conversion of the ketone or the 
exocyclic methylene group to the hydroxymethyl group corresponding to the C(10) position of 1 
and 2.  Below we describe the successful synthesis of a fully functionalized analog of α-hydroxy 
ketone 14a en route to the desired pyrrolo[1,2-a] indole thioesters 13a,b.  
Scheme 3-3. Retrosynthesis of targeted probes 13a,b. 
 
Racemic syntheses of the pyrrolo[1,2-a] indole core 
The mitosane core of the α-hydroxy ketone 13a has been previously obtained by others in 
the context of the total synthesis of mitomcyin K, FR900482 and derivatives.  In an endeavor to 
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quickly synthesize the mitomycin core, Danishefsky howed that under photolytic conditions, 
aryl nitro dienes are suitable substrates for [4 + 2] cycloaddition to form a pyrrolo-fused oxazine 
system (Scheme 3-A).29  The photolysis of nitroaryl diene 1A, which was expected to provide the 
fused oxazine 2A based on an unfunctionalized model, gave almost exclusively the hemi-aminal 
3A.  Trace amounts of 2A were isolated, and conversion of 2A into 3A supported the 
intermediacy of 2a in the formation of 3A.  The hemi-aminal could then be oxidized to the imide 
4A in moderate yield.  Stereospecific installation of the aziridine precursor to the correct face of 
the substrate was accomplished using (phenylthio)methyl azide.  Subsequent reduction of the 
imide and dehydroxylation via Barton deoxygenation f a thionothiaimidazolide provided 
tetracycle 6A.  Finally, photolytic cleavage of the triazoline followed by thioether reduction 
provided the aziridine 7A.  The α-methoxy ketone was then converted in three steps to (±)-
mitomycin K.  Although this route highlights an expdient synthesis of the mitosane core via the 
[4 + 2] cycloaddition of the arylnitroso diene, 7 steps are required to access the aziridinomitosane 
7A from hemi-aminal 3A.   
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Scheme 3-A. Danishefsky’s synthesis of (±)-mitomycin K.
 
 In another strategy, Ban and Shibasaki used a trannsannular cyclization approach to the 
hemi-aminal of a decarbamoyloxymitomycin derivative (Scheme 3-B).30 Benzazocine 1B was 
converted into allylic alcohol 2B in 6 steps with good selectivity for the cis isomer.  
Unfortunately, direct installation of the aziridine from 2B using epoxidation and subsequent ring 
opening was unsuccessful.  Therefore, alcohol 2B was converted into allylic carbamate 3B, and 
the olefin was iodinated providing 4B in good yield.  Cleavage of the carbamate with K2CO3 and 
MeOH and subsequent intramolecular displacement of the iodide by the released nitrogen formed 
the aziridine ring on the correct face of the system.  The alcohol was then oxidized with PCC to 
the benzazocinone 5B. After unsuccessful attempts to effect the transannular cyclization with 
methyl trifluoromethanesulfonate (MeOTf), it was found that TMSOTf and TBSOTf induced the 
desired ring forming event with good stereoselectivity for the trans silyl ether aminal (6B).  
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Although the TMS derivative was unstable to purificat on, the TBS derivative 6B could be 
isolated in high yield.  The presence of the benzyl protecting groups was necessary for the “criss-
cross” cyclization to occur as the TBS protected hyroquinone did not undergo cyclization.  
Global deprotection and oxidation of 6B afforded the quinone 7B in three steps.  Overall, the 
Shibisaki synthesis of the mitosane from precursor 1B equired 11 steps including 3 for aziridine 
installation.   
Scheme 3-B. Shibisaki’s synthesis of the decarbamoyloxymitomycin 7B.  
 
 A third approach that has been used extensively to ob ain the hemi-aminal core is the 
oxidation of a mitosene or pyrrolo[1,2-a] indole core.  Dmitrienko showed that the pyrrolo[1,2-a] 
indole core can be oxidized using molecular bromine in methanol followed by basic workup to 
provide 2-hydroxy-3-methoxy-indolines.28  Using a similar approach, Jimenez reported the 
oxidation of a mitosene with Davis’ reagent (Scheme 3-C).31  Jimenez synthesized the azido-
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mesylate 2C in 3 steps from 2-formylindole 1C.  Oxidation of the C(9)-C(9a) bond (mitomycin 
numbering) using Davis’ reagent provided 4C as a mixture of diastereomers most likely in 
equilibrium with the ring opened form 3C.  Each isomer could be isolated by chromatography; 
however, both reached an equilibrium mixture of 7:2 after 72h in CDCl3.  The less stable isomer 
was protected as a TBS ether providing 5C as a 1:2 mixture of diastereomers.  The 1:2 
diastereomeric ratio of 5C was retained upon conversion to 6C by reduction of the azide and 
internal mesylate displacement.  The more stable isomer of 4C was reduced and cyclized with 
PPh3 and NEt3 to aziridine 7C.  Treatment with acetic anhydride then gave the diacetate hemi-
aminal derivative 8C. 
Scheme 3-C. Jimenez’s synthesis of the mitosane 6C and 8C. 
 
 The same oxidation strategy was used in Jimenez’s total synthesis of (±)-mitomycin K 
(Scheme 3-D).32  Unfortunately, initial attempts to effect the oxidation of functionalized indole 
1D using Davis’ reagent were unsuccessful.  The desired transformation did not occur with 
hydrogen peroxide, t-butyl hydroperoxide in methanol, or m-CPBA.  Successful oxidation was 
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achieved with (hexamethylphosphoramido)oxodiperoxomolybdenum (VI) (MoO5•HMPA) 
providing a mixture of diastereomers 2D and 3D in good yield.  Equilibration of these 
stereoisomers was possible with dilute HCl in MeOH over three days.  Sequential aziridination of 
the desired diastereomer 2D with PPh3, installation of a methyl group on the aziridine nitrogen, 
and conversion of the ketone to an exocyclic olefin using Danishesky’s protocol provided (±)-
mitomycin K 6D.  The ultimate conversion of 2D to 6D confirmed the trans stereochemistry of 
the C(9a) methoxy and aziridine functional groups in 4D.  This efficient synthesis of mitosane 4D 
required 2 steps from mitosene 1D.  
Scheme 3-D. Jimenez’s racemic synthesis of (±)-mitomycin K. 
 
Asymmetric syntheses of the pyrrolo[1, 2-a]indole core 
Miller’s asymmetric approach to the mitosane core used a transannular cyclization 
strategy.33  Starting from the commercially available isatin 1E, the racemic N-Boc protected 
benzazocine 2E was obtained in good yield over nine steps (Scheme 3-E).  After screening 152 
peptide catalysts, the peptidic catalyst 3E was found to give good kinetic resolution of the 
racemic mixture with s = 27 to provide the alcohol (–)-2E with the desired stereochemistry in 
good yield (~40%, theoretical 47%) and good enantioselectivity (90% ee, 99% ee after single 
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recrystallization).  Substrate directed epoxidation of the olefin using dimethyldioxirane, followed 
by Swern oxidation provided ketone 4E in good yield.  Subsequent cyclization using Ban’s Lewis 
acid catalyzed conditions on 4E provided the desired tetracycle; however, due to difficulties 
encountered in removing the ketal, a one step cyclization and deprotection procedure was sought.  
Thus, it was found that treating 4E with trace amounts of HNO3 in MeOH at 135 °C provided the 
deprotected α-methoxy ketone 5E with the anti configuration between the methoxy and epoxide 
functionalities.  Lewis-acid catalyzed ring opening of the epoxide followed by epimerization of 
the C(9a) stereocenter under acidic conditions provided 6E as a mixture of stereoisomers.  
Mesylation of the azido-alcohol, reduction of the azide, and subsequent displacement of the 
mesylate provided the hemi-aminal 7E in 42% yield in two steps.  Only the trans-isomer was 
recovered; however, explanations for the absence of the other diastereomer were not presented. 




 The mitosane hemi-aminals also have been targeted as key intermediates in the synthesis 
of the dihydrobenzoxazine core of the natural product FR900482 by Ziegler and coworkers.34 
Oxidation of the pyrrolo nitrogen of tetracycle 1F, obtained by a radical cyclization of a chiral 
aziridinyl radical onto an appended indole,  provided N-oxide 2F (Scheme 3-F).  Further 
rearrangement of 2F under Polonovski conditions provided the desired hemi-aminals 3F-8F as 
mixtures of regioisomers (Scheme 3-F).  When R1 was an acetyl group or benzyl carbonate good 
regioselectivity favoring tetracycles 5F and 7F was obtained.  Ziegler and coworkers 
hypothesized that the acetate or carbonate, which are cis to the C(9a) proton could act as an 
internal base to facilitate regioselective formation of the iminium ion in the Polonovski reaction.  
Further oxidation of 5F with m-CPBA forms the hydroxylamine hemi-aminal core, most likely 
through generation of an N-oxide followed by ring expansion.   
Scheme 3-F. Ziegler’s asymmetric synthesis of dihydrobenzoxazine 9F. 
 Trost and coworkers used a similar strategy to that of Ziegler to accomplish the 
asymmetric synthesis of epi-FR900482.35  Using reductive amination, the functionalized o-iodo-
aniline 1G was coupled with the non-racemic aziridinol 2G (Scheme 3-G).  Further 
transformations, including a Heck arylation to form the tetracycle, resulted in the exocyclic olefin 
3G in good yield over 4 steps.  Stereoselective (2.4:1 d.r.) dihydroxylation of the olefin with 
osmium tetraoxide and carbonate formation using triphosgene provided mitosene derivative 4G.  
Oxidation of the mitosene under Polonovski conditions, m-CPBA and then Ac2O, provided 
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aminal 5G in moderate yield, apparently due to heteroatom directing effects.  The 
dihydroxylamine hemi-aminal core of FR900482 was then accessed by oxidation of 5G to 6G 
with m-CPBA.  Overall, the mitosane 5G was obtained in 6 steps after the coupling of 1G with 
chiral aziridinal 2G.  Finally, carbonate 6G was converted to epi-(+) FR900482 in good yield 
over six steps.   
Scheme 3-G. Trost’s asymmetric synthesis of epi- (+)-FR900482. 
 
The successful syntheses of the mitosane hemi-aminals described above show three 
strategies to access the tetracycle from a variety of precursors: an intramolecular cycloaddition, 
transannular cyclization, and Polonovski oxidation.  Furthermore, the hemi-aminals with an 
adjacent (C9) fully substituted sp3 or sp2 carbon can be subsequently transformed into 
intermediates leading to the mitomycins or the FR compounds.  These examples support the 
validity of our strategy for the formation of thioest rs 13a,b from mitosanes 14a or 14b.  
Compound 14a is structurally similar to the known hemi-aminals di cussed above and should be 
amenable to further functionalization.   
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Multiple strategies for the asymmetric construction f 14a,b have been considered 
(Scheme 3-4).  However, the most direct route involves construction of 14a,b from 
aziridinopyrrolidinone 15.  The formation of the C(9)-C(9a) bond of 14a,b was envisioned to 
arise from stereoselective 1,2-addition of a vinyl lithium or an acyl anion equivalent into the 
appended lactam.  Pyrrolidinone 15 was planned to be derived from 6-aryl-3,6-
diazabicyclo[3.1.0]hexane 16, furthermore known as an aziridinopyrrolidinone.  We envisioned 
three different approaches to the key aziridinopyrrolidinone 16.  Route A, an intramolecular 1,2-
addition of a lithioaziridine, derived from tin-lithium exchange of 17 into the carbamate to form 
the lactam.  Route B involves dianion formation through stepwise deprotonation and tin-lithium 
exchange of aniline 18 followed by trapping with a phosgene equivalent to install the requisite 
carbonyl.  Finally, the third approach, route C, involves transition metal catalyzed coupling of 
preformed aziridinolactam 19 with pre-functionalized aryl halide 20.  Each approach involves 
extensive use of the chiral aziridine for the key bond forming events.     




 As implied by the strategies for the synthesis of 14a,b, our group is interested in the 
efficient asymmetric construction of the aziridinomitosane by early installation of the aziridine 
moiety.  Although the acid labile aziridine often limits the chemistry available for certain 
transformations, the ability to install the stereocnters of the aziridine from the rich chiral pool 
removes the difficulties in enantioselectively installing the stereocenters at a late stage.  
Furthermore, much effort has been spent developing new reactions and methodology that are 
amenable to the presence of the acid sensitive moiety.  Therefore, while the primary goal is the 
total synthesis of 14a,b and eventually 13a,b for biosynthetic studies, a secondary goal is the 
extension of synthetic transformations that can be performed on the acid sensitive aziridine.  
Part 1: Enantioselective synthesis of 3,6-diazabicylo[3.1.0]hexanes 
Route A: Tin-lithium exchange and intramolecular 1,2-addition 
 The strategy for intramolecular 1,2-addition of a lithioaziridine into an appended 
carbamate was based on the well known Parham cyclization.  The Parham cyclization involves 
aryl metallation, usually by lithium/halogen exchange, followed by trapping an internal 
electrophile to form a ring.  This route has been used extensively to form benzofused lactams and 
natural products with the isoindolinone lactam core.36-40 Our approach differs from the 
conventional Parham cyclization in that the nucleophile is not at an sp2 carbon, anion formation 
would occur by tin-lithium exchange, and the immediate product would not be a benzofused 
lactam.41  Nevertheless, the development of route A began by determination of a suitable substrate 
for tin-lithium exchange.   
The synthesis of the first generation tin-lithium precursor began with the commercially 
available methyl 3,5-dinitrobenzoate 21 (Scheme 3-5).  Following the method of Herlt,42 one 
nitro group was displaced by LiOMe to provide 22.  The ester was saponified with LiOH to 
provide the acid in good yield, which was then transesterified with Boc2O and DMAP to give the 
t-butyl ester 23 in good yield over the two steps.  Reduction of the nitro group with Pd/C and H2 
followed by treatment with Boc2O provided the aniline-derived carbamate 24.  The carbamate 
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was then alkylated with the iodide 26 to provide the tin-lithium exchange precursor 25 in poor 
yield.  The alkylation of 24 required high temperatures, long reaction times, and  excess of 
nucleophile to proceed, and it was found that the Boc group was partially cleaved from 24 (14% 
based on 24) under the reaction conditions.  Although the reaction was inefficient, a sufficient 
quantity of 25 was obtained to attempt the tin-lithium exchange. 
Scheme 3-5. Synthesis of 25 and attempted tin-lithium exchange. 
 
The key step in this strategy was the selective generation of the lithioaziridine via tin-
lithium exchange, followed by intramolecular 1,2-addition into the carbamate.  Using previously 
optimized conditions for tin-lithium exchange, carbmate 25 was treated with excess MeLi at -78 
°C in THF.  However, assay of the crude reaction mixture by 1H NMR spectroscopy showed a 
complex mixture of products.  Purification of the mixture did not provide clean material, but 
analysis of each band by ESMS showed ions tentatively assigned to compounds 27 – 30 (Scheme 
3-5).  Although the desired lactam formation had not taken place, complete tin-lithium exchange 
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had occurred based on the disappearance of the tributylstannane substituent by 1H NMR 
spectroscopy.  The presence of destannylated Boc-protected aniline 28, suggested that 1,2-
addition of the appended lithioaziridine might have been hindered by the bulky t-butyl carbamate.  
Also, the presence of 27 and 28 suggested that there was an acidic proton present that was 
capable of quenching the lithioaziridine.  Although the source of the proton was not confirmed, 
the t-butyl benzoate at C(6) (aziridinomitosene numbering) would lower the pKa of one of the 
aryl protons, which could then be removed by an avail ble organolithium species.  The other 
products were tentatively assigned as ketone 29 and tertiary alcohol 30 based on analysis by 
ESMS and by 1H NMR spectroscopy.  The ABX dd pattern of the CH2 methylene protons of 25 
had changed, and the signals were shifted upfield from δ = 3.99 and 3.70 ppm to δ = 3.44 and 
3.38 ppm, suggesting that the CH2 was no longer next to the electron withdrawing carbamate, but 
instead next to an amine.   
Based on the multiple byproducts and side reactions during the tin-lithium exchange, a 
second generation tin-lithium exchange precursor with a smaller aniline protecting group and a 
non-activating substituent at C(6) was targeted.   Therefore, methylbenzoate 22 was reduced with 
DIBAL-H to provide benzyl alcohol 31, which was then protected as allyl ether 32 in good yield 
(Scheme 3-6).   Due to the incompatibility of the allyl group with palladium catalyzed 
hydrogenation, the remaining nitro group was reduce instead with Zn in AcOH to provide amine 
33 in good yield.  The amine was then protected as the sterically less hindered methyl carbamate 
34.  Alkylation of 34 with known mesylate 35 proved more efficient than with the Boc derivative 
25, but the product 36 was still isolated in poor to moderate yield.  Tin-lithium exchange on 36 
with 2 equiv of MeLi in THF at -78 °C resulted in aother complex mixture of products including 
ketone 38 (Table 3-1, entry 1).  When 2 equiv of MeLi was used at -78 °C in Et2O, starting 
material and ketone 38 were obtained (Table 3-1, entry 2).  However, when only 1.3 equiv of 
MeLi was used at -78 or -90 °C in Et2O, no tin-lithium exchange product was observed (Table 3-
1, entries 3 and 4).  These results suggest that tin-li h um exchange and ketone formation is slow 
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in Et2O; therefore, 36 was treated with 4 equiv of MeLi at -90 °C for 1 h.  Mostly starting 
material was recovered, but trace amounts of desired aziridinopyrrolidinone 37 and ketone 38 
were also observed (Table 3-1, entry 5).  Although the desired lactam had finally been observed, 
the presence of the ketone showed that the competitive s de reaction was still problematic even at 
-90 °C in Et2O.   
Scheme 3-6. Synthesis of 36 and tin-lithium exchange. 
 
Table 3-1. Tin-lithium exchange on 36 
Entry MeLi (equiv) Solvent T °C Time Ion by ESMS 
1 2 THF -78 1 h 555 
2 2 Et2O -78 30 min 555, 861 
3 1.3 Et2O -90 30 min 838, 861 
4 1.3 Et2O -78 30 min 838, 861 
5 4 Et2O -90 1 h 861, 539, 555 
 
As described above, the major byproduct in the tin-lithium exchange of 36 was assigned 
as ketone 38.  Electrospray mass spectrometry of the byproduct showed an ion corresponding to 
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38 (M + Na, m/z = 555) implicating loss of the tributylstannane and methyl carbamate as well as 
incorporation of a methyl group under the reaction conditions.  Furthermore, the 1H NMR 
spectrum contained the distinctive signals for the aziridine methine protons of C(1) and C(2) 
shifted downfield at δ = 2.14 (d) and 1.98 ppm (dd), while the C(3) methylene protons, consisting 
of a more complex coupling pattern, had shifted upfield to δ = 3.44 and 3.39 ppm.  The increased 
shielding and change in coupling pattern suggested that the C(3) methylene protons were 
coupling to an N-H as well as to the C(2) methine proton.   
Based on the studies of Orita et.al. on the Parham cyclization,40 the formation of the 
ketone 38 was not completely unexpected.  During the attempted synthesis of 8-oxoberbines, they 
found that alkyllithiums, including MeLi, n-BuLi, s-BuLi, and t-BuLi, induce Parham cyclization 
of 3′,4′- or 4′,5′-dialkoxy-1-(2′-bromobenzyl)-2-ethoxycarbonyl-1,2,3,4-tetrahydroisoquinolines, 
and that any excess alkyllithium adds into the desired product in a 1,2 or 1,4 addition fashion.  
They concluded that subsequent addition of alkyllithium into the amide carbonyl of the 8-
oxoberbine generated in situ is faster than the cyclization.40 Therefore, formation of the ketone 38
can be attributed to an acyl transfer type mechanism where initial addition of the lithioaziridine 
forms the tetrahedral intermediate 39 (Scheme 3-7).  Decomposition of 39 should form lactam 
37.43  Available MeLi can then attack the lactam 37 to form tetrahedral intermediate 40, followed 
by displacement of aniline to form the methyl ketone 38.44  Acyl transfer in this system is 
competitive with tin-lithium exchange according to the evidence that mixtures of starting material 
36 and ketone 38 are obtained with excess MeLi.  Overall, the inability to obtain good conversion 
to the desired lactam, to induce tin-lithium exchange with 1 equiv of base, and to suppress 




Scheme 3-7. Formation of ketone 38. 
 
Route B: Dianion formation and trapping studies 
 Our second approach to aniline derived aziridinopyrrolidinone 16 involved generation of 
a dianion that could be trapped with a phosgene equivalent.  It was envisioned that the dianion 
generated from stepwise deprotonation and tin-lithium exchange of an aniline derived aziridine 
would be capable of trapping an electrophile at the more basic carbanion.  In fact, Goswami had 
shown that homoenolate dianions can be generated from secondary amides via deprotonation and 
tin-lithium exchange, and efficiently trapped at the carbanion with 1 equiv of various 
electrophiles.45  However, if an appropriate phosgene equivalent was chosen as the electrophile, 
the deprotonated heteroatom could then also attack he electrophile in an intramolecular fashion; 
thereby forming a ring.  This approach has been used to form benzo-fused lactones and lactams 
such as phthalides46 and oxindoles47 by dianion trapping with carbon dioxide; however, no prior 
examples of the formation of 3,6-diazabicyclo[3.1.0]hexanes could be found using this anionic 
cyclization strategy. 
 The dianion approach began by targeting the aniline derivative 44 for use as a model 
substrate (Scheme 3-8).  The N-Boc aniline 42 was treated with aziridine 35 under the standard 
alkylation conditions to provide 43 in poor yield.  Removal of the Boc protecting group nder 
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commonly used acidic conditions was not viable due to the presence of the acid labile aziridine, 
and attempted hydrolysis of the Boc group under basic conditions was not successful.  Therefore, 
carbamate 43 was heated to 185 °C without solvent to provide 44 in good yield.48  Careful 
temperature control was required as overheating resulted in significant decomposition and 
reduced yield, but sufficient dianion precursor 44 became available to support studies on dianion 
formation. 
Scheme 3-8. Dianion formation on model 44. 
 
 It was expected that dianion formation would require an excess of base: one equivalent 
for deprotonation of the heteroatom, and one equivalent or more for tin-lithium exchange.45  
Therefore, 44 was treated with 2 equiv of MeLi (Table 3-2, entry 1) at -78 °C, and the anion was 
then quenched with 1.5 equiv of diethylcarbonate (CO(OEt)2).  This reaction gave mixtures of 
starting material 44, destannylated aziridine 45, and desired pyrrolidinone 46.  Treatment of 44 
with excess MeLi, in order to facilitate complete tin-lithium exchange, resulted in a higher yield 
of 45 and small quantities of ketone 47 observed by 1H NMR spectroscopy (Table 3-2, entry 2).  
The generation of destannylated aziridine 45 suggested that the lithioaziridine was being 
quenched before addition of the electrophile.  If this was correct, the most likely proton source 
was unreacted starting material 44 present in the reaction mixture due to inefficient stirring.45 In 
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order to inhibit the formation of 45, deprotonation of the aniline had to be completed b fore any 
tin-lithium exchange occurred.  
 Studies by Goswami45 and Kessler49 on dianion formation via amide deprotonation and 
tin-lithium exchange demonstrated the necessity for completely deprotonating the heteroatom 
before promoting tin-lithium exchange.  Goswami found that treating an amide with 1 equiv of n-
BuLi, allowing the reaction to stir for 8 min and then adding a second equivalent of n-BuLi, 
allowed efficient trapping of the carbanion and reduced the formation of destannylated starting 
material.45  Kessler ensured complete deprotonation of a glucosamine derivative before tin-
lithium exchange by using 1 equiv of MeLi•LiBr before adding 1.3 equiv of n-BuLi.49  Therefore, 
the dianion precursor 44 was treated with 1 equiv of n-BuLi and allowed to stir for 15 min at -60 
°C.  Then, 1 equiv of MeLi was added to promote tin-li hium exchange, and the reaction was 
quenched after 5 min with CO(OEt)2 (Table 3-2, entry 3).  The destannylated 45 was isolated in 
48% yield along with a mixture of lactam 46 and ketone 47.  The recovery of substantial 
quantities of 45 was surprising, but when the reaction was repeated nd allowed to warm to rt 
over 1 h, the desired lactam 46 was isolated in 46% yield along with trace amounts of 45 and 47 
(Table 3-2, entry 4).  Therefore, warming the reaction o rt after addition of CO(OEt)2, is essential 
for efficient cyclization.         
Table 3-2. Dianion formation on model carbamate 44 
     Results 
Entry RLi (equiv) T °C CO(OEt)2 Time 44 45 46 47 
1 MeLi( 2) -78 to rt 1.5 5 min n.d. n.d. n.d. -- 
2 MeLi (4) -78 4 5 min 4 % 39 % 12.5 %a 5 %a 
3 n-BuLi (1) 
MeLi (1) 
-78 10 5 min n.d. 48% 10 %a 5 %a 
4 n-BuLi (1) 
MeLi (1) 
-78 to rt 10 1 h -- n.d. 46 % n.d. 
a % based on integration of mixtures by 1H NMR. n.d. not determined. -- not observed by 
1H NMR spectroscopy.  
   
After the successful generation and trapping of the dianion on an aniline-derived model 
substrate, it was time to investigate the methodology n the fully functionalized aniline system 
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(Scheme 3-9).  The Boc-protected aniline 48 was synthesized in good yield from aniline 33.  
Aniline 48 was then alkylated with mesylate 35 under the standard conditions to give ca. 50% 
yield of aziridine 49.  As in the model, the Boc protecting group was removed under thermal 
conditions to provide dianion precursor 50.  Dianion formation and trapping with the optimized 
conditions provided a mixture of products including desired 37 (17%), destannylated 51 (15%), 
and starting material 50 (21%), as well as over-addition byproducts.  However, attempts to 
improve the yield of 37 were unsuccessful.  The complexity of the substrate made it difficult to 
determine the source of the proton that was trapping the dianion; however, incomplete heteroatom 
deprotonation or activation of an aryl proton for metallation could have been the culprit.  
Although the desired aziridinopyrrolidinone 37 had been obtained, the application of the dianion 
formation on the highly functionalized precursor was too inefficient to be pursued further. 
Scheme 3-9. Dianion formation on fully functionalized 50. 
Route C: Transition metal-catalyzed coupling 
 The third approach envisioned towards analogs of 16 involved formation of the aryl-
nitrogen bond via transition metal catalyzed coupling of a pre-functionalized aryl halide to an 
intact aziridinopyrrolidinone.  Pyrrolidinones are known to be efficient coupling partners in Pd 
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and Cu catalyzed amination reactions,50,51 and pre-functionalization of the aryl halide befor 
installation of the acid labile aziridine would serv  two purposes.  First, the aryl halide would not 
be susceptible to acidic conditions, and therefore, a wide range of conditions could be used to 
install the functionality.  Second, if the aryl subunit was functionalized before installation of the 
aziridine, fewer steps would be required to complete the synthesis of 13a after introduction of the 
acid labile functionality.  The key issues that needed to be addressed for this strategy were the 
synthesis of the aziridinolactam 19, the functionalization of the aryl halide, and theoptimization 
of the coupling reaction.  
 Although aziridinopyrrolidinones with the desired substitution pattern are known to some 
extent,52 literature precedents to form the 3,6-diazabicyclo[3.1.0]hexane fused ring system were 
not conducive to our synthesis.  Therefore, a new method for enantioselective formation of the 
3,6-diazabicyclo[3.1.0]hexane ring system was requir d.  Fortunately, dianion formation from a 
stannylaziridine and trapping with a phosgene equivalent provided the 3,6-
diazabicyclo[3.1.0]hexane 46 in moderate yield (Scheme 3-8).   If the phenyl substituent on the 
nitrogen was replaced with a labile nitrogen protecting group, then removal of the protecting 
group after cyclization would afford aziridinolactam 19.  Goswami showed that amides are 
suitable substrates for dianion formation; therefor, a carbamate that would undergo dianion 
formation was targeted.45   
 For the synthesis of 19, the known mesylate 35 was treated with sodium azide to displace 
the mesylate leaving group and provide the azido aziridine 52 in excellent yield (Scheme 3-10).  
The high yield of the displacement is most likely due to the small size of the nucleophile.  
Importantly, a large excess of the nucleophile was no longer needed for efficient displacement of 
the mesylate to occur.  Reduction of the azide with L AlH 4 provided the amine 53, which was 
unstable over time and to purification; therefore, it was used immediately without purification to 
form the carbamate 54.  Based on Goswami’s example,45 54 would be suitable for dianion 
formation by deprotonation of the carbamate nitrogen followed by tin-lithium exchange.  
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Furthermore, once trapping of dianion 55 had occurred to form imide 59, the imide could be 
cleaved to form the deprotected pyrrolidinone 19.  
Initial experiments focused on a two step procedure to form the ring system.  The dianion 
was generated with 1 equiv of n-BuLi and 1 equiv of MeLi under the standard conditions, and 
then the lithioaziridine was trapped with excess Mander’s reagent53 to provide the imide aziridine 
56.  Subsequent imide cleavage and ring formation with DMAP or DABCO was unsuccessful; 
however, K2CO3 in MeOH or NaOMe generated 19 in trace amounts.  The main product from 
imide cleavage was the ester 57.  Fortunately, treatment of ester 57 with NaHMDS in THF 
provided 37% of the desired aziridinopyrrolidinone 19.  Although the lactam could be generated 
in two steps, the yield was rather poor.  Therefore, it became necessary to re-evaluate the one step 
ring forming procedure. 
Scheme 3-10. Dianion formation and trapping to form aziridinolactam 19. 
 
It was determined during evaluation of the two step procedure that the dianion could be 
trapped at both anionic sites by a good electrophile such as Mander’s reagent.  However, trapping 
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both nucleophilic sites with excess electrophile, i. . formation of 56, was undesired.  Therefore, 
CO(OEt)2, which afforded the desired lactam 46 in the dianion model system, was re-evaluated 
(Scheme 3-8).54  During initial attempts at cyclization, we found it necessary to allow the reaction 
to slowly warm to rt after quenching the dianion 55 with CO(OEt)2 because immediately stopping 
the reaction after addition of the electrophile led to poor yields of the cyclized product (Table 3-2, 
entry 3).  In the event, quenching the dianion 55 with excess CO(OEt)2 and warming the reaction 
over 4 h provided the desired pyrrolidinone 19 in moderate yield (50%) along with destannylated 
aziridine  58 and trace amounts of over-addition byproducts.  The cyclized N-carboethoxy lactam 
59 was never isolated or detected by 1H NMR spectroscopy.  The reaction appeared to be 
dependent on temperature and the rate of stirring.  Therefore, the temperature was monitored 
internally and kept below -70 °C during deprotonation and tin-lithium exchange.  Also, efficient 
stirring was necessary for good conversion as the major byproduct in this transformation was the 
protiodestannylated product 58 resulting from protonation of the lithioaziridine by unreacted 54.  
The identity of 58 was confirmed by the loss of the tributyl stannane d by the presence of three 
aziridine peaks at δ = 1.73, 1.46, and 1.08 ppm in the 1H NMR spectrum.  Further optimization 
studies showed that n-BuLi was effective for tin-lithium exchange, and tha  MeLi was not 
necessary.  Therefore, optimized conditions for cyclization of 54 to pyrrolidinone 19 involved 
initial deprotonation with 1 equiv of n-BuLi at -78 °C, ten minutes of stirring, followed by 
treatment with another equiv of n-BuLi, and then trapping the red dianion with CO(OEt)2 while 
slowly warming to rt.  Over-addition byproducts were sometimes seen by 1H NMR spectroscopy 
in trace amounts.  However, with tight temperature control and mechanical stirring the 
deprotected 3,6-diazabicyclo[3.1.0]hexane 19 could be generated in 65% yield on gram scale.   
 The second issue that needed to be addressed in this route was the coupling of 
pyrrolidinone 19 with an aryl halide.  Using Buchwald’s conditions for the Cu catalyzed coupling 
of amides to aryl iodides in a model study,51 19 was treated with 12 mol % CuI, 1 equiv N,N′-
dimethylethylenediamine 60a (Figure 3.1), K3PO4, and iodobenzene in toluene at 100 °C to 
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provide the coupled product 46 in good yield (Eq 1, Table 3-3, entry 1).   Analysis of the crude 
reaction mixture by 1H NMR spectroscopy showed recovered 19 as well as the product 46.  
Fortunately, the valuable lactam 19 could be re-isolated from the reaction mixture.  
Aziridinopyrrolidinone 46 had been previously synthesized during the investigation of a dianion 
route, and as expected the 1H NMR spectrum of the new material matched that of he prior 
sample.  This was the first time that a model of the desired N-aryl aziridinopyrrolidinone 16 had 
been isolated in acceptable yield. 
 
Since the coupling reaction had worked very well on the simple aryl iodide, we expanded 
the substrate scope to include aryl halides that were functionalized at the ortho position.  It was 
hoped that ortho functionality installed before the coupling step would permit the final C-C bond 
forming event leading to the tetracycle.  Various aryl iodides were synthesized from known o-
iodobenzaldehyde 62 (Scheme 3-11).  Homologation of aldehyde 62 with the Ohira-Bestmann55 
reagent provided the iodo-alkyne 63, which was then protected as the TMS acetylene 6456 in good 
yield over the two steps.  Furthermore, the aldehyd 62 could be converted into dithiane 65 by 
treatment with propanedithiol.57  Finally, treatment of aldehyde 62 with catalytic ZnI2 and 
TBSCN provided the TBS protected cyanohydrin 66 in good yield.58  These ortho-functionalized 




Scheme 3-11. Synthesis of ortho-functionalized aryl iodides. 
 
 
Table 3-3. Copper catalyzed coupling of aryl iodides with 19a


























































      





Figure 3-1. Diamine ligands used in Cu catalyzed coupling. 
Due to the incomplete conversion to the coupled product 46 under the copper catalyzed 
conditions, we chose to optimize the reaction parameters during studies on the substrate scope.  
The TMS-acetylene iodide 64 was treated with 30 mol % CuI, 60 mol % N,N′-
dimethylcyclohexanediame, K3PO4, and heated in toluene at 100 °C.  The coupled acetylen  67 
was isolated in 48% yield (74% b.r.s.m.) (Table 3-3, entry 2).  Switching to 1,4-dioxane produced 
67 in only 22% yield after 41 h (Table 3-3, entry 3).    This experiment showed that toluene was 
the more efficient solvent, and therefore, it was used in further reactions.  Coupling of the aryl 
dithiane 65 and 19 with 30 mol% catalyst in toluene provided dithiane 68 in 67% yield (Table 3-
3, entry 4).  Although good yields were obtained, the reaction still did not go to full conversion.  
Therefore, TBS cyanohydrin 66 was treated with a stochiometric amount of CuI, andcoupled 
product 69 was isolated in good yield (Table 3-1, entry 5).  However, the reaction was not 
complete after 20 h of stirring and heating.  The copper-catalyzed coupling is known to be 
sensitive to the presence of O2,
51 and even though every precaution was taken to eliminate 
exposure to air, traces of O2 could be hindering the reaction by oxidizing the catalyst.  Although 
complete conversion was not achieved with the simpler substrates that had been used to explore 
the coupling chemistry, attention was turned to the coupling of a highly functionalized aryl 
iodide.   
In principle, coupling of a 1,3,5-trisubstituted aryl subunit with 19 would install all the 
requisite functionality for the fully functionalized system.  Therefore, the aniline derivative 33 
was converted to aryl iodide 70 under Sandmeyer conditions (Eq 2).  The reaction was very poor 
yielding (8%), but enough material was obtained in order to attempt the key coupling reaction.  
When 70 was treated with diamine ligand 60 and only 10 mol % of CuI, the lactam 37 was 
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isolated in 33% yield after 38 h (Table 3-1, entry 6).  However, the more reactive 
cyclohexanediamine ligand 61 in the presence of 30 mol % CuI provided 37 in 73% yield after 2 
days (Table 3-1, entry 7).  The reactions still did not reach full conversion, but the successful 
coupling of a highly substituted aryl iodide to the valuable aziridinopyrrolidinone 19 emphasized 
the potential of the coupling reaction of route C, and the viability of coupling the two pieces in 
order to efficiently reach the key intermediate 16.  Now that an efficient route to analogs of 16
had been developed, synthetic studies toward mitosane 14a,b could continue with investigation of 
the key tetracycle bond-forming event. 
 
Part 2: Enantioselective synthesis of a 9-oxo-pyrrol [1,2-a]indole 
Tetracycle Formation 
 Successful formation of the N-aryl aziridinopyrrolidinones 37, 46 and 67-69 was the first 
major accomplishment in the synthesis of the biosynthetic probes 13a and 13b.  The next key 
stage in the synthetic endeavor was installation of the final carbons required for tetracycle 
formation and  the final C-C bond forming event.  Many different routes to the tetracycle could be 
envisioned from the substrates obtained in the copper catalyzed amidation reactions.  For 
example, the 1,3,5-functionalized arene 37 would require a subsequent functionalization at carbon 
a (Eq 3).  Directed ortho-metallation using the methoxy substituent and lactam as directing 
groups should provide regioselective metallation at the common carbon.59  Trapping of the 
aryllithium with an appropriate electrophile and further transformation could provide vinyl halide 
71.  Finally, lithium-halogen exchange and 1,2-addition into the appended lactam would form the 
desired tetracycle 72.  Unfortunately, the susceptibility of the lactam of 37 to nucleophilic 
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addition by alkyllithiums was a concern because this route would require extensive use of strong 
base and/or alkyllithiums.  Furthermore, the poor avail bility of the aryl halide 70, as well as the 
number of steps and control of regioselectivity required to prepare an intermediate such as 71, 
made this route less desirable.  Therefore, strategies from the already synthesized o-
functionalized lactams 67 – 69 were considered. 
 Fortunately, a unique bond-forming event could be envisioned from TMS-acetylene 
substrate 67 that might solve the anticipated problems.  Cha60 and Sato61 have shown that 
modified Kulinkovich reactions are suitable for affecting intramolecular nucleophilic acyl 
substitution reactions (INAS) of alkenes and alkynes.  Sato invoked the formation of the 
nucleophilic titanacyclopropene 74 when ester 73 was treated with chlorotitaniumtriisopropoxide 
(ClTi(Oi-Pr)3).  The titanacycle reacts with the appended carbonyl t  form the titanaoxacycle 75 
(Scheme 3-12), which after hydrolysis affords the cyclized product 76.  Importantly, Sato found 
that the TMS group is essential for the reaction to occur.  Meanwhile, Cha formed the mitosane 
core using a similar approach (Scheme 3-13).  Treatm nt of the alkene 77 with 
cyclohexylmagnesium chloride formed the titanacyclopropane, which interacts with the appended 
imide to form titanaoxacyclopentane 78.  Trapping of the titanacycle with O2,
60b installed the 
requisite hydroxymethyl functionality of the mitomycins.  We envisioned a similar approach to 
the mitosane core, where the cyclization of the TMS-acetylene via a titanocyclopropene would 
give an external olefin that could be stereoselectiv ly oxidized to provide the desired 




Scheme 3-12. INAS reaction of TMS-acetylenes 
 
Scheme 3-13. Modified Kulinkovich reaction to form the mitosane core 
 
Following the Cha and Sato analogies, a mixture of TMS-acetylene 67 and 
chlorotitaniumtriisopropoxide was treated with isopropyl magnesium chloride (Scheme 3-14).  
However, the crude reaction mixture consisted of 21% unreacted starting material and a new 
product assigned as TMS alkene 80 after isolation (31%).  The 1H NMR spectrum of 80 showed a 
new doublet downfield at δ = 6.03 ppm with a J value of 15.0 Hz.  Using two-dimenionsal COSY 
NMR spectroscopy, the alkenyl proton at δ = 6.03 ppm was observed to couple with another 
alkenyl proton at δ = 7.53 ppm.  The large coupling constant was consistent with a cis olefin as 
reported by Soderquist.62  The strongly deshielded alkenyl proton can be explained by proximity 
to the amide and phenyl groups.  The formation of 80 showed that the titanium had bonded with 
the alkyne, but the desired bond forming event at the amide carbonyl had not occurred.   
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Using Cha’s conditions with cyclopentyl magnesium chloride, which promotes facile 
ligand exchange between a titanacyclopropane and the alkyne substrate, provided a complex 
mixture of products upon deuterium quench and workup.  Visible by 1H NMR spectroscopy were 
two aziridine peaks upfield at δ = 2.32 (d, J = 4.5 Hz) and 2.17 (dd, J = 4.5, 2 Hz) ppm, which 
suggested the presence of a hemi-aminal containing an exocyclic olefin (Chapter 2, Table 2.3).  
Consequently, the product of the reaction was tentaively assigned as 81.  However, the material 
decomposed as it was concentrated (indicated by a color hange from bright yellow/green to dark 
orange) and purification by silica gel chromatography provided many bands consisting of 
complex materials.  One component of the purified mixture was assigned as mitosene 82 based on 
a pair of aziridine protons at δ = 3.00 (d, J = 5.0 Hz) and 2.94 (dd, J = 4.8, 3.8 Hz) ppm observed 
in the 1H NMR spectrum (Chapter 2, Table 2.3).  Attempts to improve the reaction or to 
derivatize the major product by oxidation of the mixture with OsO4 and NMO resulted in 
complex mixtures.  Although the observation of 81 and 82 by 1H NMR spectroscopy of the crude 
reaction mixture showed that the C–C bond forming event was occurring, the inability to isolate 
the tetracycle or to oxidize it to an isolable derivative showed that this strategy was futile.  
However, other strategies to form the final tetracycli  bond could be pursued using dithiane 68 
and silylated cyanohydrin 69.  

































 We envisioned using dithiane 68 and cyanohydrin 69 as acyl anion equivalents to form 
the final C(9)-C(9a) (mitosene numbering) bond of the tetracycle.  It is known that anions 
generated by deprotonation of dithianes63 and cyanohydrins64 are nucleophiles that can add to 
carbonyls.  Therefore, various bases were screened in the attempt to deprotonate dithiane 68 for 
intramolecular 1,2-addition.  Treatment of dithiane 68 with n-BuLi resulted in addition of the n-
BuLi into the lactam in accordance with our previous studies with lactams of the 3,6-
diazabicyclo[3.1.0] hexane ring system.  Lithium diisopropyl amide (LDA) gave a complex 
mixture of products when used to deprotonate 68.  Although starting material had been 
consumed, the main component could not be identified.  By 1H NMR spectroscopy the major 
product appeared to be a dimer of the dithiane, which could have formed by an intermolecular 
process.  Finally, treatment of 68 with potassium hexamethyldisilylazide (KHMDS) and 
quenching the reaction with deuterated methanol resulted in recovered starting material with no 
deuterium incorporation (Eq 4).  Since the dithiane was not deprotonated by KHMDS and gave 
undesired side reactions with LDA and -BuLi, further anionic cyclization attempts focused on 
the cyanohydrin 69. 
 
Successful tetracycle formation was accomplished by addition of the cyanohydrin anion 
of 69 to the appended lactam.  After screening base, solvent, and temperature the optimal 
conditions for 1,2-addition were found to be slow addition of 69 as a non-homogenous solution in 
Et2O to 1.3 equiv of LiHMDS at -78 °C in Et2O, stirring for 30 min at -78 °C, followed by 
warming the reaction to 0 °C, and stirring for 10 min.  Analysis of the crude reaction mixture by 
1H NMR spectroscopy showed tetracycle 88 as a 2:1 mixture of diastereomers (Scheme 3-15).  It 
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was found that the major diastereomer was stable to purification and could be isolated, but the 
minor diastereomer decomposed on silica gel, NEt3 deactivated silica gel, and basic alumina.  
While screening bases for this transformation, it was found that KHMDS was ineffective for 
addition.  On the other hand, excess lithium diisopropylamide (LDA) effected the desired 
tetracycle formation, but the crude material was contaminated by complex side-products.     
Scheme 3-15. Protected cyanohydrin addition into lactam 69 
 
It became apparent that allowing the temperature to increase during the reaction was 
crucial for successful ring formation.  With LDA asthe base, allowing the temperature to reach 0 
°C was essential for formation of the stable isomer, while trapping the tetrahedral intermediate at 
-12 °C with Ac2O gave primarily the acetate derivative of the unstable isomer 89.  Furthermore, 
when a mixture of cyanohydrin diastereomers was treated with LDA and the reaction was 
quenched at -46 °C, only one diastereomer of cyanohydrin 69 was isolated.  This suggests that 
deprotonation occurs at -78 °C, but that warming is es ential for carbanion addition to the lactam.  
When the LiHMDS reaction was stopped at -12 to 0 °C, the more stable diastereomer was the 
major diastereomer formed; however, if the reaction was stirred at 0 °C for extensive periods of 
time (>30 min), more starting material was observed after quenching the reaction.  Although the 
origins of product ratio discrepancies when using LDA versus LiHMDS are unclear, all of these 
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observations suggest that the addition product 87 is in equilibrium with carbanion 86.  
Furthermore, stopping the reaction soon after reaching 0 °C was necessary for good conversion to 
the more stable tetracycle.     
The major diastereomer of 88 and the acetate derivative 89 could be converted to the 
ketones 90 and 91 via removal of the silylated cyanohydrin with TBAF.  Due to the locked ring 
system and the reduced flexibility with the sp2 C(9) carbon, it was possible to perform 2D 
NOESY NMR experiments.  The 2D NOESY NMR spectrum of the stable diastereomer showed 
an NOE correlation between Ha and an aryl proton on the benzene ring.  This type of through 
space interaction would only be possible if the tertiary alcohol was on the opposite face of a cis-
fused tetracycle relative to the aziridine.  On the other hand, the acetate derivative 89 showed a 
NOE correlation between Hb and the analogous aryl proton, which is only possible if the acetoxy 
group is on the same face as the aziridine.  The assigned stereochemistry was confirmed when the 
X-ray crystal structure of 90 was obtained (Fig 2).  As expected, the alcohol and aziridine are on 
opposite faces of the tetracycle, and the desired diastereomer 88 is the more stable 
thermodynamic product of the cyclization.  The stereochemistry at C(9a) obtained in the 
cyclization step matches the stereochemistry at C(9a) of mitomycin C, and is the stereochemistry 





Figure 3-2. X-ray crystal structure of tetracycle 90. 
At this stage, we had successfully synthesized analogs of the advanced intermediate 14a 
and the precursor 16 in the planned synthesis of 13a,b.  However, before applying the new 
methodology to the fully functionalized system, it seemed prudent to study addition of various 
masked methyl alcohols into the ketone to confirm that the C(10) carbon can be installed on 9-
oxo-pyrrolo[1,2-a]indole substrates.  Danishefsky showed that reductive ring opening of 
exocyclic epoxides derived from dihydrobenzoxazine derivatives provides the hydroxymethyl 
moiety of FR900482.65  Therefore, various sulfur ylides were screened for epoxide (92) formation 
from the ketone 90, but they were unreactive with the substrate.  To av id possible interference 
by the tertiary alcohol, the hydroxyl group was protected as silyl ether 93 (Scheme 3-16).  When 
ketone 93 was treated with excess trimethylsilylmethyl lithium using Danishefsky’s procedure, 
tertiary alcohol 94 was produced in 67% yield.  Furthermore, transformation of the tertiary 
alcohol into the C(10) hydroxymethyl group of 95 can be envisioned using Danishefsky’s 
precedent.29  Therefore, an efficient synthesis of the model 90 was accomplished using the 
copper-catalyzed coupling of two pre-functionalized subunits, followed by a stereoselective 
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cyclization event.  As shown below, the model keton 93 was susceptible to nucleophilic 
addition, thereby facilitating installation of the C(10) hydroxymethyl moiety.  Finally, with a 
clear strategy for preparing the 9-oxo-pyrrolo[1,2-a]indole, all that had been learned on accessing 
the α-hydroxy ketone 90 could now be applied to the synthesis of fully functionalized 14a.   
Scheme 3-16. Installation of the C(10) carbon. 
 
Synthesis of the fully functionalized 9-oxo-pyrrolo[1,2-a]indole 96 
 Investigations leading to model 90 revealed that the most efficient way to access the key 
aziridinopyrrolidinones 67-69 is coupling a pre-functionalized aryl subunit with the preformed 
aziridinopyrrolidinone 19.  Based on the chemistry utilized during these studies, the retrosynthetic 
analysis of 13a,b was revised (Scheme 3-17).  Late stage deprotection and C(10) installation can 
be envisioned from α-hydroxy ketone 96.  The tetracycle would be derived from the aldehyde 97 
via an acyl anion equivalent addition into the appended lactam.  Using the catalyzed amidation 
reaction, 3,6-diazabicylo[3.1.0]hexane 97 would be accessed from pyrrolidinone 19 and the fully 
protected and functionalized aryl triflate 98.  We decided to target the aryl triflate instead of the 
aryl iodide because of the high availability of phenols and the well precedented conversion of 
phenols into triflates.  The conversion of phenols to iodides is less precedented,66 and the 
conversion of an aryl amine into an iodide using the Sandmeyer reaction proved to be difficult on 
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a functionalized substrate (Eq 2).  Aryl triflate 98 was envisoned to arise from known dibenzyl 
aldehyde 99, which was available from 4-bromo-3,5-dihydroxy benzoic acid 100.67 
Scheme 3-17. Retrosynthetic analysis of thioesters 13a,b. 
 
 Following the procedure of Lampe,67 acid 100 was converted to aldehyde 99 in 4 steps 
with an overall yield of 33% (Scheme 3-18).  At this stage, desymmetrization of the molecule was 
required in order to obtain the desired phenol.  Therefore, using a procedure reported by 
Stoddart68 and Hendrickson69 for monodebenzylation, 99 was treated with NaOMe in MeOH and 
1,4-dioxane with 10% of Pd/C under an H2 atmosphere to cleave only one benzyl group.  As 
reported, it was important to monitor the uptake of H2 because full debenzylation of the substrate 
was possible.  However, when approximately 1 mol equiv of H2 was consumed, the 
monodebenzylated phenol 101 could be isolated in moderate yield (53%) as pale ye low crystals. 





Scheme 3-18. Synthesis of aryl-triflate 98. 
 
 At this stage, it was necessary to consider which coupling partner would be successful in 
the transition metal-catalyzed amidation reaction.  Although aryl triflates are known to undergo 
Pd-catalyzed71 amidation reactions and intramolecular copper-catalyzed amidations,72 they have 
not been reported to participate in copper-catalyzed intermolecular amidation reactions.  
Consequently, the ability of the triflate to undergo the previously optimized copper catalyzed 
coupling was suspect, and the conditions used to produce models 64-66 would need to be 
optimized for the triflate.  Furthermore, the presence of the aldehyde would complicate the 
transformation because it would activate the triflae for oxidative addition, but it could also be 
susceptible to nucleophilic attack under the reaction conditions.  In order to circumvent the 
expected sensitivity of the aldehyde, 98 was converted into cyanohydrin 102 using ZnI2-catalyzed 
cyanosilylation conditions (88%).58   Attempts to prepare the aryl iodide as the optimal coupling 
partner by nucleophilic displacement of the activated riflate with LiI were unsuccessful, so 




Scheme 3-19. Palladium catalyzed coupling of 98 and 19. 
 
Table 3-4. Transition metal-catalyzed coupling of aryl triflate with 19a 
Entry R Pd Ligand Base Temp (°C) 97 103 






80 23% 35% 






rt -- ndb 






80 9% 18% 




80 -- -- 






80 64% 9 % 






80 -- -- 




110 -- -- 
aReaction run in 1,4-dioxane. bMajor product by 1H NMR spectroscopy.  cReaction run in 
toluene. 60b = N,′N-dimethylcyclohexanediamine. nd = not determined. -- = not observed by 
1H NMR spectroscopy 
  
 Literature precedent demonstrates that palladium will catalyze aryl amidation reactions 
between amides and triflates.50  Following procedures developed by Buchwald and coworkers, 
the triflate 98 was treated with 1.2 equiv of lactam 19 in the presence of 2 mol% Pd2( ba)3, 
xantphos, and Cs2CO3 (Scheme 3-18).  Heating at 80 °C provided 23% yield of the desired adduct 
97 after 1 h (Table 3-4, entry 1).  Under these conditions, a significant amount of triflate had been 
converted into the phenol 101, most likely by nucleophilic attack at the activated sulfur atom.73  
Also, a large amount of byproduct, assigned as 103 based on ESMS ([M + H] m/z = 991), was 
isolated in 35% yield.  The byproduct had incorporated two equivalents of lactam, as evidenced 
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by two CH2 ABX methylene pairs in the 
1H NMR spectrum, as well as one equiv of triflate.  
Structural assignment of 103 was facilitated by the presence of an exchangeable proton at δ = 
8.66 ppm, and the heteronuclei coupling of the carbinolamide carbon at δ = 58.8 ppm to a proton 
at δ = 7.17 ppm.  Assuming that nucleophilic addition into the aldehyde was a result of increased 
reactivity of the substrate at high temperatures, the reaction was run at rt; however, only 103, 101, 
and 19 were detected by 1H NMR spectroscopy (Table 3-4, entry 2).  Attempts to improve the 
reaction by switching the palladium source to Pd(OAc)2 did not increase conversion to 97 (entry 
3).50  As expected, changing to copper-catalysis conditions did not give any product, most likely 
due to iminium ion formation between the diamine ligand and the aldehyde 98 (Table 3-4, entry 
4).  Based on the coupling results and the unavoidable formation of the byproduct 103, even at rt, 
it was hypothesized that the byproduct formation was b se catalyzed and that changing the base 
may be helpful.  Therefore, K3PO4, which was successful in the copper-catalyzed coupling of aryl 
iodides (Table 3-3), was tested.74  In the event, coupled product 97 was isolated in 64% yield, 
along with only 9% of 103 (Table 3-4, entry 5).  Survival of the triflate was lso improved under 
these conditions as evidenced by the increased yiel, and the decreased amount of 101 observed 
by 1H NMR spectroscopy of the crude reaction mixture.   
 Even though successful coupling had been accomplished with the aldehyde 98, coupling 
of the cyanohydrin 102 would reduce the number of steps required after installation of the 
sensitive aziridine.  Therefore, 102 was treated with Pd2(dba)3, xantphos, and Cs2CO3; however, 
decomposition products and 19 were the only compounds visible by 1H NMR spectroscopy 
(Table 3-4, entry 6).  The copper-catalyzed conditions gave only phenol 101 and lactam 19 (Table 
3-4, entry 7).  The lack of reactivity of the cyanohydrin 102 was not surprising because the 
electron withdrawing aldehyde should increase the reactivity of the conjugated triflate.  
Furthermore, the reaction might also be impeded by the sterically bulky silylated cyanohydrin.   
 The ability to access the functionalized aziridinopyrrolidinone 97 allowed the synthesis 
of the mitosane 96 to continue.  Attempts to install the silylated cyanohydrin on 97 with catalytic 
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ZnI2 and TBSCN resulted in significant decomposition of the substrate due to the Lewis acidic 
character of the catalyst (Scheme 3-20).  However, the transformation of 97 to 104 could be 
effected using Greenlee’s method (catalytic KCN, 18-crown-6 ether, and TBSCN),75 affording 
104 in approximately a 1:1 mixture of diastereomers at C(9a) in excellent yield (97%) (Scheme 3-
19). The diastereomers could be separated by silica gel chromatography, but based on model 69, 
separation was not necessary for the acyl anion addition.  Therefore, the mixture of diastereomers 
was treated with 3 equiv of LiHMDS in Et2O to afford a mixture of tetracycle 107 (54%) and 
recovered 104 (both diastereomers, 28%).  Fortunately, only one diastereomer of 107 was 
apparent by 1H NMR spectroscopy.  The 1H and 13C NMR spectra of 107 correlated very well 
with the NMR spectra of the model tetracycles.  
In comparison to model system 69, cyclization of 104 to 107 was much more 
problematic.  Following the optimized procedure developed in the model system resulted in poor 
conversion to 107 and recovery of both diastereomers of 104.  In order to achieve good 
conversion to the tetracycle, several changes in the procedure were necessary.  First, before 
addition of base, the substrate was dissolved in toluene and the solvent was removed under N2 
flow to remove any residual water.  The possibility of toluene acting as a cosolvent was 
discounted by poor conversion to 107 when toluene was added to a solution of 104 in Et2O 
(tol:Et2O, 1:2).  Second, after stirring anion 105 at -78 °C, the cloudy solution was warmed 
slowly to 0 °C.  During warming, lightening of the color near -15 °C was usually indicative of 
tetracycle formation.  Finally, it was necessary to stir the solution for longer periods of time at 0 
°C (~ 40 min) because quenching the reaction after only a few minutes at 0 °C gave poor 
conversion to 107.            
Determination of the C(9a) stereochemistry of 107using two-dimensional NOESY NMR 
spectroscopy studies was inconclusive, so the silylated cyanohydrin was cleaved to produce the 
α-hydroxy ketone 96 in good conversion.  The 13C NMR spectra of 96 showed the characteristic 
hemi-aminal carbon signal at δ = 97.5 ppm which is consistent with previously synthesized α-
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hydroxy ketone mitosanes.31,33  One - dimensional NOE difference 1H NMR spectroscopy studies 
confirmed that the alcohol was trans to the aziridine (Scheme 3-20).  Irradiation of Ha showed a 
16% enhancement of an aryl proton (Hc) and 3.4% enhancement of the C(2) aziridine proton Hd.  
Irradiation of Hb did not show any enhancement in the aryl region, but did show a 4% 
enhancement of Hd.  In the model 90, the NOE correlation between Ha and the aryl proton was 
only possible in the trans form as confirmed by the X-ray crystal structure, while the cis form 
showed a correlation between Hb and the aryl proton.   Since the expected no through space 
interaction between Hb and Hc of 108 was not observed, the diastereomer obtained in the 
cyclization does not have the tertiary alcohol and ziridine on the same face. Accordingly, the 
desired diastereomer of 96 had been accessed with excellent diastereoselectivity during the 
addition step. 




 The results of the cyclization on the fully functionalized system are different than what 
was observed in the model study of silyl cycanohydrin 69.  As mentioned above, the cyclization 
of 104 required longer reaction time at higher temperatures in contrast to the model system.  A 
decrease in reactivity of the anion of 104 due to the presence of the para electron withdrawing 
ester would account for the need of higher temperatures for cyclization.  However, the electron 
donating ortho benzyloxy group, not present in 69, would destabilize the anion 105 so that the 
equilibrium at 0 °C would favor the cyclized product 106.  Formation of larger quantities of 
cyclized product 107 than starting material 104 suggests that the equilibrium for the cyclization 
lies to the right at 0 °C (Scheme 3-20).  Also, assuming that the diastereomers of 106 equilibrate 
via anion 105, observation of only one diastereomer supports the conclusion that the equilibrium 
between 105 and 106 lies to the right.  Furthermore, in contrast to the model, these results suggest 
that the trans diastereomer 107 is both the kinetic and thermodynamic product of the cyclization 
event of anion 105 at 0 °C.   
Conclusions 
After considerable effort, an appropriately functionalized analog of the mitosane 14a has 
finally been obtained.  The plan to construct the C(9)-C(9a) bond by anion addition to the 
appended lactam proved successful on both a model an  a fully functionalized system using a 
deprotonated silyl cyanohydrin.  However, construction of the tetracycle precursor took much 
effort and a critical evaluation of three distinct strategies.  Fortunately, the powerful transition 
metal-catalyzed coupling of the key aziridinopyrrolidinone 19 with a pre-functionalized aryl 
halide or triflate allowed successful construction f the pivotal N-aziridinopyrrolidinone 
intermediate.  Following this breakthough, the synthetic obstacles leading to the key tetracycle 
could ultimately be overcome, and the α-hydroxy ketone 96 could be synthesized 
stereoselectively in 9 steps (longest linear sequence) from the known mesylate 35.  Another 
notable observation made during the synthesis of these densely functionalized pyrrolo[1,2-
a]indole derivatives was the difference in stability compared to the aziridinomitosene derivatives 
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of FK317.  Mitosanes 88-93, 107, and 96 survived silica gel chromatography and storage in 
frozen benzene in contrast to their mitosene counterparts.  The stability can be attributed to the 
absence of the indole functionality which activates the aziridine for facile ring opening.   
It is worth noting that new chemistry involving the valuable chiral aziridine was 
developed during the synthetic endeavor towards 96.  Specific highlights include the formation of 
the azirdinolactam 19 using an unprecedented dianion trapping event.  These intriguing 
conversions eventually enabled coupling of the sterically hindered chiral lactam aziridine 19 with 
a fully functionalized aryl triflate, resulting in a convergent and efficient synthesis of the 
tetracycle 96.  The stereochemistry of the fused ring system of 104 facilitates diastereoselective 
construction of the desired stereoisomer of the tetracycle during cyclization of a protected 
cyanohydrin anion.  Particularly gratifying was thediscovery that the stereoisomer needed for the 
synthetic probes 13a,b corresponds to the more stable isomer formed from cyclization of the 
lithiated cyanohydrin ether. Studies toward completion of the target biosynthetic probes 13a and 
13b can now proceed with a focus on installation of C(10) on 96, global deprotection, and 
modifications of the probe as required for recognitio  by enzymes of the biosynthetic pathways of 







General Methods.  Solvents and reagents were purified as follows: diethyl ether and 
tetrahydrofuran (THF) were distilled from sodium/benzophenone or purified using an Anhydrous 
Engineering solvent purification system using columns packed with A-2 Alumina; 
dichloromethane (CH2Cl2) was distilled from P2O5 or purified using an Anydrous Engineering 
solvent purification system using columns packed with A-2 Alumina; CH3CN was stirred over 
molecular sieves for 24 h, then distilled from P2O5; benzene, toluene, triethylamine, i-PrEt2N, 
TMEDA, and DMPU were distilled from CaH2; methanol was distilled over activated magnesium 
turnings, the purified reagents and solvents were used immediately or stored under nitrogen. 
Alkyl and aryllithiums were titrated using the procedure of Watson76 before use.  Unless 
otherwise noted, all chemicals were used as obtained from commercial sources and all reactions 
were performed under nitrogen atmosphere in glassware dried in an oven (140 °C) or flame dried 
and cooled under a stream of nitrogen.  All reactions were stirred magnetically unless otherwise 
noted and liquid reagents were dispensed with all PP/PE plastic syringes or Hamilton Gastight 
microsyringes.  Preparatory layer chromatography was performed using Whatman Partisil® K6F 
silica gel 60 Å 200 µm or 1000 µm plates. Flash chromatography was performed with 230-400 
mesh silica gel 60. 
 
 
tert-Butyl 3-(tert-butoxycarbonylamino)-5-methoxybenzoate (24). To a solution of tert-butyl 
3-amino-5-methoxy benzoate77 (0.93 mmol, 208 mg) in 9.3 mL THF was added Boc2O (2.3 
mmol, 502 mg) in one portion. The reaction flask was fitted with a reflux condenser and heated to 
60 °C in an oil bath.  After 2 d of stirring, the raction was cooled to rt.  The solution was 
partitioned between saturated aqueous NaHCO3 and Et2O and extracted 3 x with Et2O, washed 
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with H2O, and with brine.  The organic phase was dried over MgSO4 and concentrated to a white 
solid.  The solid was crystallized from warm ethyl acetate and hexanes to produce 158 mg (53%) 
of 22 as white crystals,  mp 149 °C; molecular ion calculated for C17H25NNaO5 [M + Na] = 
346.1630, found (electrospray) 346.1626, error = 1 ppm; IR (neat, cm-1) 3337, 1707, 1697; 400 
MHz 1H NMR (CDCl3, ppm) δ 7.44 (1H, br s) 7.32-7.28 (1H, m) 7.22- 7.18 (1H, m) 3.84 (3H, s) 
1.58 (9H, s) 1.52 (9H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 165.3, 160.2, 152.5, 129.5, 133.6, 
111.7, 109.4, 108.4, 81.2, 80.8, 55.6, 28.3, 28.2. 
 
 
N-Boc aniline aziridine (25). To a solution of 24 (1.42, mmol, 460 mg) in 20 mL THF and 10 
mL DMPU at -78 °C was added NaHMDS as a solution in THF (0.71 mL, 2.0 M, 1.42 mmol).  
The mixture was stirred at -78 °C for 5 min, then iodide 26 (0.47 mmol, 338 mg) in 3 mL THF 
was added via syringe, and the reaction turned light yellow.  The solution was removed from the 
cooling bath and concentrated by half with a stream of N2 while warming to rt.  The flask was 
then fitted with a reflux condenser and heated to 60 °C.  After 4 d, the reaction mixture was 
cooled to rt and acidified with pH 3 phosphate buffer.  The mixture was extracted 3 x with Et2O, 
washed  with brine, and dried over MgSO4.  Removal of the solvent under rotary evaporation 
provided a cloudy yellow oil.  The crude residue was purified by flash column chromatography (4 
x 15 cm silica gel with 9:1 hexanes: ethyl acetate, Rf = 0.31) to provide 116 mg (21%) of 25 as a 
light yellow oil.  Molecular ion calculated for [M + Na] C51H70N2NaO5Sn = 933.4204, found 
(electrospray) 933.4238, error = 3 ppm; IR (neat, cm-1) 1702; 400 MHz 1H NMR (CDCl3, ppm) δ 
7.40-7.32 (7H, m), 7.19-7.10 (10 H, m) 6.49 (1H, t, J = 2.2 Hz)  4.00 (1H, dd, J = 14.0, 8.0 Hz) 
3.70 (1H, dd, J = 14.0, 2.8 Hz) 1.55 (9H, s) 1.50-1.39 (15H, m) 1.32-1.19 (8H, m) 1.20-0.89 (7H, 
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m) 0.86 (9H, t, J = 7.2 Hz); 100 MHz 13C NMR (CDCl3, ppm) δ 165.1, 159.3, 154.1, 144.3, 
142.6, 133.2, 129.5, 127.1, 126.4, 119.7, 117.7, 81.1, 80.6, 75.5, 55.5, 34.6, 29.3, 29.2, 28.5, 28.1, 
27.3, 24.2, 13.7, 10.0. 
 
 
(3-Methoxy-5-nitrophenyl)allylmethylether (32). To a solution of starting alcohol 3178 (2.95 
mmol, 541 mg) in 30 mL toluene was added Bu4NI (0.15 mmol, 57 mg) and NaOH (5.9 mmol, 
236 mg).  Neat allylbromide (5.9 mmol, 0.51 mL) was added dropwise via syringe.  The reaction 
vessel was fitted with a reflux condenser and heated to 90 °C.  After 5 h, the non-homogenous 
orange mixture was cooled to rt and filtered through celite with Et2O.  The solvent was then 
removed under rotary evaporation.  The crude reaction mixture was purified by flash column 
chromatography (3 x 16 cm silica gel, 9:1 hexanes: ethyl actate, Rf = 0.34). Fractions 14 – 20 
provided 506 mg (77%) of product 32 as a clear colorless oil. Molecular ion calculated for 
C11H13NO2, = 223.0845, found (EI) m/z = 223.0846, error = 0.4 ppm; 500 MHz 
1H NMR (CDCl3, 
ppm) δ 7.81 (1H, d, J = 0.5 Hz) 7.64 (1H, t, J = 2.3 Hz) 7.24 (1H, d, J = 0.5 Hz) 6.0 – 5.9 (1H, m) 
5.34 (1H, ddd, J = 17.1, 3.5, 1.3 Hz) 5.25 (1H, ddd, J = 10.4, 2.8, 1.3 Hz) 4.56 (2H, s) 4.08 (2H, 
ddd, J = 5.5, 1.5, 1.5 Hz) 3.89 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 164.2, 149.3, 141.6, 
134.1, 119.7, 117.7, 114.6, 107.4, 71.7, 70.8, 55.9. 
 
 
3-(Allyloxymethyl)-5-methoxyaniline (33). To a solution of nitro 32 (1.47 mmol, 328 mg) in 6 
mL HOAc was added 1 equiv of Zn dust (8.82 mmol, 589 mg) every 10 min for 1 h.  The non-
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homogenous reaction was stirred vigorously for 2 h after which a saturated aqueous solution of 
NaHCO3 was added to neutralize the solution.  The mixture was poured into ethyl acetate and the 
aqueous phase was extracted 3 x with ethyl acetate.  Th  organic phase was then washed 3 x with 
H2O,  with saturated NaHCO3, with H2O, and then with brine.  Drying of the organic phase over 
Na2SO4 and rotary evaporation provided a cloudy orange oil.  The crude reaction mixture was 
purified by flash column chromatography (3 x 16 cm silica gel with 1:1 hexanes: ethyl acetate, Rf 
= 0.13).  Fractions 13-16 provided a clear yellow oil 33.  Molecular ion calculated for (M + H) 
C11H15NO2 = 194.1181, found (electrospray) 194.1176, error = 2.6 ppm; IR (neat, cm
-1) 3457, 
3359, 1597; 500 MHz 1H NMR (CDCl3, ppm) δ 6.31 (2H, dd, J = 7.5, 2.0 Hz) 6.16 (1H, t, J = 2.0 
Hz) 6.0-5.9 (1H, m) 5.31 (1H, ddd, J = 17.4, 3.5, 1.5 Hz) 5.20 (1H, ddd, J = 10.4, 3.0, 1.5 Hz) 
4.41 (2H, s) 4.01 (2H, ddd, J = 5.5, 1.5, 1.5 Hz) 3.76 (3H, s) 3.66 (1H, br s); 125 Hz 13C NMR 
(CDCl3, ppm) δ 160.9, 147.8, 140.8, 134.8, 117.1, 107.1, 100.3, 72.1, 71.1, 55.2. 
 
 
Methyl 3-(allyloxymethyl)-5-methoxyphenylcarbamate (34). To a solution of amine 33 (0.34 
mmol, 66 mg) in 2.2 mL ethyl acetate (HPLC grade) and 1.1 mL H2O was added solid NaHCO3.  
The non-homogenous mixture was stirred vigorously and methyl chloroformate (0.37 mmol, 0.03 
mL) was added via syringe.  After 1.5 h, the solutin was extracted 3 x with ethyl acetate, washed 
with brine, and dried over MgSO4.  Removal of the solvent under rotary evaporation provided 86 
mg (100%) of pure 34 as a clear yellow oil.  3:1 hexanes: ethyl acetate (Rf = 0.29); Molecular ion 
[M + Na] calculated for C13H17NO4Na = 274.1055; found (electrospray) = 274.1053, error = 1 
ppm; IR (neat, cm-1) 3322, 1736, 1713, 1609; 500 MHz 1H NMR (CDCl3, ppm) δ 7.06 (1H, br s) 
6.85 (1H, br s) 6.63 (1H, br t, J = 4.0 Hz) 6.59 (1H, br s) 5.95 (1H, m)  5.31 (1H, ddd, J = 17.3, 
3.5, 1.5 Hz) 5.21 (1H, ddd, J = 10.3, 2.8, 1.5 Hz) 4.46 (2H, s) 4.02 (2H, ddd, J = 5.5, 1.5, 1.5 Hz) 
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3.81 (3H, s) 3.77 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 160.4, 153.9, 140.6, 139.0, 134.6, 




methyl) carbamate (36).  To a solution of carbamate 34 (0.29 mmol, 73 mg) in 0.64 mL THF 
and 0.32 mL DMPU at -78 °C was added NaHMDS as a solution in THF (0.29 mL, 1.0 M, 0.29 
mmol) and the reaction turned olive green.  After 5 min, aziridine 3579 as a solution in THF (0.20 
mL, 0.48 M, 0.95 mmol) was added via cannula.  The reaction mixture was removed from the 
cooling bath and concentrated by half under N2 while warming to rt.  The reaction flask was then 
fitted with a reflux condenser and heated to 60 °C. After 2 d of heating, the reaction was cooled 
to rt, and 0.5 mL pH 3 phosphate buffer was added.  The mixture was then poured into H2O, 
extracted 3 x with Et2O, washed  with brine, and dried over MgSO4.  Rotary evaporation provided 
a cloudy orange oil.  The crude reaction mixture was purified by flash column chromatography 
(2.5 x 15.2 cm silica gel with 5:1 hexanes: ethyl acet te with 2% NEt3, Rf = 0.34). Fractions 19-
40 provided 56 mg (70%) of 36.  Molecular ion calculated for [M + Na] C47H62N2NaO4Sn = 
861.3629, found (electrospray) m/z = 861.3655, error = 3 ppm; IR (neat, cm-1) 1709; 500 MHz 1H 
NMR (CDCl3, ppm) δ 7.45 – 7.37 (6H, m) 7.20-7.12 (9H, m) 6.76 (1H, br s) 6.20 (1H, br s) 6.13 
(1H, br s) 5.96- 5.86 (1H, m) 5.27 (1H, ddd, J = 17.3, 3, 1.5 Hz) 5.19 (1H, ddd, J = 10.4, 3.0, 1.0 
Hz) 4.33 (2H, ABq, J = 12.3 Hz) 4.13(1H, m) 4.00-3.92 (2H, m) 3.77-3.58 (4H, s overlapping m) 
1.56 -1.40 (6H, m) 1.34 – 1.20 (7H, m) 1.10 – 0.92 (6H, m) 0.87 (9H, t, J = 7.3 Hz) 0.75 (1H, d, J
= 7.5 Hz); 100 MHz 13C NMR (CDCl3, ppm) δ 159.9, 155.7, 144.3, 141.7, 140.2, 134.7, 129.6, 
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tert-Butyl phenyl((3-tributylstannyl)-1-tritylaziridin-2-yl)methyl)carbamate (43). To a 
solution of carbamate 4280 (1.26, 243 mg) in 2.8 mL THF and 1.4 mL DMPU at 78 °C was added 
NaHMDS as a solution in THF (1.4 mL, 0.97 M, 1.38 mmol).  After 5 min of stirring, aziridine 
3579 as a solution in THF (0.42 mL, 1.0 M, 0.42 mmol) was added via syringe.  The reaction flask 
was removed from the cooling bath, warmed to rt, and concentrated by half under a stream of N2. 
After concentration, the flask was fitted with a reflux condenser and heated to 60 °C.  After 3 d, 
the reaction was cooled to rt and acidified with pH 3 phosphate buffer.  The mixture was poured 
into H2O, extracted 3 x with ethyl acetate, washed with brine, and dried over MgSO4.  Removal 
of the solvent under rotary evaporation provided a thick yellow oil.  Purification by flash column 
chromatography (3 x 15 cm silica gel, 9:1 hexanes: ethyl acetate with 2% NEt3, Rf = 0.42) 
provided 117 mg (36%) of 43 as an oil.  Molecular ion calculated for (M + H)  C45H60N2O2Sn = 
781.3755, found (electrospray) 781.3763, error = 1 ppm; IR (neat, cm-1) 1698; 400 MHz 1H NMR 
(CDCl3, ppm) 7.35-7.32 (6H, m) 7.19-7.09 (12H, m) 6.78-6.73 (2H, m) 4.00 (1H, dd, J = 14.0, 
8.0 Hz) 3.70 (1H, dd, J = 14.0, 2.8 Hz) 1.52-1.40 (7H, m) 1.32-1.22 (6H, m) 1.40-0.88 (6H, m) 
0.88 (9H, t, J = 7.2 Hz) 0.79 (1H, d, J = 7.2H); 100 MHz 13C (CDCl3, ppm) δ 154.3, 144.3, 141.4, 







N-((3-tributylstannyl)-1-tritylaziridin-2-yl)methyl)aniline 44. Carbamate 43 was heated neat 
with stirring to 180 °C in a sand bath.  The sand bath temperature was maintained near 180 °C, 
but peaked at 190 °C.  After 25 min of heating and stirring, the brown residue was cooled to rt.  
Purification by preparatory plate TLC on silica gel60 Å (20 cm x 20 cm x 1000 µm) pretreated 
with NEt3 fumes in 9 x 1 hexanes: ethyl acetate (Rf = 0.60) provided 46 mg (71%) of 44.  
Molecular ion calculated for [M + Na] C40H52N2Sn = 681.3231, found (electrospray) 681.3248, 
error = 2.5 ppm; IR (neat, cm-1) 3381; 500 MHz 1H NMR (CDCl3, ppm) δ 7.50-7.42 (5H, m) 
7.28-7.10 (12H, m) 6.73 (1H, m) 6.50 (2H, dd, J = 8.5, 1.0) 3.91 (1H, dd, J = 5.5, 5.7 Hz) 3.29 
(1H, ddd, J = 11.5, 5.5, 4.0 Hz) 3.15 (1H, ddd, J = 11.5, 5.7, 5.4) 1.57 (1H, ddd, J = 6.5, 5.4, 4.0) 
1.50-1.32 (6H, m) 1.30-1.21 (6H, m) 1.10-0.88 (7H, m) 0.84 (9H, J = 7.3 Hz); 100 MHz 13C 
NMR (CDCl3, ppm) δ 148.2, 144.4, 129.6, 129.1, 128.3, 127.4, 126.6, 117.5, 113.2, 75.6, 46.9, 
34.9, 29.2, 27.4, 24.7, 13.7, 10.2.  Signal at 126.3 ppm due to trace contamination of sample with 
aziridine 43.   
 
 
(1S,5S)3-phenyl-6-trityl-3,6-diazabicyclo[3.1.0]hexan-2-one (46). To a solution of 44 (0.026 
mmol, 18 mg) in 0.52 mL THF at -78 °C was added n-BuLi as a solution in hexanes (19 µL, 1.56 
M, 0.29 mmol).  The reaction turned light orange and then faded to pale yellow.  After 10 min of 
stirring in the cold bath, MeLi as a solution in Et2O (32 µL, 0.794 M, 0.26 mmol) was added via 
microsyringe. The solution became light pink.  The solution was warmed in a dry ice chloroform 
bath for 8 min, and the color faded to yellow within 5 min.  Then the solution was cooled to -78 
138 
 
°C and diethylcarbonate (0.26 mmol, 0.03 mL) was added via syringe.  The reaction flask was 
removed from the cooling bath and warmed to rt.  After 1 h, the mixture was acidified with 0.6 
mL saturated aqueous NH4Cl and poured into H2O.  Extraction of the mixture 3 x with Et2O, 
washing  with brine, drying over MgSO4, and removal of the solvent provided a yellow oily solid.  
Purification by preparatory plate TLC on silica gel60 Å (20 cm x 20 cm x 1000 µm, 3:1 hexanes: 
ethyl acetate) provided 5 mg (46%) of 46.  Molecular ion calculated for [M + Na] 
C29H24N2NaO = 439.1786, found (electrospray) 439.1765, error = 5 ppm; IR (neat, cm-1) 1702; 
400 MHz 1H NMR (CDCl3, ppm) δ 7.7-7.66 (2H, m) 7.54-7.48 (6H, m) 7.42-7.37 (2H, m) 7.34-
7.22 (9H, m) 7.20-7.14 (1H, m) 4.11 (1H, dd, J = 10.5, 1.0 Hz) 3.86 (1H, dd, J = 10.5, 4.0 Hz) 
2.55 (1H, dd, J = 4.8, 4.0 Hz) 2.51 (1H, dd, J = 4.8, 0.8 Hz); 100 MHz 13C NMR (CDCl3, ppm) δ 
171.3, 143.8, 139.5, 129.1, 128.9, 127.9, 127.2, 124.6, 119.8, 73.8, 50.6, 39.7, 31.8.  
 
 
 tert-Butyl 3-allyloxymethyl-5-methoxyphenylcarbamate (48). To a solution of amine 33 (0.70 
mmol, 135 mg) in 7 mL THF was added Boc2O (1.75 mmol, 394 mg) in one portion.  The 
reaction vessel was fitted with a reflux condenser and heated to 60 °C.  After 18 h, the solution 
was cooled to rt and poured into H2O.  The mixture was washed 3 x with Et2O, washed  with 
brine, and dried over MgSO4.  Rotary evaporation provided a pale yellow oil.  Purification of the 
crude reaction mixture by flash column chromatography (2 x 15 cm silica gel, 3:1 hexanes: ethyl 
acetate, Rf = 0.33) provided 163 mg (80%) of product 48 in fractions 9-13.  Molecular ion 
calculated for [M + Na] C16H23NNaNO4 = 316.1525, found (electrospray) m/z = 316.1512, error = 
4 ppm; IR (neat, cm-1) 3322, 1726, 1702, 1604; 500 MHz 1H NMR (CDCl3, ppm) δ 7.00 ( 1H, br 
s) 6.86 (1H, br s) 6.60 (1H, br s) 6.50 (1H, br s) 6.0 – 5.9 (1H, m) 5.30 (1H, ddd, J = 17.4, 3, 1.3 
Hz) 5.20 (1H, ddd, J = 9.8, 2.7, 1.3 Hz) 4.45 (2H, s) 4.01 (2H, ddd, J = 6.0, 1.2, 1.0 Hz) 3.79 
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(3H, s) 1.51 (9H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 160.3, 152.5, 140.4, 129.5, 134.6, 




methyl)carbamate (49). To a solution of aniline 46 (0.78 mmol, 229 mg) in 1.7 mL THF and 
0.87 mL DMPU at -78 °C was added sodium hexamethyldisilylazide as a solution in THF (0.88 
mL, 0.89 mmol) via syringe.  The solution turned dark yellow.  After 5 min of stirring, aziridine 
3579 (0.26 mmol, 185 mg) was added as a solution in 0.60 mL THF dropwise via cannula, and the 
yellow solution turned green.  The reaction vessel was removed from the cooling bath and 
warmed to rt while concentrating by half under a stream of N2.  After reaching rt, the reaction 
vessel was fitted with a reflux condenser and heated to 60 °C.  Over the heating period, 1 mL of 
THF was added to maintain solvent volume.  After 4 d of heating, the reaction was cooled to rt 
and acidified with pH 3 phosphate buffer.  The mixture was partitioned between H2O and ethyl 
acetate, and extracted 3 x with ethyl acetate.  Thecombined organic phases were washed with 
brine, dried over Na2SO4, and concentrated under reduced pressure to an orange/brown oil.  
Purification of the crude residue by flash column chromatography (3 x 15 cm silica gel with 9:1 
hexanes: ethyl acetate with 2% NEt3, Rf = 0.37) provided 150 mg of 49.  Molecular ion 
calculated for [M + N] C50H68N2NaO4Sn = 903.4099, found (electrospray) 903.4119, error = 2 
ppm; IR (neat, cm-1) 1695, 1594; 500 MHz 1H NMR (CDCl3, ppm) δ 7.37-7.36 (5H, d, J = 7.0 
Hz) 7.18-7.12 (9H, m) 6.72 (1H, s) 6.29 (1H, s) 6.26 (1H, s) 5.96-5.86 (1H, m) 5.25 (1H, ddd, J =
17.3, 3, 1.5 Hz) 5.17 (1H, ddd, J = 10.4, 3, 1.0) 4.32 (2H, ABq, J = 12.5 Hz) 3.99 (1H, dd, J = 
14.3, 8.0 Hz) 3.97-3.89 (2H, m) 3.67 (1H, dd, J = 14.3, 2.5 Hz) 3.62 (3H, s) 1.52-1.38 (15H, m) 
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1.32-1.22 (9H, m) 1.06-0.90 (6H, m) 0.86 (9H, t, J = 7.3 Hz) 0.79 (1H, d, J = 7.0 Hz); 125 MHz 
13C NMR (CDCl3, ppm) δ 159.7, 154.2, 144.4, 142.4, 139.8, 134.7, 129.6, 127.1, 126.4, 118.2, 
117.0, 111.8, 110.5, 75.5, 71.6, 71.0, 55.3, 52.6, 34.1, 29.7, 29.3, 29.2, 28.6, 27.6, 27.4, 24.2, 




(50). Aniline 49 (0.14 mmol) was heated neat in a sand bath to ~ 190 °C under a flow of N2. After 
30 min, the brown residue was cooled to rt.  Purification of the residue by preparatory plate TLC 
(200 x 200 x 1000, 9:1 hexanes: ethyl acetate, Rf =0.29) provided 75 mg (69%) of 50.  
Molecular ion calculated for [M + Na] C45H50N2NaO2Sn = 803.3574, found (electrospray) 
803.3610, error = 4.5 ppm; IR (neat, cm-1) 3374; 400 MHz 1H NMR (CDCl3, ppm) δ 7.49-7.43 
(6H, m) 7.30-7.18 (9H, m) 6.29 (1H, d, J = 1.2 Hz) 6.11 (1H, s, ) 6.00-5.90 (2H, m) 5.30 (1H, 
ddd, J = 21.5, 4.5, 2.0 Hz) 5.20 (1H, ddd, J = 13, 3.3, 1.5 Hz) 4.41 (2H, s) 4.02-3.99 (2H, m) 3.94 
(1H, dd, J = 4.8, 4.8 Hz) 3.76 (3H, s) 3.27 (1H, ddd, J = 11.6, 4.8, 4.0 Hz) 3.15 (1H, ddd, J = 
11.6, 5.6, 4.8 Hz) 1.59-1.20 (13H, m) 1.12-0.80 (16H, m); 100 MHz 13C NMR (CDCl3, ppm) δ 
160.9, 149.5, 144.4, 140.5, 134.9, 129.6, 127.4, 126.7, 117.0, 105.6, 102.1, 98.3, 75.6, 72.3, 71.0, 






(2S,3S)-2-(Azidomethyl)-3-(tributylstannyl)-1-tritylaziridine (52). To a solution of mesylate 
3579 (0.72 mmol, 493 mg) in 7.2 mL DMF was added NaN3 (2.16 mmol, 140.4 mg).  The reaction 
flask was fitted with a reflux condenser and the non-h mogenous solution was heated to 60 °C.  
After 25 h, the temperature was increased to 85 °C.  After 2 d total reaction time, the reaction was 
cooled to rt and poured into H2O.  The mixture was extracted 3 x with Et2O, washed with brine, 
and dried over MgSO4.  Rotary evaporation provided a yellow oil.  The crude reaction mixture 
was purified by flash column chromatography (3.5 x 15.24 cm, 15:1 hexanes: ethyl acetate with 
2% NEt3, Rf = 0.66 in 3:1 hexanes: ethyl acetate) andprovided 408 mg (90%) of 52.  Molecular 
ion calculated for [M + Na] C34H46N4NaSn = 631.2823, found (electrospray) m/z = 631.2834, 
error = 2 ppm; IR (neat, cm-1) 2095; 400 MHz 1H NMR (CDCl3, ppm) δ 7.48-7.46 (6H, m) 7.29-
7.17 (9H, m) 3.51 (1H, dd, J = 15.9, 6.9 Hz) 3.37 (1H, dd, J = 15.9, 6.9) 1.50-1.36 (7H, m) 1.32-
1.22 (6H, m) 1.02-0.90 (7H, m) 0.86 (9H, t, J = 9 Hz);  100 MHz 13 C NMR (CDCl3, ppm) δ 
144.2, 129.5, 127.3, 126.6, 75.5, 55.0, 34.6, 29.1, 27.4, 25.1, 13.7, 10.1. 
 
 
ethyl ((2S,3S)-3-(tributylstannyl)-1-tritylaziridin-2-yl)methylcarbamate (54).  To a mixture 
of LiAlH 4 (11.2 mmol, 449 mg) in 24 mL Et2O at 0 °C was added aziridine 51 as a solution in 29 
mL Et2O (5.3 mmol, 3.34 mg) dropwise via cannula.  The reaction was stirred and warmed to rt 
in the cooling bath.  After 2.5 h, the reaction vessel was cooled in an ice water bath, and the 
mixture was slowly quenched by sequential addition of 0.45 mL H2O, 0.45 mL 15% NaOH, 1.35 
mL H2O.  After stirring the mixture vigorously, the white precipitate was filtered through celite 
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with Et2O.  Solvent removal under reduced pressure provided 53 as a colorless oil.  Due to 
significant loss of material during chromatrography, t e material was taken into the next 
transformation without purification.  A small sample of the material was purified by flash column 
chromatography (2 x 15 cm silica gel with 3:1 hexanes:ethyl acetate, 2% NEt3, Rf = 0.67) to 
provide clean 53.  Molecular ion calculate for [M + Na] C34H48N2NaSn = 605.2918, found 
(electrospray) 605.2921, error = 0.5 ppm; IR (neat, cm-1) 3390; 500 MHz 1H NMR (CDCl3, ppm) 
δ 7.50-7.48 (6H, m) 7.30-7.22 (6H, m) 7.22-7.16 (3H, m) 2.82 (2H, m) 1.52-1.38 (6H, m) 1.34-
1.22 (10H, m) 1.02-0.82 (16H, m) unidentified peaks t ; 125 MHz 13C NMR (CDCl3, ppm) δ 
144.6, 129.6, 127.3, 126.5, 75.4, 46.0, 38.7, 29.2, 27.4, 24.7, 13.7, 10.3.  
 
To a solution of amine 53 (5.3 mmol) and 1.10 mL NEt3 in 50 mL CH2Cl2 at 0 °C was added 
ethyl chloroformate ( 6.4 mmol, 0.64 mL) via syringe.  The reaction flask was removed from of 
the cooling bath and warmed to rt.  After 2.5 h, the reaction was cooled in a 0 °C ice bath, and 
saturated aqueous NaHCO3 was added.  The mixture was poured into H2O and extracted 3 x with 
CH2Cl2, washed with brine, and dried over Na2SO4. Rotary evaporation provided a cloudy 
colorless oil.  Purification of the crude reaction mixture by flash column chromatography (7 x 15 
cm silica gel with 9:1 hexanes: ethyl acetate, Rf = 0.35) provided 2.41 g (92% over two steps) of 
54.  Molecular ion calculated for [M + Na] C37H 52N2NaO2Sn = 699.2948, found (electrospray) 
m/z = 699.2976, error = 4 ppm; IR (neat, cm-1) 3419, 1721; 400 MHz 1 H NMR (CDCl3, ppm) δ 
7.46-7.44 (6H, m) 7.28-7.24 (6H, m) 7.22-7.18 (3H, m) 4.72 (1H, br s) 4.14-4.02 (2H, m) 3.34 
(1H, d, J = 2.5 Hz) 1.52-1.36 (7H, m) 1.31-1.18 (8H, m) 1.02-0.9 (6H, m) 0.86 (9H, t, J = 7.3 
Hz); 100 MHz 13C NMR (CDCl3, ppm) δ 156.4, 144.3, 129.5, 127.4, 126.7, 75.5, 60.8, 44.5, 35.0, 





Imide 56.  An oven dried flask cooled under N2 flow was charged with a solution of amide 54 in 
toluene.  The toluene was removed under a flow of N2, and the reaction vessel was fitted with a 
thermocouple.  To a solution of amide 54 (0.20 mmol, 134.4 mg) in 4 mL THF at -77 °C 
(internal) was added n-BuLi as a solution in hexanes (0.63 M, 0.35 mL, 0.22 mmol) dropwise via 
syringe (temperature < -75 °C).  The reaction color turned bright yellow over ten minutes.  A 
solution of MeLi in diethyl ether (0.83 M, 0.24 mL, 0.20 mmol) was added dropwise via syringe 
(temperature > -75 °C), and the yellow color darkened.  The solution was warmed to -67 °C and 
stirred for 10 min, then cooled to -77 °C.  To the solution was added Mander’s reagent (1.0 
mmol, 0.08 mL) dropwise via syringe, and the temperature spiked to -70 °C.  After stirring the 
reaction in the cold bath for 1 h, the solution was quenched at low temperature with MeOH.  
After warming to rt, the mixture was poured into H2O and extracted 3 x with Et2O.  The 
combined organic phases were washed with brine and drie over MgSO4.  Removal of the solvent 
under reduced pressure provided a cloudy yellow oil.  Purification of the residue by preparatory 
plate TLC (200 x 200 x 10000, with 1:1 hexanes: ethyl acetate, Rf = 0.66) provided 57 mg (57%) 
of imide 56.  Molecular ion calculated for [M + Na] C29H30N2NaO6 = 525.2002, found 
(electrospray) 525.2014, error = 2.3ppm; IR (neat, cm-1) 1794, 1748; 400 MHz 1H NMR (CDCl3, 
ppm) 7.52-7.47 (6H, m) 7.20-7.19 (9H, m) 4.27 (1H, dd, J = 14.7, 2.4) 4.17-4.09 (2H, m) 3.97 
(1H, dd, J = 14.7, 7.8 Hz) 3.80 (3H, s) 3.76 (unidentified peak, 0.4H) 3.69 (3H, s) 1.94 (1H, d, J 
= 6.0 Hz) 1.78 (1H, ddd, J = 7.8, 6.0, 2.4 Hz) 1.52 (3H, t, J = 7.2 Hz); 100 MHz 13C NMR 






(1S,5S)-6-Trityl-3,6-diazabicyclo[3.1.0]hexan-2-one (19). An oven dried 3-neck flask was fitted 
with a mechanical stirrer and thermocouple.  The flask was cooled under N2, then charged with 
54 (3.6 mmol, 2.4 g) and 70 mL THF, and the solution was cooled to -76.8 °C.  To the solution 
was added n-BuLi as a solution in hexanes (1.46 M, 3.65 mmol, 2.5 mL) dropwise via syringe 
maintaining the internal temperature below -75.5 °C. The dark yellow solution stirred for 20 min, 
then a second equivalent of n-BuLi in hexanes (1.46 M, 3.80 mmol, 2.6 mL) was added slowly to 
maintain the internal temperature below -75 °C.  The yellow color darkened to red upon addition.  
The temperature of the red dianion was maintained at -76 °C for 30 min, and then neat CO(OEt)2 
(10.8 mmol, 1.3 mL) was added dropwise via syringe.  Slow addition of the electrophile was 
essential to maintain the temperature below -75 °C.  After the first few drops the red color began 
to fade to yellow.  The reaction vessel was pulled to the top of the cooling bath and slowly 
warmed to 19 °C over 4.5 h.  The solution was poured into H2O and extracted 3 x with Et20, the 
combined organics were washed with brine, and then dri d over MgSO4.  Removal of the solvent 
under rotary evaporation provided a white amorphous solid consisting of 19, and 
protiodestannylated material.  The highly insoluble material was loaded onto a silica gel plug (5.5 
x 5 cm silica gel) eluted with 500 mL 2:1 hexanes: ethyl acetate, and then the solid at the top of 
the plug was dissolved with CHCl3 and eluted with 500 mL 100% ethyl acetate to provide 804 
mg (65%) of 19 (1:2 hexanes: ethyl acetate, Rf = 0.30);  mp = decomposition 262 °C; Molecular 
ion calculated for [M + Na] C23H20N2NaO = 363.1473, found (electrospray) 363.1483, error = 2.8 
ppm; IR (neat, cm-1) 3225, 1701; 500 MHz 1H NMR (CDCl3, ppm) δ 7.50-7.46 (5H, m) 7.32-7.22 
(10H, m) 5.21 (1H, br s) 3.72 (1H, d, J = 10.5 Hz) 3.38 (1H, dd, J = 10.5, 4.0 Hz) 2.52 (1H, ddd, 
J = 4.5, 4.0, 1.5) 2.25 (1H, ddd, J = 4.5, 1.5, 1.0 Hz ); 125 MHz 13C NMR (CDCl3, ppm) δ 175.5, 





2-(2-Iodophenyl)-3,6-dithiane (65). To a solution of 2-iodobenzaldehyde (commercially 
available) 61 (1.23 mmol, 286 mg) in 12 mL CH2Cl2 was added 1,3-propanedithiol (1.19 mmol, 
0.12 mL).  Neat BF3•Et2O (0.23 mmol, 0.03 mL) was added via syringe, and the reaction turned 
cloudy.  The reaction solution was stirred at rt fo 18 h, then aqueous saturated NaHCO3 was 
added.  The mixture was extracted 3 x with CH2 l2, the combined organic phase was washed 
with brine, and then dried over Na2SO4.  Removal of the solvent under rotary evaporation 
provided an off-white solid consisting of 326 mg (82%) of 65 (9:1 hexanes: ethyl acetate, Rf = 
0.38) and 22 mg of 61   Molecular ion calculated for C10H11IS2 = 321.9347, found (EI) 321.9352, 
error = 1.6 ppm; 500 MHz 1H NMR (CDCl3, ppm) δ 7.82 (1H, dd, J = 8.0, 1.5 Hz) 7.65 (1H, dd, 
J = 7.8, 1.7 Hz) 7.36 (1H, td, J = 14.0, 3.7 Hz) 6.98 (1H, td, J = 13.5, 3.9 Hz) 5.42 (1H, s) 3.14 
(2H, m) 2.95 (1H, m) 2.92 (1H, m) 2.23-2.15 (1H, m) 2.00-1.88 (1H, m); 125 MHz 13C NMR 
(CDCl3, ppm) δ 141.5, 139.6, 130.0, 129.1, 129.0, 99.5, 56.7, 32.4, 25.1. 
 
 
2-(tert-Butyldimethylsilyloxy)-2-(2-iodopheny)acetonitrile (66).  To a solution of 2-
iodobenzaldehyde (commercially available) (3.1 mmol, 708 mg) and ZnI2 (0.09 mmol, 29 mg) in 
31 mL CH2Cl2 at rt was added tetrabutylammonium cyanide (3.7 mmol, 522 mg) in one portion.  
After 5.5 h, the reaction mixture was filtered through celite with CH2Cl2, and the solvent was 
removed under rotary evaporation to provide a dark yellow oil.  The crude residue was purified 
by flash column chromatography (4 x 15 cm silica gel with 15:1 hexanes: ethyl acetate, Rf = 0.44 
9:1 hexanes: ethyl acetate) to provide 1.03 g (89%) of cyanohydrin 66.  Molecular ion calculated 
for [M + Na + MeOH] C15H24INNaO2Si = 428.0519, found (electrospray) 428.0520, error = 0.2 
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ppm; IR 1934; 400 MHz 1H NMR (CDCl3, ppm) δ 7.85 (1H, dd, J = 7.6, 1.2 Hz) 7.69 (1H, dd, J 
= 7.6, 1.6 Hz) 7.45 (1H, td, J = 14.0, 3.8 Hz) 7.10 (1H, td, J = 13.6, 3.8 Hz) 5.64 (1H, s) 0.94 
(9H, s) 0.26 (3H, s) 0.17 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 139.6, 138.7, 131.0, 129.0, 




To a mixture of pyrrolidinone 19 (0.14 mmol, 48 mg), K3PO4 (0.29 mmol, 62 mg), and CuI (0.03 
mmol, 5 mg) in 1.2 mL toluene under an atmosphere of N2 was added N,N′-dimethylcyclohexane 
diamine (0.06 mmol, 10 µL) via microsyringe following the procedure of Klapars.81  The iodide 
64 (0.09 mmol, 26 mg) as a solution in 0.6 mL toluene was added to the mixture via cannula.  
The mixture was then heated to 100 °C.  After 26 h, the gray mixture was cooled to rt, filtered 
through silica gel with ethyl acetate and the soluti n was concentrated to a dark tan oil.  
Purification of the crude residue by preparatory plate chromatography (200 x 200 x 1000, 3:1 
hexane: ethyl acetate, Rf = 0.41) provided 22 mg (48%) of 67 as a clear colorless oil.  Molecular 
ion calculated for [M + Na] C34H32N2NaOSi = 535.2182, found (electrospray) 535.2194; IR (neat, 
cm-1) 2242, 2149, 1705; 400 MHz 1H NMR (CDCl3, ppm) δ 7.56-7.51 (7H, m) 7.44-7.40 (2H, m) 
7.34-7.22 (10H, m) 4.22 (1H, dd, J = 10.8 4.0) 3.91 (1H, d, J = 10.8) 2.55 (1H, dd, J = 4.8, 4.0) 
2.47 (1H, d, J = 4.8 Hz) 0.134 (9H, s); 100 MHz 13C NMR (CDCl3, ppm) 172.1, 143.0, 140.2, 





(1S,5S)-3-(2-Dithianylphenyl)-6-trityl-3,6-diazabicyclo[3.1.0]hexan-2-one (68).  To a mixture 
of iodide 65 (0.23 mmol, 74 mL), lactam 19 (0.27 mmol, 88 mg), K3PO4 (0.46 mmol, 98 mg), and 
CuI (0.07 mmol, 13 mg) in 2.3 mL degassed toluene under an N2 atmosphere was added N,N′-
dimethylcyclohexane diamine (0.14 mmol, 23 µL) via microsyringe.  The mixture was heated to 
110 °C.  After 20 h, the grey mixture was cooled to rt, filtered through silica gel with ethyl 
acetate, and concentrated.  The residue was purified by flash column chromatography (2 x 15 cm 
silica gel with 2:1 hexanes:ethyl acetate) to provide 75 mg (61%) of dithiane 68 contaminated 
with 3.6 mg of aldehyde corresponding to acid catalyzed hydrolysis of the dithiane.  Pure samples 
of 68 can be obtained by purification on NEt3 deactivated silica gel (2:1 hexanes: ethyl acetate, 
2% NEt3, Rf = 0.19).  Molecular ion calculated for [M+Na] C33H30N2NaS2 = 557.1697, found 
(electrospray) 557.1705, error = 1.4 ppm; IR (neat, cm-1) 3056, 1704; 500 MHz 1H NMR (CDCl3, 
45 °C, ppm) δ 7.80 (1H, dd, J = 7.5, 1.5 Hz) 7.58 (6H, m) 7.40-7.30 (8H, m) 7.28-7.22 (4H, m) 
7.15 (1H, d, J = 8.0) 5.70 (1H, br s) 4.14 (1H, d, J = 11.0 Hz) 3.74 (1H, dd, J = 11.0, 4.5 Hz) 
3.04-2.93 (2H, m) 2.83 (1H, m) 2.72 (1H, m) 2.61 (1H, dd, J = 4.5, 4.5 Hz) 2.53 (1H, d, J = 4.5 
Hz) 1.98-1.82 (2H, m) NMR sample heated to resolve broad peaks; 100 MHz 13C NMR (CDCl3, 
35 °C, ppm) δ 171.8, 144.1, 137.6, 135.4, 129.9, 129.4, 129.3, 129.2, 128.7, 127.9, 127.3, 73.8, 






3,6-Diazabicyclo[3.1.0]hexan-2-one (37). To a mixture of pyrrolidinone 19 (0.038 mmol, 13.1 
mg), K3PO4 (0.64 mmol, 13.6 mg), and CuI (0.01 mmol, 1.9 mg) in 0.60 mL toluene under an 
atmosphere of N2 was added N, N′-dimethylcyclohexane diamine (0.02 mmol, 3 µL) via 
microsyringe according to the method of Klapars.81   The iodide 70 was added as a solution in 
toluene (0.31 M, 0.32 mmol, 0.10 mL).  The reaction mixture was heated to 100 °C, and the 
reaction turned a grayish/purple color.  During the reaction course, lost solvent was replaced with 
0.50 mL toluene, and after 48 h of heating and stirring, the reaction was cooled to rt and filtered 
through silica gel with ethyl acetate.  The crude mixture was purified by preparatory plate TLC 
on silica gel 60 Å (20 cm x 20 cm x 1000 µm) with 1:1 hexanes: ethyl acetate (Rf = 0.61) to 
provide 12 mg (73%) of lactam 37. Molecular ion calculated for [M + Na] C34H32N2NaO3 = 
539.2311, found (electrospray) 539.2313, error = 0.4 ppm; IR (neat, cm-1) 1705; 400 MHz 1H 
NMR (CDCl3, ppm) δ 7.50 (6H, d, J = 7.6 Hz) 7.34-7.22 (10H, m) 7.18 (1H, m) 6.74 (1H, m) 
5.98 (1H, m) 5.33 (1H, ddd, J = 21.5, 4.0, 2.0 Hz)  5.23 (1H, ddd, J = 13.0, 3.5, 1.5 Hz) 4.53 (2H, 
s) 4.10 (1H, d, J = 10.8 Hz) 4.06 (2H, ddd, J = 7.1, 1.5, 1.5Hz) 3.85 (3H, s) 3.82 (1H, dd, J =
10.8, 4.0 Hz) 2.53 (1H, dd, J = 4.9, 3.6 Hz) 2.49 (1H, dd, J = 4.9, 0.8 Hz); 100 MHz 13C NMR 
(CDCl3, ppm) δ 171.3, 160.2, 143.8, 140.7, 140.4, 134.6, 129.1, 127.8, 127.1, 117.3, 110.8, 
108.9, 105.2, 73.8, 72.0, 71.2, 55.4, 50.7, 39.9, 31.8. 
 
 
Protected cyanohydrin 69. To a mixture of pyrrolidinone 19 (0.29 mmol, 99 mg) K3PO4 (0.48 
mmol, 102 mg), and CuI (0.24 mmol, 47 mg) in 0.80 mL toluene under an atmosphere of N2 was 
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added N, N′-dimethylcyclohexane diamine (0.48 mmol, 78 µL) via microsyringe and the mixture 
became teal green.  The iodide 66 (0.24 mmol, 90 mg) as a solution in 0.40 mL toluene, was 
added via cannula.  The reaction mixture was heated to 110 °C and the color turned gray at ~80 
°C.  After 38.5 h, the reaction mixture was cooled to rt and filtered through silica gel with ethyl 
acetate.  Solvent removal under rotary evaporation pr vided a brown oil.  Purification by flash 
column chromatography (2 x 15 cm silica gel with 3 x 1 hexanes: ethyl acetate, Rf = 0.37, 0.27) 
provided 80 mg (57%) of a mixture of two diastereomrs of product 69. Molecular ion calculated 
for [M + Na] C37H39N3NaO2Si = 608.2709, found (electrospray) 608.2722, error = 2 ppm; IR 
(neat, cm-1) 1701; Diastereomer 1: 500 MHz 1H NMR (CDCl3, ppm) 7.74 (1H, d, J = 7.5 Hz) 
7.58-7.42 (7H, m) 7.36-7.28 (6H, m) 7.28-7.73 (5H, m) 5.91 (1H, s) 4.08 (1H, d, J = 11.0 Hz) 
3.95 (1H, ddd, J = 11.0, 4.0, 0.7 Hz) 2.63 (1H, dd, J = 5.5, 4.0 Hz) 2.51 (1H, d, J = 5.5 Hz) 0.99 
(9H, s) 0.30 (3H, s) 0.22 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 171.8, 142.8, 135.4, 124.7, 
129.8, 129.1, 128.6, 127.9, 127.2, 126.6, 119.4, 73.8, 60.2, 53.1, 38.3, 33.2, 25.6, 18.2, -5.3. 
Diastereomer 2: 500 MHz 1H NMR (CDCl3, ppm) δ 7.82-7.78 (1H, m) 7.64-7.50 (6H, m) 7.46-
7.38 (2H, m) 7.34-7.28 (6H, m) 7.28-7.22 (1H, m) 7.18-7.12 (1H, m) 5.97 (1H, s) 4.19 (1H, d, J = 
10.8 Hz) 3.79 (1H, dd, J = 11.2, 4.0 Hz)   100 MHz 13C NMR (CDCl3, ppm) 171.7, 143.8, 135.1, 
134.7, 130.1, 129.2, 128.9, 127.9, 127.2, 127.0, 126.7, 119.6, 74.2, 59.7, 52.3, 38.4, 33.4, 25.6, 
18.2, -5.18, -5.22. 
 
 
1-(allyloxymethyl)-3-iodo-5-methoxybenzene 70.  To a solution of 33 (1.01 mmol, 196 mg) in 
4.8 mL HCl at 4 °C was added NaNO2 as a solution in H2O (0.50 mL, 1.52 mmol, 84 mg) slowly 
via syringe.  The pink solution turned dark brown.  The diazonium salt was stirred at 0 °C for 45 
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min.  Cold KI was added dropwise via syringe, the solution was diluted with 10 mL CH2Cl2, and 
warmed to rt.  After 4 h, the mixture was poured into 15 % (w/v) NaOH, washed 3 x with H2O 
and back extracted with CH2Cl2.  The organic phase was then washed with aq. NaS2O3, and dried 
over Na2SO4.  Removal of the solvent under rotary evaporation provided a brown oil.  
Purification of the residue by 2 preparatory TLC plates (200 x 200 x 1000, 50:9:1 
Hex:CH2Cl2:MeOH) provided 23 mg (8%) of 70.  Molecular ion calculated for C13H11IO2 = 
303.9960, found (EI) 303.9948, error = 4 ppm; 400 MHz 1H NMR (CDCl3, ppm) δ 7.29-7.27 
(2H, m) 7.16 (1H, dd, J = 2.0, 2.0 Hz) 6.86 (1H, m) 6.00-5.89 (1H, m) 5.31 (1H, ddd, J = 21.6, 
4.3, 1.5 Hz) 5.22 (1H, ddd, J = 13.0, 3.5, 1.5 Hz) 4.34 (2H, s) 4.04-4.01 (2H, ddd, J = 7, 2, 1.8 
Hz) 3.78 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 160.1, 141.7, 124.4, 128.8, 122.2, 117.4, 
112.8, 94.2, 71.2, 70.9, 55.4. 
 
 
Mitosane model cyanohydrin OTBS ether 88. To a solution of LiHMDS (0.18 mmol, 31 mg) 
in 1 mL Et2O at -78 °C (internal temperature) was added the cyanohydrin 69 (0.14 mmol, 80 mg) 
in 3.6 mL Et2O in three portions over 20 min (max internal temp during addition was -64 °C).  
The cloudy mixture turned dark yellow in color after he addition was complete.  The mixture 
was stirred at -76 °C for 10 min, warmed to -10 °C, and then placed in a 0 °C ice bath.  The 
reaction was quenched after 10 min at 0 °C with 1.0 mL saturated NH4Cl, and then stirred 
vigorously for 40 min.  The mixture was partitioned between H2O and Et2O, and extracted 3 x 
with Et2O.  The combined organic phases were washed with brine, dried over MgSO4, and 
concentrated to a light brown oil.  The residue waspurified by preparatory plate TLC (200 x 200 
x 1000 µm silica gel, 3:1, hexanes: ethyl acetate) o provide 64 mg (80 %) of 88 as a mixture of 
diastereomers (0.82:0.11:0.07).  The mixture of diastereomers was sufficiently pure to use in the 
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subsequent reaction. Selected data for the major 9a(S)-diastereomer: Molecular ion calculated for 
[M + Na] C37H39N3NaO2Si = 608.3, found (electrospray, nominal) 608.2; IR (neat, cm
-1) 3501; 
500 MHz 1H NMR (CDCl3, ppm) δ 7.60-7.52 (1H, d, J = 7.5 Hz) 6.99 (1H, t, J = 7.5 Hz)  6.81 
(1.0H, d, J = 8.0 Hz) 4.16 (1H, s) 3.85 (1H, d, J = 12.8 Hz) 3.39 (1H, d, J = 12.8) 2.30 (2H, 
narrow m) 0.86 (9H, s) 0.34 (3H, s) -0.09 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 154.6, 
144.1, 132.8, 129.2, 127.4, 126.5, 126.3, 126.0, 119.1, 117.4, 110.2, 103.7, 74.5, 73.4, 51.3, 43.0, 




Mitosane model protected acetate 89.  To a solution of diisopropylamine (0.17 mmol, 24µL) in 
1 mL THF at 0 °C  (internal) was added n-BuLi as a solution in hexanes (1.49 M, 0.11 mL, 0.16 
mmol) via syringe.  The solution was stirred at 1 °C for 15 min, and then cooled to -78 °C.  The 
lactam 69 was added as a solution in THF (0.60 mL, 0.079 mmol) sl wly via cannula 
(temperature spiked to -70 °C), and the solution became orange.  After stirring for 20 min at -70 
°C, the reaction was warmed to -24 °C, and maintained at the temperature with a dry ice bath.  
After two hours, acetic anhydride (0.17 mmol, 16µL) was added dropwise via syringe.  The 
brown solution was warmed to 15 °C, and poured into Et2O and H2O.  The mixture was extracted 
3 x with Et2O, washed  with brine, and dried over MgSO4.  Removal of the solvent provided a 
brown oil consisting of a mixture of products.  The fraction of interest was unstable over 20 min 
on silica gel, silica gel deactivated with NEt3 fumes, and basic alumina.  However, quick  partial 
purification by two consecutive developments on a preparatory plate TLC (200 x 200, 5:1 
hexanes: ethyl acetate, 2% NEt3) was possible to provide a mixture enriched in 89. Molecular ion 
calculated for [M + Na] C39H41N3NaO3Si = 650.3, found (nominal) 650.2; partial spectroscopic 
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data for 89: 500 MHz 1H NMR (CDCl3, ppm) δ 4.31 (1H, C(3)Ha, d, J = 9.5 Hz) 3.27 (1H, C(1), 
d, J = 3.0 Hz) 2.96 (1H, C(3)Hb, dd, J = 9.5, 3.5 Hz) 2.60 (1H, C(2), dd, J = 3.5, 3.0 Hz); 100 
MHz 13C NMR (CDCl3, ppm) δ 109.1 [C(9a)], 55.4 [C(3)], 43.8 [C(1)], 41.1 [C(2)]; Carbon 
assignments are based on HSQC NMR spectroscopy. 
 
 
2-Hydroxy-9-trityl-6,9-diaza-4,5-benzotricyclo[6.1.0 2,6]nonan-3-one 90. To a solution of 
cyanohydrin 88 (0.034 mmol, 20 mg) in 0.70 mL THF at 0 °C was added 41 µL of 
tetrabutylammonium fluoride as a solution in THF (1.0 M) dropwise via microsyringe.  Upon the 
first drop the solution color turned tan, which faded to yellow.  The reaction solution was allowed 
to stir and warm to rt in the cooling bath.  After 1 h, 45 min, the solution was diluted with Et2O, 
and the mixture was extracted 3 x with Et2O, and the combined organic phase was washed with 
brine, and then dried over MgSO4. Removal of the solvent provided a bright yellow/green oil.  
Purification by analytical preparatory plate TLC on silica gel 60 Å (20 cm x 20 cm x 200 µm) 
with 1:1 hexanes: ethyl acetate (Rf = 0.47) provided 12 mg (80%) of 90.  The sample was 
crystallized from 0.30 mL of warm Et2O with > 0.05 mL acetone.   Molecular ion calculated for 
[M + Na] C30H24N2NaO2 = 467.1735, found (electrospray) 467.1738, error = 0.6 ppm; IR (neat, 
cm-1) 3392, 1704, 1609; 500 MHz 1H NMR (CDCl3, ppm) δ 7.75 (1H, d, J = 7.5 Hz) 7.66 (1H, 
m) 7.21-7.12 (15H, m) 7.00 (2H, m) 3.81 (1H, d, J = 12.0 Hz) 3.57 (1H, dd, J = 12.0, 2.0 Hz) 
2.75 (1H, s) 2.42 (1H, d, J = 4.5 Hz) 2.29 (1H, dd, J = 4.2, 1.7 Hz); 100 MHz 13C NMR (CDCl3, 
ppm) δ = 198.9, 163.9, 143.8, 138.6, 129.0, 127.5, 126.8, 124.7, 122.2, 120.9, 112.4, 97.0, 74.0, 
51.4, 41.9, 40.4.  The stereochemistry was assigned based on the correlation of Ha and Hc 






Mitosane model protected ketone 91. To a solution of 89 (0.02 mmol, 11 mg) in 0.20 mL THF 
at 0 °C was added TBAF as a solution in THF (1.0M, .027 mmol, 27 µL) via syringe. The 
solution was stirred and warmed to rt; after 45 min, the solution was diluted with Et2O and poured 
into a saturated solution of NaHCO3.  The mixture was extracted 3 x with Et2O, washed with 
brine, and dried over MgSO4.  Solvent removal provided a residue consisting of an unstable 
mixture of products including 91.  Separation (partial) by analytical preparatory plate TLC (200 
x200, in 1:1 hexanes, ethyl acetate, Rf = 0.50) provided a yellow residue enriched in 91.  Partial 
spectroscopic data for 91: 500 MHz 1H NMR (CDCl3, ppm) δ 4.19 (1H, C(3)Ha, dd, J = 12.0, 1.0 
Hz) 3.52 (1H, C(3)Hb, dd, J = 12.0, 4.5Hz) 2.51 (1H, C(1), d, J = 5.5 Hz) 2.44 (1H, C(2) ddd, 
5.5, 4.5, 1.0 Hz); 100 MHz 13C NMR (CDCl3, ppm) δ 169.5 (O2CMe), 143.9 (C9a), 137.5, 123.7, 
122.0, 114.9,  57.6 (C3), 44.6 (C1), 41.9 (C2).  Proton and carbon assignments are based on 
COSY and HSQC NMR spectroscopy.  The assigned stereochemistry is based on was assigned 
based on correlations between Hb and Hc by two - dimensional NOESY NMR spectroscopy. 
 
 
Mitosane model TMS protected α-hydroxy ketone 93. To a solution of 90 (0.20 mmol, 89 mg) 
and N, N-dimethylaminopyridine (0.60 mmol, 73 mg) in 2 mL CH2Cl2 at 0 °C was added NEt3 
(1.2 mmol, 1.7 mL).  Trimethylchlorosilane (0.60 mmol, 0.08 mL) was added dropwise via 
syringe.  After 1 h of warming and stirring, the solution was cooled in a 0 °C ice bath and diluted 
with CH2Cl2.  The mixture was poured into saturated aqueous NaHCO3 and extracted 3 x with 
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CH2Cl2, dried over Na2SO4, and the organic phase was concentrated to a tan oil.  The crude 
residue was purified by flash column chromatography (1.5 x 15 cm, 3:1 hexanes: ethyl acetate, Rf 
= 0.53) to provide 71 mg (69%) of 93.  Molecular ion calculated for [M + Na] C33H32N2NaO2Si = 
539.3231, found (electrospray) 539.2142, error = 2 ppm; IR (neat, cm-1) 1721, 1609; 400 MHz 1H 
NMR (CDCl3, ppm) δ 7.77 (1H, m) 7.64 (1H, m) 7.21-7.12 (15H, m) 7.20-6.94 (2H, m) 3.79 (1H, 
d, J = 12.0 Hz) 3.44 (1H, dd, J = 12.0, 2.0 Hz) 2.46 (1H, d, J = 4.0 Hz) 2.19 (1H, dd, J = 4.0, 2.0 
Hz) 0.02 (8H, s); 100 MHz 13C NMR (CDCl3, ppm) 199.3, 163.3, 143.9, 138.0, 129.1, 127.5, 
126.7, 124.4, 123.2, 120.7, 112.2, 98.1, 74.0, 51.3, 42.8, 40.4, 1.07. 
 
 
Tertiary trimethylsilylmethyl alcohol 94.  To a solution of 93 (0.029 mmol, 15 mg) in 1.4 mL 
THF at -10 °C (internal) was added trimethylsilylmethyllithium as a solution in ether (0.48 M, 
0.15 mmol, 0.31 mL) dropwise via syringe (temperature < -8 °C) following the procedure of 
Danishefsky.29  The tan solution was quenched after 10 min with 1 mL saturated NH4Cl.  The 
mixture was extracted 3 x with ethyl acetate, washed with brine, and dried over Na2SO4.  Solvent 
removal under rotary evaporation provided a brown oil consisting of 1 diastereomer of a new 
product.  The residue was purified by preparatory plate TLC (200 x 200 x 200, 3:1 hexanes: ethyl 
acetate, Rf = 0.53) pretreated with NEt3 fumes to provide 12 mg (67%) of 94.  Molecular ion 
calculated for [M + Na] C37H44N2NaO2Si2 = 627.2839, found (electrospray) 627.2842, error = 0.5 
ppm; IR (neat, cm-1) 3545; 500 MHz 1H NMR (CDCl3, ppm) δ 7.30-7.24 (2H, m) 7.22-7.13 (15H, 
m) 6.87 (H, t, J = 7.0 Hz) 6.69 (1H, d, J = 8.0 Hz) 3.89 (1H, d, J = 12.4 Hz) 3.41 (1H, dd, J = 
12.4, 1.2 Hz) 2.34 (1H, s) 2.13 (2H, narrow m) 1.31 (2H, s) -0.04 (3H, s) -0.14 (3H, s); 100 MHz 
13C NMR (CDCl3, ppm) δ 151.9, 144.1, 135.3, 129.4, 129.0, 127.8, 126.8, 124.2, 118.7, 110.5, 





tert-Butyl (3-benzyloxy)-4-formyl-5-hydroxybenzoate (101).  An oven dried 3-neck flask was 
equipped with a 2-way joint leading to a volumetric cylinder adapted to measure gas evolution.  
The flask was charged with aldehyde 9967 (4.1 mmol, 1.72 g), Pd/C (0.08 mmol, 85 mg), 32 mL 
MeOH, 8 mL 1,4-dioxane, and 1.3 mL NaOMe (4.9 M, 6.15 mmol).  Hydrogen gas was bubbled 
through the reaction mixture and used to fill the volumetric cylinder by 42 mL.  After 1.5 h, 35 
mL of H2 was added, and after another 30 min, 15 mL of H2 was added.  The reaction was 
monitored by TLC, and after consumption of 91 mL H2 (measured using the volumetric cylinder) 
the reaction mixture was filtered though celite with Et2O.  The orange organic phase was acidified 
with 2.0 M HCl to produce a bright yellow solution.  The yellow organic phase was washed 2 x 
with H2O and with brine.  It was then dried over MgSO4, and the solvent was removed under 
reduced pressure to provide a pale yellow solid consisti g of phenol 101, diol, and 99.  The crude 
residue was recrystallized from warm CHCl3 and small amounts of Et2O to provide 651 mg 
(48%) of phenol 101;  mp = 162 °C; Molecular ion calculated for [M + Na] C19H20NaO5 = 
351.1208, found (electrospray) 351.1202, error = 1.7 ppm; IR (neat, cm-1) 1715, 1656; 500 MHz 
1H NMR (CDCl3, ppm) δ 11.86 (1H, s) 10.44 (1H, s) 7.44-7.36 (5H, m) 7.15 ( H, br s) 7.10 (1H, 
d, J = 1.5 Hz) 5.19 (2H, s) 1.59 (9H, s); 100 MHz 13C NMR (CDCl3, ppm) 194.5, 164.2, 163.2, 
161.2, 140.5, 135.5, 128.8, 128.5, 127.6, 112.8, 111.5, 102.7, 82.3, 70.9, 28.0. 
 
 
tert-Butyl (3-benzyloxy)-4-formyl-5-(trifluoromethylsulfonyloxy)benzoate (98). To a solution 
of phenol 101 (1.16 mmol, 381 mg) in 12 mL toluene was added 9 mL of a 30% solution of 
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K3PO4 in H2O (w/v).  The biphasic mixture was stirred vigorously and cooled in a 0 °C ice bath.  
Neat trifluoromethanesulfonic anhydride (Tf2O) (2.3 mmol, 0.39 mL) was added slowly via 
syringe.  The cloudy reaction turned pale yellow and cleared while stirring.  The reaction mixture 
was removed from the cooling bath and warmed to rt while stirring vigorously.  After 1.5 h, the 
phases were separated and the organic phase was washed with brine, and then dried over Na2SO4.  
Removal of the solvent under rotary evaporation provided a yellow oil.  The crude residue was 
purified by flash column chromatography (3.5 x 16 cm, 5:1 hexanes: ethyl acetate, Rf = 0.36) to 
provide 429 mg (80%) of triflate 98. Molecular ion calculated for [M + Na] C20H19F3NaO7S = 
483.0701, found (electrospray) = 483.0714, error = 3 ppm; IR (neat, cm-1) 1718, 1700, 1423; 500 
MHz 1H NMR (CDCl3, ppm) 10.51 (1H, s) 7.75 (1H, s) 7.50-7.35 (6H, m) 5.27 (H, s) 1.61 (9H, 
s); 100 MHz 13C NMR (CDCl3, ppm) δ 186.2, 162.8, 161.9, 147.9, 138.7, 134.9, 129.1, 129.0, 
127.8, 120.7, 118.7 (q, J = 320 Hz),117.2, 115.8, 114.1, 83.4, 72.0, 28.1. 
 
 
Triflate 102. To a solution of aldehyde 98 (0.27 mmol, 125 mg) in 2.7 mL CH2Cl2 was added 
ZnI2 (0.008 mmol, 3 mg) and tert-butyldimethylsilyl cyanide (0.33 mmol, 47 mg).  The mixture 
was stirred for 4 h at rt, then diluted with CH2Cl2 and filtered through celite.  Solvent removal 
under N2 flow provided an orange oil.  The residue was purified by flash column chromatography 
(2.5 x 15 cm silica gel with 9:1 hexanes: ethyl acet te, Rf = 0.30) to provide 142 mg (88%) of 
102 a clear colorless oil. Molecular ion calculated for [M + Na] C27H34F3NO7SSi = 624.1675, 
found (electrospray) = 624.1672, error = 0.5 ppm; IR (neat, cm-1) 1721, 1617, 1581; 500 MHz 1H 
NMR (CDCl3, ppm) 7.65 (1H, d, J = 1.3 Hz) 7.57 (1H, d, J = 1.3 Hz) 7.48-7.35 (5H, m) 6.04 
(1H, s, ) 5.22 (2H, s) 1.59 (9H, s) 0.84 (9H, s) 0.16 (3H, s) 0.07 (3H, s); 100 MHz 13C NMR 
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(CDCl3, ppm) δ 163.0, 156.7, 148.0, 135.6, 134.9, 128.8, 128.7, 12 .8, 122.2, 117.5, 115.0, 




N-aryl-3,6-diazabicyclo[3.1.0]hexan-2-one 97. To a two-neck flask fitted with a three-way joint 
was added pyrrolidinone 19 (0.93 mmol, 340 mg) and K3PO4 (1.09 mmol, 229 mg).  Under a 
glove box atmosphere was added Pd2(dba)3, (0.015 mmol, 14 mg) and xantphos ligand (0.046 
mmol, 27 mg).  The flask was fitted with a reflux condenser, and using the three way joint the 
system was evacuated and back filled 3 x with Ar.  To the system was added 3 mL 1,4-dioxane, 
and triflate 98 (0.77 mmol, 356 mg) in 3 mL 1,4-dioxane.  The orange/red reaction flask was 
heated to 80 °C and turned olive green near 60 °C.  After 18 h of heating, the mixture was cooled 
to rt, filtered through silica gel with CH2Cl2, and concentrated under reduced pressure to an 
orange oil consisting of product 97 and phenol 101 (19%).  The crude residue was purified by 
flash column chromatography (4 x 15 cm silica gel with 3:1 hexanes: ethyl acetate, Rf = 0.27 ) to 
provide 320 mg (64%) of 97 as an amorphous solid. Molecular ion calculated for C42H38N2NaO5 
= 673.2678, found (electrospray) = 673.2699, error = 3 ppm; IR (neat, cm-1) 1708; 500 MHz 1H 
NMR (CDCl3, ppm) δ 10.47 (1H, s) 7.64 (1H, d, J = 1.5 Hz) 7.57-7.50 (7H, m) 7.47-7.34 (6H, m) 
7.31 (6H, t, J = 8.0 Hz) 7.27-7.22 (3H, m) 5.22 (2H, s) 4.07 (1H, d, J = 10.5) 3.85 (1H, dd, J = 
10.5, 4.0 Hz) 2.59 (1H, dd, J = 4.5, 4.0 Hz) 2.44 (1H, d, J = 4.5 Hz) 1.61 (9H, s); 100 MHz 13C 
NMR (CDCl3, ppm) δ 189.4, 171.6, 163.9, 160.6, 143.9, 137.6, 127.2, 135.5, 129.2, 128.8, 128.5, 





carbinolamide 103.  An oven dried 2-neck flask was fitted with a 3-way joint, and charged with 
aziridinopyrrolidinone 19 (1.07 mmol, 365 mg), Cs2CO3 (1.25 mmol, 407 mg), Pd(OAc)2 (0.009 
mmol, 2 mg), and xantphos (0.013 mmol, 8 mg).  The flask was fitted with a reflux condenser 
and the system was evacuated and backfilled 3 x with Ar using the three way joint.  Under an Ar 
atmosphere, the triflate 98 was added as a solution in 1,4-dioxane (0.89 mL, 0.88 mmol, 405 mg) 
via syringe.  The non-homogenous orange mixture was he ted to 80 °C and stirred vigorously.  
After 3 h, the mixture was cooled to rt, diluted with CH2Cl2, filtered through silica gel, and 
concentrated under reduced pressure.  The crude mixture consisted of lactam 19, phenol 101, 97, 
and carbinolamide 103.  Purification of the crude residue by flash column chromatography (4 x 
15 cm silica gel, 3:1 hexane: ethyl acetate) provided 159 mg (~18%) of 103 contaminated by 
small amounts of impurities.  The material was then purified again by preparatory plate 
chromatography (200 x 200 x 1000, 1:1 hexanes: diethyl ther, Rf = 0.13, developed plate twice).    
Molecular ion calculated for [M + Na] C65H58N4NaO6 = 1013.4254, found (electrospray) 
1013.4263, error = 1 ppm; IR (neat, cm-1) 3240, 1711, 1677; 400 MHz 1H NMR (CDCl3, ppm) δ 
8.66 (1H, s) 7.50-7.34 (14H, m) 7.26-7.15 (23H, m) 5.13 (2H, ABq, J = 12.2 Hz) 4.01 (1H, d, J = 
10.8 Hz) 3.88 (1H, d, J = 11.2 Hz) 3.70 (1H, dd, J = 10.8, 3.6 Hz) 3.09 (1H, dd, J = 10.6, 3.0 Hz) 
2.55 (1H, dd, J = 4.4, 3.6 Hz) 2.43 (1H, d, J = 4.4 Hz) 2.31 (2H, narrow m) 1.57 (9H, s); 100 
MHz 13C NMR (CDCl3, ppm) δ 173.3, 172.6, 165.1, 156.8, 156.4, 143.7, 136.2, 134.0, 129.1, 
128.5, 127.9, 127.9, 127.8, 127.3, 127.2, 127.1, 114.7, 114.2, 105.1, 81.4, 74.0, 73.8, 70.8, 58.8, 





N-aryl-3,6-diazabicyclo[3.1.0]hexan-2-one cyanohydrin ether 104. To a solution of 97 (0.28 
mmol, 182 mg) in 4 mL CH2Cl2 at 0 °C was added 18-crown-6 ether as a solution in CH2Cl2 (1.6 
mL, 0.11 mmol, 29 mg) via cannula.  To the clear soluti n was added tetrabutylammonium 
cyanide (0.42 mmol, 61 mg) and then potassium cyanide (0.05 mmol, 3.4 mg).  The non-
homogenous solution was stirred and warmed to rt in the cooling bath.  After 2 h, the solvent was 
removed under rotary evaporation to provide a tan oil. The residue was purified by flash column 
chromatography (2 x 16 cm silica gel, 1:1 hexanes, ether, Rf = 0.56, 0.26) to give two 
diastereomers in a ratio of ca 1:1 (diastereomer 1:2). Molecular ion calculated for [M + Na] 
C49H53N3NaO5Si = 812.3652, found (electrospray) 814.3672, error = 2.5 ppm; IR (neat, cm
-1) 
1710; Diastereomer 1: 400 MHz 1H NMR (55 °C, CDCl3, ppm) δ 7.62 (1H, d, J = 1.2 Hz) 7.53-
7.48 (9H, m) 7.40-7.20 (12H, m) 5.9 (1H, s) 5.23 (2H, ABq, J = 12.0 Hz) 4.01 (1H, d, J = 10.8 
Hz) 3.80 (1H, br d, J = 8.0 Hz) 2.59 (1H, dd, J = 4.4, 4.2 Hz) 2.51 (1H, d, J = 4.4 Hz) 1.55 (9H, 
s) 0.78 (9H, s) 0.08 (3H, s) 0.00 (3H); 100 MHz 13C NMR (55 °C, CDCl3, ppm) δ 172.2, 164.0, 
157.6, 143.8, 138.2, 135.8, 135.2, 129.2, 128.6, 128.2, 127.8, 127.6, 127.1, 122.0, 119.7, 113.1, 
81.9, 74.1, 71.3, 56.6, 54.0, 38.3, 33.3, 28.1, 25.4, 18.0, -5.2, -5.3; Diastereomer 2: 500 MHz 1  
NMR (45 °C, CDCl3, ppm) δ 7.61 (1H, s) 7.54-7.44 (9H, m) 7.41-7.22 (14H, m) 5.87 (1H, br s) 
5.24 (1H, d, J = 11.5 Hz) 5.19 (1H, d, J = 11.5 Hz) 4.06 (1H, dd, J = 10.7, 3.7 Hz) 3.91 (1H, d, J 
= 10.7 Hz) 2.63 (1H, dd, J = 4.5, 3.7 Hz) 2.52 (1H, d, J = 4.5) 1.56 (9H, s) 0.78 (9H, s) 0.07 (3H, 
s) -0.03 (3H, s); 100 MHz 13C NMR (45 °C, CDCl3, ppm) δ 171.6, 164.2, 157.7, 144.0, 135.9, 
135.3, 129.3, 128.7, 128.3, 127.95, 127.88, 127.7, 12 .6, 127.3, 118.4, 113.0, 82.0, 74.1, 71.5, 
56.5, 53.8, 38.4, 33.2, 28.2, 25.5, 18.0, -5.0, -5.2.  1H NMR spectroscopy was conducted at 
temperatures between 45 – 55 °C in order to resolve the C(1), C(2), and C(3) proton signals.  13C
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NMR spectroscopy was conducted at temperatures between  45 – 55°C in order to resolve the 
C(3) carbon signal.  
 
 
Protected mitosane cyanohydrin 107.  A solution of 104 (0.33 mmol, 264 mg) in toluene was 
concentrated under a stream of N2.  To the resulting residue was added 5.5 mL Et2O, and a white 
precipitate appeared.  The mixture was stirred vigorously and cooled to -78 °C (internal).   To the 
mixture was added LiHMDS as a solution in Et2O (5 mL, 0.99 mmol, 171 mg) slowly to keep the 
temperature below -76 °C.  The mixture immediately urned bright yellow upon addition of the 
base.  The mixture was stirred at -78 °C for 30 min, and was then warmed to 0 °C slowly over 30 
min.  The reaction lightened to pale yellow near -17 °C.  When the reaction temperature reached 
0.5 °C, the vessel was placed in a 0 °C bath, and was allowed to stir.  After 40 min of stirring, 2 
mL saturated NH4Cl was added, the reaction exothermed to 6 °C, then cooled to 3 °C.  The 
mixture was extracted 3 x with ethyl acetate, washed with brine, and dried over MgSO4, and 
concentrated under reduced pressure to give a yellow residue consisting of 107, and the two 
diastereomers of 104 in a ratio of 2:1 (prod: starting material).  The crude residue was purified by 
flash column chromatography (3 x 15 cm silica gel, 2:1 hexanes: ether, Rf =  0.41) to provide 153 
mg (58%) of 107.  Molecular ion calculated for [M + Na] C49H53N3NaO5Si = 814.3652, found 
(electrospray) 814.3672, error = 2.5 ppm; IR (neat, cm-1) 3426, 1713, 1700, 1594; 500 MHz 1H
NMR (CDCl3, ppm) δ 7.58-7.52 (8H, m) 7.84-7.36 (2H, m) 7.34-7.28 (7H, m) 7.26-7.22(4H, m) 
7.10 (1H, d, J = 1.0 Hz) 5.22 (2H, ABq, J = 11.8 Hz) 4.19 (1H, d, J = 10.0 Hz) 3.39 (1H, s) 2.96 
(1H, dd, J = 10.0, 3.5 Hz) 2.70 (1H, d, J = 4.5 Hz) 2.58 (1H, dd, J = 4.5, 3.5 Hz) 1.59 (9H, s) 0.41 
(9H, s) 0.00 (3H, s) -0.40 (3H, s); 100 MHz 13C NMR (CDCl3, ppm) 164.9, 155.1, 153.7, 143.9, 
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136.9, 135.7, 129.4, 128.6, 128.2, 127.9, 127.9, 127.1, 122.9, 117.7, 109.8, 107.7, 104.3, 81.6, 
76.4, 74.3, 70.5, 54.3, 42.5, 41.4, 28.1, 25.2, 17.9, -4.7, -4.8.  
 
 
9-oxo-pyrrolo[1,2a[indole mitosane 96. To a solution of 107 (0.024 mmol, 19 mg) in 0.50 mL 
THF at 0 °C was added TBAF dropwise via syringe.  Upon the first drop, the solution turned 
bright yellow.  The reaction solution was allowed to s ir and warm to rt in the cooling bath.  After 
2.5 h, the solution was cooled in a 0 °C bath and saturated aqueous NaHCO3 was added.  The 
mixture was extracted 3 x with CH2Cl2, and the combined organic phase was washed with brine
and dried over MgSO4. Removal of the solvent under rotary evaporation provided a fluorescent 
yellow/green residue.  The crude residue was purified by analytical preparatory plate TLC on 
silica gel 60 Å (20 cm x 20 cm x 200 µm) with 3:1 hexanes: ethyl acetate (Rf = 0.25) to provide 
12 mg (77%) of a bright yellow/green oil.  Molecular ion calculated for [M + Na]  C42H38N2NaO5 
= 673.2678, found (electrospray) = 673.2688 , error = 1.5 ppm; IR (neat, cm-1) 3421, 1705, 1615, 
1584; 500 MHz 1H NMR (CDCl3, ppm) δ 7.61 (2H, d, J = 7.0) 7.45-7.40 (2H, m) 7.37-7.37 (1H, 
m) 7.21-7.10 (15H, m) 7.05 (1H, s) 5.35 (2H, ABq, J = 12.2 Hz) 3.84 (1H, d, J = 12.0 Hz) 3.52 
(1H, dd, J = 12.0, 2.0 Hz) 2.98 (1H, s) 2.41 (1H, d, J = 4.5 Hz) 2.26 (1H, dd, J = 4.5, 2.0 Hz) 1.64 
(9H, s); 100 MHz 13C NMR (CDCl3, ppm) δ 195.9, 164.9, 164.7, 157.3, 143.8, 142.3, 136.1, 
129.1, 128.7, 128.0, 127.6, 126.9, 126.9, 113.4, 105.4, 104.6, 97.5, 82.2, 74.0, 70.4, 51.4, 41.8, 
40.1, 28.2.  The stereochemistry was assigned based on a 16% NOE enhancement between Ha 
and Hc (7.05 ppm) and by analogy to model 90.  
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 Yellow needles of sd40 were grown from a diethyl ether solution at 25 deg. C.  A crystal 
of dimensions 0.34 x 0.19 x 0.13 mm was mounted on a Bruker SMART APEX CCD-based X-
ray diffractometer equipped with a low temperature device and fine focus Mo-target X-ray tube 
(λ = 0.71073 A) operated at 1500 W power (50 kV, 30 mA).  The X-ray intensities were 
measured at 85(1) K; the detector was placed at a distance 5.055 cm from the crystal.  A total of 
3182 frames were collected with a scan width of 0.5° in ω and 0.45° in phi with an exposure time 
of 15 s/frame.  The integration of the data yielded a total of 132594 reflections to a maximum 2θ 
value of 56.70° of which 12817 were independent and 11858 were greater than 2σ(I).  The final 
cell constants (Table 1) were based on the xyz centroids of 9977 reflections above 10σ(I).  
Analysis of the data showed negligible decay during data collection; the data were processed with 
SADABS and corrected for absorption.  The structure was solved and refined with the Bruker 
SHELXTL (version 2008/3) software package, using the space group P2(1) with Z = 2 for the 
formula 4(C30H24N2O2)•C4H10O.  There are 4 crystallographically independent molecules in 
the asymmetric unit.  All of the molecules have the same ‘S’ chirality based on assignment to a 
known center.  During refinement, Friedel pairs were merged for this light-atom structure.  All 
non-hydrogen atoms were refined anisotropically with the hydrogen atoms placed in idealized 
positions except for those involved in hydrogen bonding which were allowed to refine 
isotropically.  Full matrix least-squares refinement based on F2 converged at R1 = 0.0368 and 
wR2 = 0.0913 [based on I > 2sigma(I)], R1 = 0.0410 and wR2 = 0.0943 for all data.  Additional 
details are presented in Table 1 and are given as Supporting Information in a CIF file. 
 
Sheldrick, G.M. SHELXTL, v. 2008/3; Bruker Analytical X-ray, Madison, WI, 2008. 
172 
 
Sheldrick, G.M. SADABS, v. 2008/1.  Program for Empirical Absorption Correction of Area 
Detector Data, University of Gottingen: Gottingen, Germany, 2008.   
Saint Plus, v. 7.53a, Bruker Analytical X-ray, Madison, WI, 2008. 
 
 
      Table 1.  Crystal data and structure refinement for sd40. 
  
  
      Identification code               sd40 
  
      Empirical formula                 C124 H106 N8 O9 
  
      Formula weight                    1852.17 
  
      Temperature                       85(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Monoclinic,  P2(1) 
  
      Unit cell dimensions              a = 20.3120(9) A alpha = 90°. 
                                        b = 9.5308(4)A beta =107.355(1)°. 
                                        c = 26.2849(12) A gamma = 90 °. 
  
      Volume                            4856.8(4) A^3 
  
      Z, Calculated density             2,  1.267 Mg/m^3 
  
      Absorption coefficient            0.080 mm^-1 
  
      F(000)                            1956 
  
      Crystal size                      0.34 x 0.19 x 0.13 mm 
  
      Theta range for data collection   1.05 to 28.35 deg. 
  
      Limiting indices                  -27<=h<=27, -12<=k<=12, -35<=l<=35 
  
      Reflections collected / unique    132594 / 12817 [R(int) = 0.0514] 
  
      Completeness to theta = 28.35     99.7 % 
  
      Absorption correction             Semi-empirical from equivalents 
  
      Max. and min. transmission        0.9897 and 0.9733 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    12817 / 1 / 1288 
  
      Goodness-of-fit on F^2            1.030 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0368, wR2 = 0.0913 
  




      Absolute structure parameter      0(10) 
  
      Largest diff. peak and hole       0.527 and -0.320 e.A^-3 
  
 
          
Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for sd40. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          O(1)         2113(1)       6300(2)       9357(1)       24(1) 
          O(2)         1781(1)       9235(2)       9106(1)       23(1) 
          O(3)         2452(1)       1337(2)       -248(1)       25(1) 
          O(4)         2830(1)       4254(2)         30(1)       24(1) 
          O(5)         2554(1)       4075(2)       5555(1)       26(1) 
          O(6)         2573(1)       1086(2)       5745(1)       25(1) 
          O(7)         2587(1)       8810(2)       5128(1)       27(1) 
          O(8)         2656(1)       5916(2)       4794(1)       23(1) 
          O(9)         6112(1)       4971(2)       2827(1)       34(1) 
          N(1)         1088(1)       8933(2)       9699(1)       17(1) 
          N(2)          157(1)       7390(2)       8959(1)       15(1) 
          N(3)         3836(1)       3623(2)       -226(1)       18(1) 
          N(4)         4316(1)       2088(2)        684(1)       16(1) 
          N(5)         1375(1)       1238(2)       5233(1)       17(1) 
          N(6)         1064(1)       2598(2)       6046(1)       15(1) 
          N(7)         3877(1)       6370(2)       5076(1)       18(1) 
          N(8)         3743(1)       7965(2)       4199(1)       16(1) 
          C(1)         1738(1)       6979(2)       9550(1)       17(1) 
          C(2)         1358(1)       8325(2)       9286(1)       17(1) 
          C(3)          419(1)       9628(2)       9450(1)       18(1) 
          C(4)          150(1)       8927(2)       8911(1)       18(1) 
          C(5)          719(1)       8081(2)       8815(1)       17(1) 
          C(6)         -345(1)       6518(2)       8550(1)       15(1) 
          C(7)         -973(1)       6264(2)       8752(1)       16(1) 
          C(8)        -1001(1)       6778(2)       9242(1)       18(1) 
          C(9)        -1562(1)       6465(2)       9424(1)       20(1) 
          C(10)       -2091(1)       5620(2)       9127(1)       21(1) 
          C(11)       -2070(1)       5113(2)       8635(1)       21(1) 
          C(12)       -1520(1)       5444(2)       8449(1)       19(1) 
          C(13)           2(1)       5078(2)       8548(1)       16(1) 
          C(14)         516(1)       4624(2)       8999(1)       19(1) 
          C(15)         832(1)       3318(2)       9010(1)       23(1) 
          C(16)         623(1)       2429(2)       8574(1)       24(1) 
          C(17)          95(1)       2854(2)       8129(1)       23(1) 
          C(18)        -211(1)       4164(2)       8114(1)       19(1) 
          C(19)        -563(1)       7229(2)       8002(1)       17(1) 
          C(20)       -1119(1)       8166(2)       7868(1)       19(1) 
          C(21)       -1280(1)       8932(2)       7397(1)       25(1) 
          C(22)        -900(1)       8755(3)       7041(1)       28(1) 
          C(23)        -350(1)       7826(3)       7166(1)       26(1) 
          C(24)        -177(1)       7084(2)       7645(1)       21(1) 
          C(25)        1140(1)       7916(2)      10090(1)       16(1) 
          C(26)        1551(1)       6771(2)      10042(1)       17(1) 
          C(27)        1679(1)       5664(2)      10406(1)       21(1) 
          C(28)        1386(1)       5722(2)      10820(1)       22(1) 
          C(29)         976(1)       6869(2)      10867(1)       21(1) 
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          C(30)         846(1)       7970(2)      10508(1)       19(1) 
          C(31)        2973(1)       1895(2)       -297(1)       18(1) 
          C(32)        3304(1)       3205(2)         20(1)       18(1) 
          C(33)        4441(1)       4213(2)        184(1)       22(1) 
          C(34)        4386(1)       3619(2)        706(1)       20(1) 
          C(35)        3696(1)       2946(2)        601(1)       18(1) 
          C(36)        4561(1)       1256(2)       1188(1)       16(1) 
          C(37)        4370(1)       1948(2)       1656(1)       18(1) 
          C(38)        4800(1)       2939(2)       1987(1)       20(1) 
          C(39)        4597(1)       3616(2)       2385(1)       25(1) 
          C(40)        3958(1)       3338(2)       2452(1)       27(1) 
          C(41)        3519(1)       2382(2)       2119(1)       24(1) 
          C(42)        3726(1)       1690(2)       1728(1)       21(1) 
          C(43)        5348(1)       1091(2)       1312(1)       18(1) 
          C(44)        5692(1)       1459(2)        946(1)       22(1) 
          C(45)        6406(1)       1267(2)       1067(1)       26(1) 
          C(46)        6778(1)        691(3)       1547(1)       31(1) 
          C(47)        6441(1)        305(3)       1912(1)       34(1) 
          C(48)        5735(1)        510(2)       1798(1)       25(1) 
          C(49)        4228(1)       -210(2)       1059(1)       18(1) 
          C(50)        3928(1)       -640(2)        538(1)       21(1) 
          C(51)        3624(1)      -1963(2)        421(1)       27(1) 
          C(52)        3630(1)      -2887(2)        828(1)       31(1) 
          C(53)        3946(1)      -2489(2)       1350(1)       32(1) 
          C(54)        4237(1)      -1164(2)       1466(1)       25(1) 
          C(55)        3905(1)       2556(2)       -568(1)       18(1) 
          C(56)        3389(1)       1528(2)       -641(1)       17(1) 
          C(57)        3347(1)        386(2)       -984(1)       21(1) 
          C(58)        3832(1)        286(2)      -1256(1)       23(1) 
          C(59)        4345(1)       1314(2)      -1183(1)       24(1) 
          C(60)        4396(1)       2447(2)       -841(1)       22(1) 
          C(61)        2053(1)       3313(2)       5377(1)       19(1) 
          C(62)        1968(1)       1890(2)       5628(1)       18(1) 
          C(63)         956(1)        429(2)       5503(1)       20(1) 
          C(64)        1136(1)       1058(2)       6056(1)       18(1) 
          C(65)        1751(1)       1978(2)       6135(1)       16(1) 
          C(66)         901(1)       3313(2)       6500(1)       16(1) 
          C(67)         110(1)       3517(2)       6330(1)       17(1) 
          C(68)        -303(1)       3233(2)       5814(1)       18(1) 
          C(69)       -1008(1)       3527(2)       5662(1)       20(1) 
          C(70)       -1306(1)       4134(2)       6018(1)       21(1) 
          C(71)        -896(1)       4425(2)       6536(1)       25(1) 
          C(72)        -198(1)       4102(2)       6691(1)       23(1) 
          C(73)        1207(1)       4805(2)       6543(1)       20(1) 
          C(74)        1330(1)       5429(2)       6102(1)       25(1) 
          C(75)        1575(1)       6801(2)       6129(1)       36(1) 
          C(76)        1684(1)       7571(3)       6590(1)       45(1) 
          C(77)        1557(1)       6969(3)       7032(1)       41(1) 
          C(78)        1323(1)       5593(3)       7012(1)       29(1) 
          C(79)        1165(1)       2472(2)       7019(1)       18(1) 
          C(80)         763(1)       1407(2)       7142(1)       20(1) 
          C(81)        1031(1)        519(2)       7575(1)       24(1) 
          C(82)        1705(1)        684(3)       7899(1)       29(1) 
          C(83)        2109(1)       1739(3)       7786(1)       28(1) 
          C(84)        1845(1)       2624(2)       7350(1)       22(1) 
          C(85)        1055(1)       2261(2)       4864(1)       17(1) 
          C(86)        1443(1)       3493(2)       4915(1)       18(1) 
          C(87)        1208(1)       4641(2)       4579(1)       20(1) 
          C(88)         570(1)       4536(2)       4196(1)       20(1) 
          C(89)         186(1)       3290(2)       4144(1)       20(1) 
          C(90)         418(1)       2142(2)       4471(1)       19(1) 
          C(91)        3128(1)       8199(2)       5166(1)       18(1) 
          C(92)        3174(1)       6903(2)       4826(1)       18(1) 
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          C(93)        4151(1)       5733(2)       4668(1)       20(1) 
          C(94)        3739(1)       6427(2)       4151(1)       18(1) 
          C(95)        3147(1)       7187(2)       4250(1)       17(1) 
          C(96)        3666(1)       8863(2)       3718(1)       16(1) 
          C(97)        4399(1)       9121(2)       3681(1)       17(1) 
          C(98)        4984(1)       8587(2)       4053(1)       19(1) 
          C(99)        5643(1)       8878(2)       4016(1)       23(1) 
          C(100)       5723(1)       9727(2)       3610(1)       23(1) 
          C(101)       5142(1)      10265(2)       3237(1)       24(1) 
          C(102)       4488(1)       9959(2)       3268(1)       21(1) 
          C(103)       3204(1)       8183(2)       3202(1)       18(1) 
          C(104)       2483(1)       8289(2)       3068(1)       21(1) 
          C(105)       2060(1)       7617(2)       2619(1)       25(1) 
          C(106)       2345(1)       6835(3)       2295(1)       29(1) 
          C(107)       3058(1)       6698(2)       2427(1)       27(1) 
          C(108)       3482(1)       7368(2)       2877(1)       22(1) 
          C(109)       3374(1)      10277(2)       3836(1)       18(1) 
          C(110)       3051(1)      11212(2)       3426(1)       24(1) 
          C(111)       2807(1)      12501(2)       3541(1)       31(1) 
          C(112)       2870(1)      12881(2)       4061(1)       31(1) 
          C(113)       3197(1)      11980(2)       4469(1)       28(1) 
          C(114)       3452(1)      10693(2)       4359(1)       21(1) 
          C(115)       4246(1)       7388(2)       5422(1)       17(1) 
          C(116)       3821(1)       8467(2)       5512(1)       18(1) 
          C(117)       4088(1)       9554(2)       5872(1)       21(1) 
          C(118)       4786(1)       9557(2)       6135(1)       22(1) 
          C(119)       5208(1)       8483(2)       6042(1)       21(1) 
          C(120)       4953(1)       7397(2)       5687(1)       21(1) 
          C(121)       6719(1)       4151(3)       3023(1)       32(1) 
          C(122)       6506(1)       2674(3)       3100(1)       34(1) 
          C(123)       6256(1)       6407(3)       2802(1)       38(1) 
          C(124)       5581(2)       7184(3)       2615(1)       42(1) 
         ________________________________________________________________ 
  
 
           Table 3.  Bond lengths [A] and angles [deg] for sd40. 
           _____________________________________________________________ 
  
            O(1)-C(1)                     1.219(2) 
            O(2)-C(2)                     1.398(2) 
            O(3)-C(31)                    1.225(2) 
            O(4)-C(32)                    1.395(2) 
            O(5)-C(61)                    1.224(2) 
            O(6)-C(62)                    1.403(2) 
            O(7)-C(91)                    1.223(2) 
            O(8)-C(92)                    1.396(2) 
            O(9)-C(123)                   1.405(3) 
            O(9)-C(121)                   1.420(3) 
            N(1)-C(25)                    1.395(2) 
            N(1)-C(2)                     1.472(2) 
            N(1)-C(3)                     1.476(2) 
            N(2)-C(5)                     1.462(2) 
            N(2)-C(4)                     1.470(2) 
            N(2)-C(6)                     1.494(2) 
            N(3)-C(55)                    1.393(3) 
            N(3)-C(32)                    1.469(2) 
            N(3)-C(33)                    1.482(2) 
            N(4)-C(35)                    1.462(2) 
            N(4)-C(34)                    1.466(2) 
            N(4)-C(36)                    1.496(2) 
            N(5)-C(85)                    1.392(2) 
            N(5)-C(62)                    1.472(2) 
            N(5)-C(63)                    1.476(2) 
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            N(6)-C(65)                    1.468(2) 
            N(6)-C(64)                    1.474(2) 
            N(6)-C(66)                    1.494(2) 
            N(7)-C(115)                   1.388(2) 
            N(7)-C(92)                    1.473(2) 
            N(7)-C(93)                    1.477(2) 
            N(8)-C(95)                    1.459(2) 
            N(8)-C(94)                    1.472(2) 
            N(8)-C(96)                    1.497(2) 
            C(1)-C(26)                    1.466(2) 
            C(1)-C(2)                     1.549(3) 
            C(2)-C(5)                     1.522(2) 
            C(3)-C(4)                     1.514(3) 
            C(4)-C(5)                     1.491(3) 
            C(6)-C(19)                    1.533(2) 
            C(6)-C(7)                     1.540(2) 
            C(6)-C(13)                    1.544(3) 
            C(7)-C(8)                     1.396(3) 
            C(7)-C(12)                    1.397(3) 
            C(8)-C(9)                     1.392(3) 
            C(9)-C(10)                    1.383(3) 
            C(10)-C(11)                   1.392(3) 
            C(11)-C(12)                   1.385(3) 
            C(13)-C(14)                   1.396(3) 
            C(13)-C(18)                   1.396(3) 
            C(14)-C(15)                   1.397(3) 
            C(15)-C(16)                   1.388(3) 
            C(16)-C(17)                   1.390(3) 
            C(17)-C(18)                   1.390(3) 
            C(19)-C(24)                   1.398(3) 
            C(19)-C(20)                   1.400(3) 
            C(20)-C(21)                   1.389(3) 
            C(21)-C(22)                   1.389(3) 
            C(22)-C(23)                   1.386(3) 
            C(23)-C(24)                   1.395(3) 
            C(25)-C(30)                   1.398(3) 
            C(25)-C(26)                   1.404(3) 
            C(26)-C(27)                   1.396(3) 
            C(27)-C(28)                   1.388(3) 
            C(28)-C(29)                   1.402(3) 
            C(29)-C(30)                   1.383(3) 
            C(31)-C(56)                   1.451(3) 
            C(31)-C(32)                   1.540(3) 
            C(32)-C(35)                   1.516(3) 
            C(33)-C(34)                   1.518(3) 
            C(34)-C(35)                   1.491(3) 
            C(36)-C(37)                   1.541(3) 
            C(36)-C(43)                   1.541(3) 
            C(36)-C(49)                   1.545(3) 
            C(37)-C(42)                   1.400(3) 
            C(37)-C(38)                   1.400(3) 
            C(38)-C(39)                   1.392(3) 
            C(39)-C(40)                   1.385(3) 
            C(40)-C(41)                   1.388(3) 
            C(41)-C(42)                   1.387(3) 
            C(43)-C(44)                   1.393(3) 
            C(43)-C(48)                   1.399(3) 
            C(44)-C(45)                   1.400(3) 
            C(45)-C(46)                   1.377(3) 
            C(46)-C(47)                   1.385(3) 
            C(47)-C(48)                   1.389(3) 
            C(49)-C(50)                   1.386(3) 
            C(49)-C(54)                   1.401(3) 
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            C(50)-C(51)                   1.397(3) 
            C(51)-C(52)                   1.383(3) 
            C(52)-C(53)                   1.383(3) 
            C(53)-C(54)                   1.389(3) 
            C(55)-C(60)                   1.395(3) 
            C(55)-C(56)                   1.405(3) 
            C(56)-C(57)                   1.400(3) 
            C(57)-C(58)                   1.381(3) 
            C(58)-C(59)                   1.401(3) 
            C(59)-C(60)                   1.390(3) 
            C(61)-C(86)                   1.463(3) 
            C(61)-C(62)                   1.541(3) 
            C(62)-C(65)                   1.524(2) 
            C(63)-C(64)                   1.513(3) 
            C(64)-C(65)                   1.489(3) 
            C(66)-C(79)                   1.535(3) 
            C(66)-C(73)                   1.542(3) 
            C(66)-C(67)                   1.545(2) 
            C(67)-C(68)                   1.392(3) 
            C(67)-C(72)                   1.401(3) 
            C(68)-C(69)                   1.395(3) 
            C(69)-C(70)                   1.384(3) 
            C(70)-C(71)                   1.394(3) 
            C(71)-C(72)                   1.387(3) 
            C(73)-C(74)                   1.391(3) 
            C(73)-C(78)                   1.401(3) 
            C(74)-C(75)                   1.393(3) 
            C(75)-C(76)                   1.377(4) 
            C(76)-C(77)                   1.388(4) 
            C(77)-C(78)                   1.390(3) 
            C(79)-C(80)                   1.400(3) 
            C(79)-C(84)                   1.404(3) 
            C(80)-C(81)                   1.392(3) 
            C(81)-C(82)                   1.390(3) 
            C(82)-C(83)                   1.385(3) 
            C(83)-C(84)                   1.395(3) 
            C(85)-C(86)                   1.398(3) 
            C(85)-C(90)                   1.400(3) 
            C(86)-C(87)                   1.398(3) 
            C(87)-C(88)                   1.387(3) 
            C(88)-C(89)                   1.405(3) 
            C(89)-C(90)                   1.384(3) 
            C(91)-C(116)                  1.453(3) 
            C(91)-C(92)                   1.543(3) 
            C(92)-C(95)                   1.524(3) 
            C(93)-C(94)                   1.519(3) 
            C(94)-C(95)                   1.491(3) 
            C(96)-C(97)                   1.539(3) 
            C(96)-C(109)                  1.541(3) 
            C(96)-C(103)                  1.542(3) 
            C(97)-C(98)                   1.391(3) 
            C(97)-C(102)                  1.402(3) 
            C(98)-C(99)                   1.399(3) 
            C(99)-C(100)                  1.387(3) 
            C(100)-C(101)                 1.388(3) 
            C(101)-C(102)                 1.386(3) 
            C(103)-C(108)                 1.393(3) 
            C(103)-C(104)                 1.403(3) 
            C(104)-C(105)                 1.391(3) 
            C(105)-C(106)                 1.383(3) 
            C(106)-C(107)                 1.391(3) 
            C(107)-C(108)                 1.393(3) 
            C(109)-C(114)                 1.393(3) 
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            C(109)-C(110)                 1.401(3) 
            C(110)-C(111)                 1.391(3) 
            C(111)-C(112)                 1.384(3) 
            C(112)-C(113)                 1.380(3) 
            C(113)-C(114)                 1.396(3) 
            C(115)-C(120)                 1.396(3) 
            C(115)-C(116)                 1.405(3) 
            C(116)-C(117)                 1.399(3) 
            C(117)-C(118)                 1.379(3) 
            C(118)-C(119)                 1.401(3) 
            C(119)-C(120)                 1.387(3) 
            C(121)-C(122)                 1.503(4) 
            C(123)-C(124)                 1.507(4) 
  
            C(123)-O(9)-C(121)          112.55(19) 
            C(25)-N(1)-C(2)             107.89(15) 
            C(25)-N(1)-C(3)             119.75(15) 
            C(2)-N(1)-C(3)              110.30(14) 
            C(5)-N(2)-C(4)               61.15(13) 
            C(5)-N(2)-C(6)              118.86(14) 
            C(4)-N(2)-C(6)              120.38(15) 
            C(55)-N(3)-C(32)            108.33(15) 
            C(55)-N(3)-C(33)            121.69(16) 
            C(32)-N(3)-C(33)            110.05(15) 
            C(35)-N(4)-C(34)             61.23(13) 
            C(35)-N(4)-C(36)            118.27(14) 
            C(34)-N(4)-C(36)            119.44(15) 
            C(85)-N(5)-C(62)            108.03(15) 
            C(85)-N(5)-C(63)            118.99(15) 
            C(62)-N(5)-C(63)            110.46(14) 
            C(65)-N(6)-C(64)             60.79(13) 
            C(65)-N(6)-C(66)            118.88(14) 
            C(64)-N(6)-C(66)            119.01(15) 
            C(115)-N(7)-C(92)           108.21(15) 
            C(115)-N(7)-C(93)           121.16(16) 
            C(92)-N(7)-C(93)            110.11(14) 
            C(95)-N(8)-C(94)             61.17(12) 
            C(95)-N(8)-C(96)            119.19(14) 
            C(94)-N(8)-C(96)            119.98(15) 
            O(1)-C(1)-C(26)             130.71(18) 
            O(1)-C(1)-C(2)              123.00(17) 
            C(26)-C(1)-C(2)             106.28(15) 
            O(2)-C(2)-N(1)              114.07(16) 
            O(2)-C(2)-C(5)              106.22(15) 
            N(1)-C(2)-C(5)              104.09(15) 
            O(2)-C(2)-C(1)              112.99(15) 
            N(1)-C(2)-C(1)              104.06(14) 
            C(5)-C(2)-C(1)              115.29(16) 
            N(1)-C(3)-C(4)              104.15(15) 
            N(2)-C(4)-C(5)               59.15(12) 
            N(2)-C(4)-C(3)              111.58(16) 
            C(5)-C(4)-C(3)              108.31(15) 
            N(2)-C(5)-C(4)               59.70(12) 
            N(2)-C(5)-C(2)              113.67(15) 
            C(4)-C(5)-C(2)              107.25(15) 
            N(2)-C(6)-C(19)             111.97(15) 
            N(2)-C(6)-C(7)              107.24(14) 
            C(19)-C(6)-C(7)             110.92(15) 
            N(2)-C(6)-C(13)             106.46(14) 
            C(19)-C(6)-C(13)            113.19(15) 
            C(7)-C(6)-C(13)             106.69(15) 
            C(8)-C(7)-C(12)             118.58(17) 
            C(8)-C(7)-C(6)              122.00(16) 
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            C(12)-C(7)-C(6)             119.36(16) 
            C(9)-C(8)-C(7)              120.27(18) 
            C(10)-C(9)-C(8)             120.62(18) 
            C(9)-C(10)-C(11)            119.51(18) 
            C(12)-C(11)-C(10)           120.03(18) 
            C(11)-C(12)-C(7)            120.95(17) 
            C(14)-C(13)-C(18)           118.11(18) 
            C(14)-C(13)-C(6)            119.95(17) 
            C(18)-C(13)-C(6)            121.84(16) 
            C(13)-C(14)-C(15)           121.13(19) 
            C(16)-C(15)-C(14)           120.07(19) 
            C(15)-C(16)-C(17)           119.16(19) 
            C(18)-C(17)-C(16)           120.71(19) 
            C(17)-C(18)-C(13)           120.76(18) 
            C(24)-C(19)-C(20)           117.78(17) 
            C(24)-C(19)-C(6)            121.62(17) 
            C(20)-C(19)-C(6)            120.26(16) 
            C(21)-C(20)-C(19)           121.19(18) 
            C(22)-C(21)-C(20)           120.4(2) 
            C(23)-C(22)-C(21)           119.25(19) 
            C(22)-C(23)-C(24)           120.4(2) 
            C(23)-C(24)-C(19)           120.95(19) 
            N(1)-C(25)-C(30)            126.71(18) 
            N(1)-C(25)-C(26)            112.88(16) 
            C(30)-C(25)-C(26)           120.39(18) 
            C(27)-C(26)-C(25)           121.27(17) 
            C(27)-C(26)-C(1)            131.54(18) 
            C(25)-C(26)-C(1)            107.05(16) 
            C(28)-C(27)-C(26)           118.14(19) 
            C(27)-C(28)-C(29)           120.37(19) 
            C(30)-C(29)-C(28)           121.95(18) 
            C(29)-C(30)-C(25)           117.89(18) 
            O(3)-C(31)-C(56)            129.95(18) 
            O(3)-C(31)-C(32)            123.12(17) 
            C(56)-C(31)-C(32)           106.93(16) 
            O(4)-C(32)-N(3)             114.63(16) 
            O(4)-C(32)-C(35)            104.76(15) 
            N(3)-C(32)-C(35)            104.69(15) 
            O(4)-C(32)-C(31)            113.50(15) 
            N(3)-C(32)-C(31)            103.99(15) 
            C(35)-C(32)-C(31)           115.24(16) 
            N(3)-C(33)-C(34)            104.24(15) 
            N(4)-C(34)-C(35)             59.26(12) 
            N(4)-C(34)-C(33)            111.68(17) 
            C(35)-C(34)-C(33)           108.20(16) 
            N(4)-C(35)-C(34)             59.50(12) 
            N(4)-C(35)-C(32)            114.31(15) 
            C(34)-C(35)-C(32)           107.31(16) 
            N(4)-C(36)-C(37)            112.48(15) 
            N(4)-C(36)-C(43)            106.88(14) 
            C(37)-C(36)-C(43)           111.50(15) 
            N(4)-C(36)-C(49)            106.05(14) 
            C(37)-C(36)-C(49)           111.43(15) 
            C(43)-C(36)-C(49)           108.20(15) 
            C(42)-C(37)-C(38)           117.94(17) 
            C(42)-C(37)-C(36)           119.98(17) 
            C(38)-C(37)-C(36)           121.83(17) 
            C(39)-C(38)-C(37)           120.75(19) 
            C(40)-C(39)-C(38)           120.3(2) 
            C(39)-C(40)-C(41)           119.66(19) 
            C(42)-C(41)-C(40)           120.03(19) 
            C(41)-C(42)-C(37)           121.26(19) 
            C(44)-C(43)-C(48)           117.92(18) 
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            C(44)-C(43)-C(36)           122.18(17) 
            C(48)-C(43)-C(36)           119.86(17) 
            C(43)-C(44)-C(45)           120.71(19) 
            C(46)-C(45)-C(44)           120.5(2) 
            C(45)-C(46)-C(47)           119.4(2) 
            C(46)-C(47)-C(48)           120.4(2) 
            C(47)-C(48)-C(43)           121.1(2) 
            C(50)-C(49)-C(54)           117.75(19) 
            C(50)-C(49)-C(36)           121.32(17) 
            C(54)-C(49)-C(36)           120.91(17) 
            C(49)-C(50)-C(51)           121.3(2) 
            C(52)-C(51)-C(50)           120.3(2) 
            C(53)-C(52)-C(51)           119.2(2) 
            C(52)-C(53)-C(54)           120.5(2) 
            C(53)-C(54)-C(49)           121.0(2) 
            N(3)-C(55)-C(60)            127.63(18) 
            N(3)-C(55)-C(56)            112.49(16) 
            C(60)-C(55)-C(56)           119.85(18) 
            C(57)-C(56)-C(55)           121.89(17) 
            C(57)-C(56)-C(31)           130.87(18) 
            C(55)-C(56)-C(31)           107.22(17) 
            C(58)-C(57)-C(56)           118.17(19) 
            C(57)-C(58)-C(59)           119.77(19) 
            C(60)-C(59)-C(58)           122.75(18) 
            C(59)-C(60)-C(55)           117.57(19) 
            O(5)-C(61)-C(86)            130.48(19) 
            O(5)-C(61)-C(62)            123.04(17) 
            C(86)-C(61)-C(62)           106.48(16) 
            O(6)-C(62)-N(5)             113.81(16) 
            O(6)-C(62)-C(65)            107.57(15) 
            N(5)-C(62)-C(65)            104.49(15) 
            O(6)-C(62)-C(61)            111.79(15) 
            N(5)-C(62)-C(61)            104.00(14) 
            C(65)-C(62)-C(61)           115.10(16) 
            N(5)-C(63)-C(64)            104.19(15) 
            N(6)-C(64)-C(65)             59.40(12) 
            N(6)-C(64)-C(63)            112.57(16) 
            C(65)-C(64)-C(63)           108.64(15) 
            N(6)-C(65)-C(64)             59.81(11) 
            N(6)-C(65)-C(62)            113.08(15) 
            C(64)-C(65)-C(62)           107.13(15) 
            N(6)-C(66)-C(79)            111.71(15) 
            N(6)-C(66)-C(73)            107.44(15) 
            C(79)-C(66)-C(73)           112.88(15) 
            N(6)-C(66)-C(67)            106.57(14) 
            C(79)-C(66)-C(67)           112.31(15) 
            C(73)-C(66)-C(67)           105.48(15) 
            C(68)-C(67)-C(72)           118.42(17) 
            C(68)-C(67)-C(66)           122.03(16) 
            C(72)-C(67)-C(66)           119.38(16) 
            C(67)-C(68)-C(69)           120.64(17) 
            C(70)-C(69)-C(68)           120.56(18) 
            C(69)-C(70)-C(71)           119.24(18) 
            C(72)-C(71)-C(70)           120.26(18) 
            C(71)-C(72)-C(67)           120.85(18) 
            C(74)-C(73)-C(78)           118.6(2) 
            C(74)-C(73)-C(66)           120.03(18) 
            C(78)-C(73)-C(66)           121.21(19) 
            C(73)-C(74)-C(75)           120.6(2) 
            C(76)-C(75)-C(74)           120.4(3) 
            C(75)-C(76)-C(77)           119.7(2) 
            C(76)-C(77)-C(78)           120.3(2) 
            C(77)-C(78)-C(73)           120.4(3) 
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            C(80)-C(79)-C(84)           117.79(18) 
            C(80)-C(79)-C(66)           120.73(16) 
            C(84)-C(79)-C(66)           120.99(17) 
            C(81)-C(80)-C(79)           121.09(18) 
            C(82)-C(81)-C(80)           120.4(2) 
            C(83)-C(82)-C(81)           119.2(2) 
            C(82)-C(83)-C(84)           120.6(2) 
            C(83)-C(84)-C(79)           120.8(2) 
            N(5)-C(85)-C(86)            112.87(16) 
            N(5)-C(85)-C(90)            126.47(18) 
            C(86)-C(85)-C(90)           120.65(18) 
            C(87)-C(86)-C(85)           121.33(17) 
            C(87)-C(86)-C(61)           131.42(19) 
            C(85)-C(86)-C(61)           107.13(17) 
            C(88)-C(87)-C(86)           118.16(19) 
            C(87)-C(88)-C(89)           120.13(18) 
            C(90)-C(89)-C(88)           122.20(18) 
            C(89)-C(90)-C(85)           117.52(18) 
            O(7)-C(91)-C(116)           130.37(19) 
            O(7)-C(91)-C(92)            122.87(17) 
            C(116)-C(91)-C(92)          106.76(16) 
            O(8)-C(92)-N(7)             114.07(16) 
            O(8)-C(92)-C(95)            104.94(15) 
            N(7)-C(92)-C(95)            104.27(14) 
            O(8)-C(92)-C(91)            113.56(15) 
            N(7)-C(92)-C(91)            103.69(15) 
            C(95)-C(92)-C(91)           116.24(16) 
            N(7)-C(93)-C(94)            104.11(15) 
            N(8)-C(94)-C(95)             58.99(12) 
            N(8)-C(94)-C(93)            111.67(16) 
            C(95)-C(94)-C(93)           108.26(15) 
            N(8)-C(95)-C(94)             59.84(12) 
            N(8)-C(95)-C(92)            113.33(15) 
            C(94)-C(95)-C(92)           107.17(15) 
            N(8)-C(96)-C(97)            106.57(14) 
            N(8)-C(96)-C(109)           106.14(14) 
            C(97)-C(96)-C(109)          108.10(15) 
            N(8)-C(96)-C(103)           112.64(15) 
            C(97)-C(96)-C(103)          111.06(15) 
            C(109)-C(96)-C(103)         112.01(15) 
            C(98)-C(97)-C(102)          118.22(17) 
            C(98)-C(97)-C(96)           122.47(17) 
            C(102)-C(97)-C(96)          119.28(17) 
            C(97)-C(98)-C(99)           120.85(18) 
            C(100)-C(99)-C(98)          120.22(19) 
            C(99)-C(100)-C(101)         119.34(18) 
            C(102)-C(101)-C(100)        120.48(19) 
            C(101)-C(102)-C(97)         120.87(18) 
            C(108)-C(103)-C(104)        118.00(18) 
            C(108)-C(103)-C(96)         121.40(17) 
            C(104)-C(103)-C(96)         120.46(17) 
            C(105)-C(104)-C(103)        120.97(19) 
            C(106)-C(105)-C(104)        120.25(19) 
            C(105)-C(106)-C(107)        119.57(19) 
            C(106)-C(107)-C(108)        120.2(2) 
            C(103)-C(108)-C(107)        121.02(19) 
            C(114)-C(109)-C(110)        117.84(18) 
            C(114)-C(109)-C(96)         120.70(17) 
            C(110)-C(109)-C(96)         121.41(17) 
            C(111)-C(110)-C(109)        120.7(2) 
            C(112)-C(111)-C(110)        120.7(2) 
            C(113)-C(112)-C(111)        119.1(2) 
            C(112)-C(113)-C(114)        120.5(2) 
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            C(109)-C(114)-C(113)        121.0(2) 
            N(7)-C(115)-C(120)          127.19(18) 
            N(7)-C(115)-C(116)          112.55(16) 
            C(120)-C(115)-C(116)        120.21(18) 
            C(117)-C(116)-C(115)        121.49(17) 
            C(117)-C(116)-C(91)         131.33(18) 
            C(115)-C(116)-C(91)         107.17(17) 
            C(118)-C(117)-C(116)        118.16(19) 
            C(117)-C(118)-C(119)        120.17(19) 
            C(120)-C(119)-C(118)        122.46(18) 
            C(119)-C(120)-C(115)        117.50(18) 
            O(9)-C(121)-C(122)          108.13(19) 
            O(9)-C(123)-C(124)          108.2(2) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
            
  
    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for sd40. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    O(1)     21(1)      31(1)      21(1)       3(1)       9(1)       6(1) 
    O(2)     23(1)      26(1)      18(1)       0(1)       7(1)     -10(1) 
    O(3)     20(1)      32(1)      24(1)      -4(1)       9(1)      -6(1) 
    O(4)     26(1)      25(1)      22(1)       3(1)       6(1)      11(1) 
    O(5)     17(1)      35(1)      24(1)       6(1)       3(1)      -6(1) 
    O(6)     21(1)      32(1)      21(1)      -2(1)       4(1)      12(1) 
    O(7)     16(1)      33(1)      30(1)      -6(1)       5(1)       4(1) 
    O(8)     21(1)      25(1)      22(1)       3(1)       6(1)      -7(1) 
    O(9)     28(1)      29(1)      43(1)       0(1)       6(1)      -1(1) 
    N(1)     19(1)      17(1)      15(1)      -1(1)       4(1)      -1(1) 
    N(2)     15(1)      14(1)      16(1)      -1(1)       4(1)      -1(1) 
    N(3)     18(1)      18(1)      19(1)       2(1)       5(1)      -2(1) 
    N(4)     16(1)      15(1)      16(1)       1(1)       3(1)      -1(1) 
    N(5)     19(1)      17(1)      15(1)       0(1)       5(1)       2(1) 
    N(6)     16(1)      14(1)      16(1)      -1(1)       5(1)       1(1) 
    N(7)     18(1)      17(1)      19(1)       1(1)       6(1)       2(1) 
    N(8)     16(1)      15(1)      18(1)       1(1)       6(1)       1(1) 
    C(1)     13(1)      22(1)      16(1)       1(1)       3(1)      -2(1) 
    C(2)     16(1)      19(1)      17(1)      -1(1)       5(1)      -1(1) 
    C(3)     21(1)      15(1)      19(1)      -2(1)       4(1)       2(1) 
    C(4)     20(1)      15(1)      17(1)       0(1)       3(1)      -1(1) 
    C(5)     17(1)      18(1)      15(1)       1(1)       4(1)      -2(1) 
    C(6)     17(1)      15(1)      14(1)      -1(1)       4(1)       0(1) 
    C(7)     14(1)      15(1)      17(1)       2(1)       5(1)       2(1) 
    C(8)     20(1)      15(1)      19(1)       0(1)       6(1)       1(1) 
    C(9)     21(1)      24(1)      16(1)       1(1)       7(1)       2(1) 
    C(10)    17(1)      24(1)      24(1)       3(1)       8(1)       2(1) 
    C(11)    16(1)      21(1)      25(1)      -2(1)       5(1)       0(1) 
    C(12)    19(1)      19(1)      18(1)      -2(1)       6(1)       1(1) 
    C(13)    16(1)      16(1)      18(1)       0(1)       8(1)      -1(1) 
    C(14)    21(1)      17(1)      20(1)       2(1)       8(1)       0(1) 
    C(15)    24(1)      21(1)      23(1)       5(1)       7(1)       4(1) 
    C(16)    30(1)      18(1)      27(1)       2(1)      14(1)       4(1) 
    C(17)    28(1)      21(1)      24(1)      -6(1)      13(1)      -2(1) 
    C(18)    20(1)      20(1)      18(1)      -2(1)       8(1)      -1(1) 
    C(19)    18(1)      16(1)      15(1)       0(1)       3(1)      -3(1) 
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    C(20)    20(1)      19(1)      16(1)      -1(1)       3(1)      -1(1) 
    C(21)    23(1)      23(1)      22(1)       3(1)      -2(1)      -1(1) 
    C(22)    32(1)      32(1)      18(1)       7(1)       2(1)      -5(1) 
    C(23)    28(1)      33(1)      19(1)       2(1)       8(1)      -6(1) 
    C(24)    21(1)      23(1)      18(1)      -1(1)       5(1)      -2(1) 
    C(25)    15(1)      18(1)      15(1)      -2(1)       1(1)      -4(1) 
    C(26)    15(1)      22(1)      14(1)       0(1)       4(1)      -1(1) 
    C(27)    19(1)      23(1)      19(1)       2(1)       4(1)       2(1) 
    C(28)    24(1)      24(1)      16(1)       3(1)       4(1)      -2(1) 
    C(29)    21(1)      25(1)      18(1)      -3(1)       7(1)      -6(1) 
    C(30)    20(1)      20(1)      19(1)      -5(1)       6(1)      -3(1) 
    C(31)    16(1)      21(1)      16(1)       0(1)       3(1)       2(1) 
    C(32)    18(1)      18(1)      19(1)       2(1)       5(1)       3(1) 
    C(33)    23(1)      19(1)      22(1)       2(1)       3(1)      -5(1) 
    C(34)    21(1)      15(1)      20(1)       0(1)       3(1)      -2(1) 
    C(35)    19(1)      17(1)      17(1)      -1(1)       4(1)       2(1) 
    C(36)    15(1)      16(1)      15(1)       0(1)       3(1)       0(1) 
    C(37)    19(1)      17(1)      16(1)       1(1)       4(1)       3(1) 
    C(38)    20(1)      20(1)      18(1)       1(1)       3(1)       1(1) 
    C(39)    28(1)      24(1)      20(1)      -5(1)       1(1)       3(1) 
    C(40)    32(1)      30(1)      18(1)      -2(1)       7(1)       8(1) 
    C(41)    22(1)      32(1)      20(1)       3(1)       8(1)       5(1) 
    C(42)    20(1)      23(1)      19(1)       0(1)       4(1)      -1(1) 
    C(43)    16(1)      17(1)      20(1)      -3(1)       3(1)       0(1) 
    C(44)    19(1)      21(1)      25(1)      -2(1)       6(1)      -1(1) 
    C(45)    22(1)      26(1)      34(1)      -6(1)      13(1)      -3(1) 
    C(46)    18(1)      37(1)      38(1)      -7(1)       5(1)       7(1) 
    C(47)    25(1)      42(1)      30(1)       1(1)       1(1)      11(1) 
    C(48)    23(1)      28(1)      25(1)       4(1)       7(1)       6(1) 
    C(49)    16(1)      16(1)      23(1)      -2(1)       7(1)      -1(1) 
    C(50)    19(1)      19(1)      23(1)      -3(1)       5(1)       1(1) 
    C(51)    23(1)      23(1)      33(1)      -9(1)       5(1)      -1(1) 
    C(52)    29(1)      19(1)      48(1)      -6(1)      15(1)      -5(1) 
    C(53)    42(1)      20(1)      40(1)       4(1)      21(1)      -3(1) 
    C(54)    32(1)      20(1)      25(1)       1(1)      12(1)      -2(1) 
    C(55)    18(1)      19(1)      16(1)       4(1)       3(1)       2(1) 
    C(56)    16(1)      20(1)      15(1)       3(1)       3(1)       2(1) 
    C(57)    18(1)      23(1)      19(1)       2(1)       3(1)       1(1) 
    C(58)    27(1)      24(1)      20(1)       0(1)       7(1)       6(1) 
    C(59)    22(1)      30(1)      24(1)       7(1)      12(1)       7(1) 
    C(60)    18(1)      24(1)      23(1)       6(1)       7(1)      -1(1) 
    C(61)    16(1)      24(1)      19(1)       3(1)       7(1)       2(1) 
    C(62)    16(1)      21(1)      16(1)       1(1)       4(1)       4(1) 
    C(63)    26(1)      15(1)      19(1)      -1(1)       9(1)      -1(1) 
    C(64)    23(1)      14(1)      18(1)      -1(1)       8(1)       2(1) 
    C(65)    16(1)      17(1)      16(1)       2(1)       5(1)       4(1) 
    C(66)    15(1)      14(1)      18(1)      -2(1)       4(1)       1(1) 
    C(67)    16(1)      15(1)      19(1)       0(1)       5(1)       0(1) 
    C(68)    20(1)      16(1)      18(1)       1(1)       6(1)       1(1) 
    C(69)    20(1)      19(1)      18(1)       2(1)       3(1)      -2(1) 
    C(70)    15(1)      24(1)      24(1)       1(1)       4(1)      -1(1) 
    C(71)    21(1)      32(1)      25(1)      -6(1)      10(1)       2(1) 
    C(72)    19(1)      30(1)      18(1)      -6(1)       5(1)      -1(1) 
    C(73)    14(1)      14(1)      30(1)      -4(1)       3(1)       0(1) 
    C(74)    19(1)      18(1)      39(1)       4(1)       7(1)       2(1) 
    C(75)    20(1)      19(1)      64(2)      12(1)       6(1)       1(1) 
    C(76)    20(1)      15(1)      87(2)      -1(1)      -2(1)       0(1) 
    C(77)    24(1)      24(1)      62(2)     -19(1)      -5(1)       3(1) 
    C(78)    20(1)      25(1)      38(1)     -12(1)       2(1)       1(1) 
    C(79)    18(1)      21(1)      14(1)      -2(1)       5(1)       3(1) 
    C(80)    20(1)      24(1)      16(1)      -2(1)       6(1)       2(1) 
    C(81)    33(1)      24(1)      20(1)       2(1)      13(1)       4(1) 
    C(82)    31(1)      37(1)      19(1)       7(1)       8(1)      12(1) 
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    C(83)    23(1)      42(1)      17(1)       0(1)       3(1)       7(1) 
    C(84)    20(1)      28(1)      18(1)      -1(1)       6(1)       2(1) 
    C(85)    18(1)      19(1)      15(1)       0(1)       8(1)       4(1) 
    C(86)    15(1)      22(1)      16(1)       2(1)       6(1)       1(1) 
    C(87)    21(1)      21(1)      21(1)       3(1)       9(1)      -1(1) 
    C(88)    21(1)      22(1)      17(1)       4(1)       6(1)       4(1) 
    C(89)    17(1)      26(1)      16(1)      -2(1)       4(1)       4(1) 
    C(90)    19(1)      21(1)      18(1)      -2(1)       5(1)       0(1) 
    C(91)    17(1)      21(1)      18(1)       0(1)       6(1)      -1(1) 
    C(92)    16(1)      18(1)      20(1)       0(1)       5(1)      -2(1) 
    C(93)    23(1)      17(1)      21(1)       2(1)       8(1)       3(1) 
    C(94)    22(1)      14(1)      19(1)       0(1)       7(1)       0(1) 
    C(95)    17(1)      15(1)      17(1)       1(1)       4(1)      -1(1) 
    C(96)    16(1)      16(1)      16(1)       1(1)       3(1)       1(1) 
    C(97)    17(1)      15(1)      20(1)      -2(1)       6(1)      -1(1) 
    C(98)    20(1)      18(1)      20(1)       1(1)       6(1)      -1(1) 
    C(99)    17(1)      23(1)      26(1)      -2(1)       4(1)       1(1) 
    C(100)   20(1)      23(1)      28(1)      -5(1)      11(1)      -5(1) 
    C(101)   26(1)      23(1)      25(1)       0(1)      12(1)      -3(1) 
    C(102)   22(1)      19(1)      21(1)       2(1)       6(1)       0(1) 
    C(103)   21(1)      16(1)      16(1)       1(1)       4(1)      -2(1) 
    C(104)   22(1)      19(1)      20(1)       1(1)       3(1)       0(1) 
    C(105)   21(1)      26(1)      24(1)       3(1)      -2(1)      -2(1) 
    C(106)   35(1)      27(1)      19(1)       0(1)      -1(1)      -8(1) 
    C(107)   37(1)      25(1)      20(1)      -2(1)      10(1)      -4(1) 
    C(108)   23(1)      22(1)      20(1)       1(1)       7(1)      -1(1) 
    C(109)   13(1)      15(1)      24(1)       0(1)       4(1)      -1(1) 
    C(110)   22(1)      21(1)      26(1)       1(1)       4(1)       1(1) 
    C(111)   26(1)      19(1)      43(1)       5(1)       2(1)       6(1) 
    C(112)   24(1)      18(1)      51(1)      -8(1)      10(1)       0(1) 
    C(113)   26(1)      23(1)      36(1)     -11(1)      13(1)      -4(1) 
    C(114)   20(1)      18(1)      26(1)      -2(1)       8(1)      -2(1) 
    C(115)   19(1)      18(1)      14(1)       3(1)       6(1)       0(1) 
    C(116)   15(1)      23(1)      16(1)       2(1)       5(1)       0(1) 
    C(117)   22(1)      23(1)      19(1)       0(1)       8(1)       1(1) 
    C(118)   23(1)      26(1)      18(1)      -1(1)       6(1)      -5(1) 
    C(119)   15(1)      27(1)      21(1)       6(1)       4(1)      -2(1) 
    C(120)   18(1)      23(1)      20(1)       6(1)       5(1)       3(1) 
    C(121)   24(1)      33(1)      38(1)      -1(1)       6(1)       0(1) 
    C(122)   26(1)      30(1)      40(1)      -4(1)       4(1)       2(1) 
    C(123)   40(1)      36(1)      40(1)       6(1)      15(1)      -2(1) 
    C(124)   54(2)      35(1)      34(1)       3(1)       9(1)      10(1) 
    _______________________________________________________________________ 
  
 
         Table 5.  Hydrogen coordinates ( x 10^4) and isotropic 
         displacement parameters (A^2 x 10^3) for sd40. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          H(2)         1991(15)      9750(40)      9350(12)      39(8) 
          H(4)         2654(15)      4680(40)      -267(12)      43(8) 
          H(6)         2544(16)       420(40)      5516(13)      48(9) 
          H(8)         2685(14)      5510(30)      5094(11)      35(7) 
          H(3A)         482         10648          9410          22 
          H(3B)         100          9483          9665          22 
          H(4A)        -196          9409          8609          21 
          H(5A)         760          7984          8447          20 
          H(8A)        -636          7343          9453          22 
          H(9A)       -1581          6836          9754          24 
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          H(10A)      -2466          5388          9257          25 
          H(11A)      -2434          4539          8428          25 
          H(12A)      -1514          5109          8110          23 
          H(14A)        653          5213          9304          23 
          H(15A)       1190          3037          9318          27 
          H(16A)        838          1542          8578          28 
          H(17A)        -59          2241          7832          28 
          H(18A)       -568          4441          7806          23 
          H(20A)      -1391          8281          8103          23 
          H(21A)      -1652          9580          7318          30 
          H(22A)      -1016          9265          6716          34 
          H(23A)        -90          7694          6923          32 
          H(24A)        210          6472          7730          25 
          H(27A)       1959          4893         10372          25 
          H(28A)       1464          4981         11072          26 
          H(29A)        782          6890         11154          25 
          H(30A)        565          8739         10544          23 
          H(33A)       4423          5251           185          26 
          H(33B)       4877          3914           120          26 
          H(34A)       4607          4109          1051          24 
          H(35A)       3449          2975           878          21 
          H(38A)       5235          3153          1940          24 
          H(39A)       4898          4273          2612          30 
          H(40A)       3822          3799          2725          32 
          H(41A)       3077          2201          2158          29 
          H(42A)       3424          1029          1505          25 
          H(44A)       5441          1843           611          26 
          H(45A)       6635          1537           815          32 
          H(46A)       7262           560          1627          38 
          H(47A)       6694          -103          2242          41 
          H(48A)       5511           253          2054          30 
          H(50A)       3928           -23           254          25 
          H(51A)       3413         -2230            61          33 
          H(52A)       3420         -3784           750          38 
          H(53A)       3963         -3127          1632          38 
          H(54A)       4446          -902          1827          30 
          H(57A)       2996          -301         -1029          25 
          H(58A)       3817          -477         -1492          28 
          H(59A)       4671          1234         -1376          29 
          H(60A)       4753          3123          -793          26 
          H(63A)       1077          -580          5519          23 
          H(63B)        458           534          5315          23 
          H(64A)       1071           501          6360          21 
          H(65A)       2105          2045          6492          20 
          H(68A)       -104          2836          5563          21 
          H(69A)      -1286          3308          5311          23 
          H(70A)      -1784          4349          5912          26 
          H(71A)      -1095          4846          6783          30 
          H(72A)         74          4280          7048          27 
          H(74A)       1245          4916          5779          30 
          H(75A)       1667          7208          5827          43 
          H(76A)       1847          8509          6606          54 
          H(77A)       1631          7499          7351          49 
          H(78A)       1240          5186          7317          35 
          H(80A)        299          1288          6926          23 
          H(81A)        751          -206          7648          29 
          H(82A)       1887            81          8196          35 
          H(83A)       2569          1862          8008          33 
          H(84A)       2130          3338          7276          26 
          H(87A)       1477          5470          4612          24 
          H(88A)        392          5309          3968          24 
          H(89A)       -246          3233          3876          24 
          H(90A)        154          1303          4429          23 
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          H(93A)       4079          4704          4651          24 
          H(93B)       4650          5930          4745          24 
          H(94A)       3691          5968          3799          22 
          H(95A)       2694          7246          3965          20 
          H(98A)       4935          8017          4336          23 
          H(99A)       6037          8493          4270          27 
          H(10F)       6170          9938          3588          28 
          H(10D)       5193         10848          2958          28 
          H(10B)       4095         10322          3007          25 
          H(10C)       2281          8829          3286          25 
          H(10G)       1573          7695          2536          30 
          H(10H)       2056          6395          1984          35 
          H(10I)       3256          6145          2210          33 
          H(10E)       3968          7268          2964          26 
          H(11E)       2997         10962          3066          29 
          H(11H)       2594         13127          3258          37 
          H(11I)       2691         13751          4136          37 
          H(11F)       3248         12237          4828          33 
          H(11G)       3683         10091          4644          26 
          H(11B)       3796         10271          5934          25 
          H(11D)       4981         10288          6379          27 
          H(11C)       5686          8500          6230          26 
          H(12B)       5248          6686          5626          25 
          H(12F)       7009          4537          3367          39 
          H(12G)       6990          4164          2766          39 
          H(12C)       6223          2677          3344          50 
          H(12D)       6918          2099          3250          50 
          H(12E)       6238          2285          2755          50 
          H(12H)       6527          6563          2550          45 
          H(12I)       6529          6751          3157          45 
          H(12J)       5304          6804          2272          63 
          H(12K)       5670          8183          2575          63 
          H(12L)       5329          7072          2878          63 
         ________________________________________________________________ 
  
 
 Table 6.  Hydrogen bonds for sd40 [A and deg.]. 
 ____________________________________________________________________________ 
  
 D-H...A                      d(D-H)      d(H...A)    d(D...A)    <(DHA) 
  
 O(2)-H(2)...O(3)#1           0.82(3)     1.92(3)     2.716(2)    163(3) 
 O(4)-H(4)...O(1)#2           0.86(3)     1.98(3)     2.741(2)    147(3) 
 O(6)-H(6)...O(7)#3           0.86(4)     1.86(4)     2.714(2)    170(3) 
 O(8)-H(8)...O(5)             0.86(3)     1.90(3)     2.713(2)    157(3) 
 ____________________________________________________________________________ 
  
 Symmetry transformations used to generate equivalent atoms: 
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